tsawon lokacin da aka fara bayyanar cututtukan?
kuma za a iya magance ciwon kirji ta wannan hanyar musamman a cikin shekaru masu zuwa.
da kuma samun zazzabi
kuma kana bukatar ka auna yawan karfin jini ta hanyar kwayar cutar cholesterol.
kana da zazzabi a yanzu?
kuna jin ciwon kirji a yanzu?
kana kuma da matsalar numfashi
Za ku iya gaya mani wasu alamun da kuke nunawa tare da wannan?
kuma yaya zafin jiki yake
kuma ina da tari
kuma ina da mura ina tari
kuma ina da ciwon kirji mai tsanani
kuma wannan shine lokacin da kuka fi dacewa da cutar mura ta ƙura da ƙurar da ke fitowa daga tsire-tsire
kuma yana haifar maka da ciwon kirji
kuma ina ganin ina da zazzabi kadan.
kuma ina so ka bayyana inda kake jin ciwon a kirji
kuma suna da zazzabi kadan
da kuma ciwon sukari
kuma kun san ina jin kirji na kamar zai fashe
kuma ka san mutane suna yi min ba'a a koyaushe
kuma kana da ciwon kirji
kuma ka ce wannan yana ciwo a kirjinka
wani a cikin iyalinka yana da ciwon zuciya ciwon zuciya ciwon zuciya ciwon zuciya mai tsanani high jini
Shin kuna da wasu alamun ko matsalolin ciwon jijiyoyin jiki?
akwai wasu mutane a cikin iyali da ke fama da irin wannan cutar da ke nuna alamun cutar?
kuna da wasu alamun cutar?
kuna jin cewa akwai rashin jin daɗi?
kana ci gaba da jin ciwo a kirji
saboda wannan shine lokacin da mutane ke kamuwa da mura
amma kuma ba za mu iya watsi da ciwon kirji ba wanda ke haifar da ciwon zuciya
amma mafi muhimmanci matsalar a yanzu shine ciwon kirji.
amma ina da matsalar numfashi
amma na san mutane da yawa sun yi mini ba'a
amma muna bukatar mu magance duk wani ciwon kirji da cikakken iko.
amma kana numfashi daidai a wannan lokacin?
'Gama na manta da wannan ciwon kirji gaba daya.
kana jin kamar wani yana matsa maka a kirji
har yanzu kana jin kamar akwai iska a cikinka
Shin suna kokawa game da rashin lafiya da ke nuna alamun cutar?
Shin kuna da wani ciwo mai tsanani kamar hawan jini ko wani irin ciwo?
kuna da wasu matsalolin kiwon lafiya na yau da kullun kamar ciwon sukari?
Shin akwai rashin numfashi tare da wannan ciwon kirji?
kana da hawan jini?
Shin akwai wani abu da zai iya kawo wannan?
Shin ka san alamun da ke nuna hakan?
Kuna ganin hoton?
sha da yawa yau
amma ina daukar gwajin ciwon sukari.
duk da haka yana da alamun bayyanar cututtuka kamar yadda na sani
Yaya zafin jikinka yake?
Yaya karfin jini naka yake?
ci gaba da samun zazzabi mai tsanani
idan kana da zazzabi na digiri talatin da takwas da rabi ko sama da haka
idan kuna ganin alamun ku da matsalolin ku sun tabbatar da cewa kuna da kyau
jiya na kamu da zazzabi
Ni ma na samu zazzabi kadan.
jiya ina da zazzabi
Ina da ciwo mai tsanani a nan cikin kirji.
Ina da matsalar numfashi.
Zan aiko maka da hoto.
yau ina da ciwon kirji
yau ciwon kai kawai nake da shi da zazzabi
Ina tsammanin mura ce.
Ina tsammanin mura ce mai laushi.
Ina jin kamar wani mai nauyi yana zaune a kirjina?
duk ya fara da ciwon kai da zazzabi a lokaci guda
Ina jin zafi a tsakiyar kirji.
yana ci gaba da zama kamar ciwon kirji
a cikin kirji na
Yana tsakiyar kirji na
Yana tsakiyar kirji na
Ina jin zafi a kirji.
Ina da matukar damuwa game da ciwon kirji na yanzu.
Ina so ki gaya min da kuma bayyana min wannan ciwon kirji.
kamar hawan jini ko ciwon sukari
kamar tsakiyar dama a kirji
yanzu kana da zazzabi na amfana da parasitamoro mai dadi
Mary, kwana nawa ne yanzu da kake da alamun cutar?
yanzu kun ce kuna da ciwon kirji
wani lokacin ina jin zafi a kirji
To, shin akwai wasu alamun da kake nunawa da kuma rashin lafiya banda ciwo?
ko kuwa kana jin kamar mutum yana zaune a kan kirjinka?
da kyau kamar wuta ne da ciwon kai da ciwon jijiya.
a tsakiyar dama a kirji
Nuna mini a wannan hoton inda kake jin zafi
daga zazzabi
don haka kuna tsammanin wasu daga cikin waɗannan alamun zasu iya zama masu alaƙa da ciki?
shin yaranku suna da irin wannan alamun?
Ka faɗa mini game da ciwon kirjinka
wuta tana ƙaruwa da dare
Na yi zazzabi kwana biyu da suka gabata
Wuta ta fara ƙaruwa a daren jiya
Wannan shi ne Dr. Porter wanda ke aiki a cibiyar da ake daukar marasa lafiya zuwa sashen kulawa mai tsanani.
Za ka iya gaya mani dalla-dalla game da ciwon kirjinka?
shi ne lokacin da nake jin zafi a cikin jikina a cikin kirji
shi ne abin da na sha wahala a lokacin da na ji zafi mai tsanani a kirji
haka ne idan ina da wannan ciwon kirji
wane irin ciwo kake da shi a kirjinka?
yaushe wannan ciwon kirji ya fara?
wane ne ke da ciwon kirji?
ina jin wannan ciwon kirji da yake ɓoye a cikin kirji t
kamar kirjinka ya yi tsalle.
Na san ina da ciwon sukari da dai sauransu.
ka ce kana jin wannan ciwon kirji
Adadin cututtukan da ke tattare da cutar coronavirus (COVID-19) ya karu cikin sauri a cikin EU/European Economic Area da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Adadin yawan masu kamuwa da cutar coronavirus (COVID-19) a kowace ƙasa ta EU/EEA da Burtaniya ya nuna cewa, duk da bambancin yanayi tsakanin ƙasashe, cutar COVID-19 tana yaduwa cikin sauri a duk ƙasashe.
Bisa ga abin da ya faru a Italiya, jihohi, asibitoci da cibiyoyin kulawa da gaggawa suna buƙatar ƙarin shiri don karɓar yawan adadin marasa lafiya na COVID-19 da za a buƙaci kulawa, musamman a cikin kulawa mai tsanani.
A ranar 31 ga Disamba, 2019, an gano wasu mutane da ke fama da cutar sankarar bargo a Wuhan, Lardin Hubei, China.
A ranar 9 ga Janairun 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta kasar Sin ta bayyana cewa an kamu da cutar coronavirus ta biyu da aka sani da SARS-CoV-2.
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Bayanai na yanzu sun nuna cewa kusan kashi 80% na mutanen da ke kamuwa da COVID-19 suna fama da rashin lafiya mai sauƙi, wato, cututtukan numfashi tare da ko ba tare da cutar sankarar bargo ba, kuma yawancin suna murmurewa.
A cikin kusan kashi 14 cikin ɗari na marasa lafiya, COVID-19 yana haifar da mummunan rashin lafiya wanda ke buƙatar asibiti yayin da kusan kashi 6 cikin ɗari na marasa lafiya ke ci gaba da rashin lafiya wanda ke buƙatar kulawa a cikin ɗakunan gaggawa.
Yawan mutuwar marasa lafiya a asibiti daga COVID-19 ya kai kusan 4%.
A cikin wannan binciken, mun bincika jimlar adadin masu kamuwa da COVID-19 a kowace ƙasa ta Tarayyar Turai/EEA da Ingila (UK) kuma mun kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta yawan adadin masu cutar COVID-19 a cikin EU/EEA da UK da na Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Cutar COVID-19 a cikin EU/EEA da UK
Bayan China, COVID-19 ya ci gaba da yaduwa zuwa wasu ƙasashe kuma ana samun ci gaba a cikin yaduwar cutar COVID-19 a duk faɗin duniya.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar Eurosurveillance 2020 na 5 ga Maris, Spiteri da abokan aikinsa sun ba da rahoton ƙididdigar farko na tabbatar da cutar COVID-19 a Turai bisa ga ma'anar WHO.
A cikin EU/EEA, an tabbatar da farko uku daga Faransa a ranar 24 ga Janairu 2020 a cikin mutanen da suka dawo daga Wuhan, Lardin Hubei, China.
Tun daga ranar 15 ga Maris, 2020, an sami wasu cututtukan COVID-19 a cikin dukkan ƙasashe 30 na EU/EEA da Ingila (UK), wanda ya haifar da 39,768 da mutuwar 1,727, daga cikinsu 17,750 da mutuwar 1,441 a Italiya kadai.
Don gano yawan adadin masu cutar COVID-19 da kuma yadda yake yaduwa gaba ɗaya
A Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC), ana ba da rahoton ƙididdigar cutar COVID-19 ta kowace ƙasa a duniya, wanda aka samo daga tushe mai tushe kamar Ma'aikatar Lafiya, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, ana sabunta su kowace rana da ƙarfe 8:00.
An yi amfani da wannan bayanan don nazarin halin da ake ciki na yawan masu cutar COVID-19 a cikin EU/EEA da UK, da kuma kwatanta su da na Italiya.
Don nuna halin da ake ciki na yawan masu cutar COVID-19, mun tattara adadin masu cutar COVID-19 na kwanaki 14, don haka muna mai da hankali kan yanayin yaduwar COVID-19 a cikin kowace ƙasa ta EU/EEA da Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma nuna adadin masu kamuwa da cutar a kowace ƙasa da aka bayar a ranar 15 ga Maris, 2020 da ƙarfe 8:00 na dare idan aka kwatanta da Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Matsayin yawan masu kamuwa da COVID-19 a cikin EU/EEA da UK
Adadin adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da Burtaniya a cikin kwanaki 14 ya kasance daidai da na lardin Hubei, China (Figure 1).
Gabaɗaya a cikin EU/EEA da UK, lambobin COVID-19 sun fara tashi a kusan 21 ga Fabrairu sannan kuma sun tashi sama a kusan 28 ga Fabrairu, 2020 (Ƙarin Bayani).
Wannan ya fi yawaita ne saboda karuwar yawan masu cutar a Italiya, amma duk sauran ƙasashen EU/EEA da UK sun sami karuwar adadin masu cutar COVID-19 (Ƙarin Bayani).
Hoto na 2 ya nuna kimanin adadin masu cutar COVID-19, a cikin EU/EEA da UK da Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya nuna cewa, a ranar 15 ga Maris da ƙarfe 8:00, sauran ƙasashe 15 na EU/EEA da Burtaniya sun riga sun ba da rahoton jimlar adadin masu cutar kamar Italiya a makonni 3 da suka gabata ko ƙasa da haka.
Sakamakon bincikenmu ya nuna cewa adadin sabbin cututtukan COVID-19 zai karu cikin sauri a cikin EU/EEA da UK.
Canje-canje a cikin yawan adadin masu cutar COVID-19 ya nuna cewa cutar tana yaduwa daidai a duk ƙasashe.
Wannan ya kasance duk da bambancin matakan gwaji na ƙasa, daidaitaccen tsarin kiwon lafiya, da bambancin yanayin cutar daga ƙasa zuwa ƙasa, da kuma bambancin ladabi don zaɓar waɗanda za a gwada don tabbatar da cutar COVID-19, gami da gwajin waɗanda ba su yi ba.
A farkon watan Maris na 2020, likitoci a yankunan da ke fama da cutar a Italiya sun ba da rahoton cewa kusan kashi 10% na masu cutar COVID-19 suna buƙatar kulawa a dakunan gaggawa kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da dakunan gaggawa a waɗannan yankuna sun riga sun karɓi adadi mai yawa.
Bayanai kan asibitocin COVID-19 ko wuraren kulawa na gaggawa a halin yanzu suna samuwa a matakin EU/EEA a halin yanzu a cikin kashi 6% da 1% na masu cutar (ba a nuna bayanai ba).
Koyaya, dole ne a tattara su sosai don tattara bayanai game da marasa lafiya da ake bi a halin yanzu waɗanda ke mai da hankali kan adadin ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddigar ƙiddig
Binciken 201011 ya nuna cewa akwai ɗakunan kulawa da gaggawa da na marasa lafiya masu sauƙi a Turai, daga gadaje 29.2 a Jamus zuwa 4.2 ga kowane mutum 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙarancin kayan aiki fiye da Italiya (sun sami gadaje marasa lafiya 12.5 ga kowane mutum 100,000 a 201011).
A cikin sabon fasalin na shida na ECDC Rapid Review of COVID-19 Challenges, an ba da misalai na yawan marasa lafiya da ke cikin kulawa, tare da kimantawa ga kowane memba na EU/EEA da UK na yawan marasa lafiya na COVID-19 da ke asibiti da kusan kashi 90% na yawan gadajen ICU.
Tunda har yanzu wasu yankuna a cikin EU/EEA da UK ne ke da mafi yawan marasa lafiya, kuma asibitoci da dakunan jinya galibi suna karɓar mutane daga takamaiman yanki, yakamata a sami bayanan marasa lafiya da gadajen jinya a cikin ƙididdigar yanki na 2 (NUTS-2).
Misali daga Italiya da kuma yanayin da ake ciki a wasu ƙasashe ya nuna cewa annobar COVID-19 tana yaduwa cikin sauri a cikin EU/EEA da UK.
Saboda haka, ƙasashe, asibitoci da cibiyoyin kulawa da gaggawa dole ne su kasance a shirye don ci gaba da yaduwar cutar SARS-CoV-2 a cikin al'umma tare da karuwar yawan masu cutar COVID-19 da ke neman kulawa, musamman a cikin masu ciwo mai tsanani, kamar yadda yake a yankunan da cutar ta shafa a Italiya.
Kamar yadda aka nuna a cikin sabon binciken gaggawa na ECDC, yana da mahimmanci a yi amfani da saurin aiki da kuma matakan farko na duniya don hana yaduwar SARS-COV-2, don haka yin amfani da hanyoyin kariya maimakon zama a gida, saboda ƙaruwar yawan masu cutar da ake tsammani na iya hana masu yanke shawara da ma'aikatan asibiti damar yin nazari, fahimtar juna da kuma aiwatar da matakan da suka dace idan ba a dauki matakin da ya dace ba.
Binciken gaggawa na matsala yana nuna matakan kiwon lafiyar jama'a don rage tasirin cutar.
Akwai wasu ƙananan damar da ƙasashe za su iya amfani da su don haɓaka matakan da suke ɗauka don rage yaduwar SARS-CoV-2 da tasirinsa ga tsarin kiwon lafiya.
Idan ba a yi hakan ba, cibiyoyin kiwon lafiya a wasu ƙasashen EU/EEA na iya fuskantar ƙaruwar yawan marasa lafiya a cikin kwanaki ko makonni masu zuwa.
Cutar annobar coronavirus ta 2019 (COVID-19), wacce cutar coronavirus ta 2 (SARS-CoV-2) ke haifarwa, ta riga ta kashe mutane sama da 3,000 kuma ta kamu da mutane sama da 80,000 a China da sauran sassan duniya, wanda hakan ya zama bala'i ga ɗan adam.
Kamar sauran ƙwayoyin cuta masu kama da su, SARS-CoV, wanda ya haifar da mummunan mura (SARS) a cikin dubban mutane a 2003, SARS-CoV-2 ana iya yada shi ta hanyar kwari kuma yana da alamun bayyanar cututtuka iri ɗaya.
Amma COVID-19 ba ta da haɗari da kisa kamar SARS duk da cewa tana saurin yaduwa kuma tana shafar tsofaffi fiye da matasa kuma tana shafar maza fiye da mata.
Saboda yawan adadin rahotanni game da wannan sabon cuta, wannan takaddar tana ƙoƙari ta samar da cikakken bincike mai amfani game da wannan batun da ake ci gaba da bincike.
Muna mai da hankali kan mahimman bayanai kamar ilimin cutar, abin da ke haifar da ita, cutar, yadda ake tantancewa, magani, yaduwa da rigakafi.
Ko da yake har yanzu akwai tambayoyi da yawa da za a amsa, muna fatan wannan gwajin zai taimaka wajen ganowa da kuma kawar da wannan cuta mai haɗari.
Bikin bazara na 25 ga Janairu, 2020 ya zama tarihi ga duk Sinawa da aka umarce su da su zauna a gida a duk lokacin hutu da kuma makonni masu zuwa saboda annobar sabuwar cutar.
Wannan kwayar cutar tana da kamanceceniya da kwayar cutar coronavirus (CoV) wacce ta haifar da mummunar cutar mura (SARS) a 2003; kuma Hukumar Lafiya ta Duniya (WHO) ta sake masa suna SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma an sake kiran cutar da ke haifar da cutar COVID-19 (COVID-19).
Cutar ta fara ne a Wuhan, China, kuma ta bazu zuwa duk ƙasar da kuma kusan ƙasashe 50 a duniya.
A ranar 2 ga Maris, 2020, sama da mutane 80,000 sun sami tabbacin kamuwa da cutar COVID-19, wanda sama da 40,000 aka sallama kuma sama da 3,000 sun mutu.
Hukumar Lafiya ta Duniya ta yi gargadin cewa COVID-19 shine babban makiyi na duniya kuma yana iya zama mafi haɗari fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga labarai sama da 200 game da COVID-19 wanda ya haɗa da cutar da ke haifar da ita, cutar, asalinta, bincike da magani tun lokacin da aka buga rahoton farko a ranar 7 ga Janairu 2020 wanda ya bayyana yanayin kwayar cutar da aka gano a cikin marasa lafiya daban-daban.
Wannan bita yana ƙoƙari ya taƙaita binciken da aka riga aka yi akan wannan sabon abu kuma babban bincike.
A duk lokacin da zai yiwu, za mu yi ƙoƙarin kwatanta COVID-19 da SARS da kuma wasu cututtukan da ke haifar da CoV, kamar cutar mura ta Gabas ta Tsakiya (MERS, wanda aka gano a cikin 2012).
Za mu sake nazarin darussan da muka koya har zuwa yanzu game da hana yaduwar cutar da gano musabbabinta da kuma wasu mahimman tambayoyin da ba a amsa ba.
Kwayoyin cutar CoVs, waɗanda aka fi ɗauka a matsayin ƙwayoyin cuta marasa mutuwa, suna da ƙarancin cutar ta 4 na mafi yawan cututtukan mura a kusan kashi 15 cikin ɗari.
Duk da haka, a cikin wannan karni, mun sami ɓarkewar CoVs biyu masu saurin kamuwa da mutane, SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar cutar a China a 2003 da Saudi Arabiya a 2012, sannan daga baya suka bazu zuwa wasu ƙasashe da yawa tare da yawan kamuwa da cuta da mutuwa.
Saboda haka, COVID-19 na yau shine annoba ta uku ta CoV a tarihin ɗan adam.
Kamar yadda aka nuna a cikin Hoto Hoto 1.1, an fara samun cutar sankarar bargo a Wuhan a ranar 31 ga Disamba, 2019 lokacin da aka sanar da Hukumar Lafiya ta Kasa ta kasar Sin.
Bayan kwana bakwai, an buga takaddun da ke bayyana yanayin CoV.
Mutum na farko da ya mutu a Wuhan ya bayyana a ranar 15 ga Janairu, 2020.
A halin yanzu, annobar ta bazu cikin sauri zuwa wasu biranen, larduna da ƙasashe makwabta.
A ranar 20 ga Janairu, an sanar da cewa wasu likitoci sun kamu da cutar, wanda ke nuna cewa mutane na iya kamuwa da cutar.
A ranar 23 ga Janairu, an sanya birnin Wuhan cikin keɓewa kuma an dakatar da duk hanyoyin sufuri.
A ranar 24 ga Janairu, binciken farko na likita game da cutar ya nuna cewa daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka isa kasuwar kayan abincin teku ta Wuhan inda ake zargin cewa wata dabba ce ta haifar da cutar.
A ranar 30 ga Janairu, WHO ta ayyana cutar a matsayin bala'in kiwon lafiya na duniya.
A lokacin da aka buga wannan rahoton, cutar ta riga ta bazu ko'ina cikin China da wasu ƙasashe kusan 50 a duniya (Hoto (Hoto 2).2).
Saboda saurin yaduwar cutar, yana da wahala a tantance iyakar cutar da tasirin ta.
A ranar 11 ga Fabrairu, 2020, binciken cibiyoyi daban-daban na marasa lafiya 8,866 ciki har da 4,021 da aka tabbatar da cutar COVID-19 ya ba da cikakken hoto game da halin da annobar ke ciki a shafin yanar gizon (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Mutane da ke fama da cutar SARS-CoV-2 suna da shekaru daban-daban, amma sun fi yawaita tsakanin shekaru 30 zuwa 65.
Kusan rabin (47.7%) na masu kamuwa da cutar sun haura shekaru 50, kaɗan kaɗan sun kasance ƙasa da 20, kuma mutane 14 kawai ke ƙarƙashin shekaru 10.
Maza sun fi kamuwa da SARS-CoV-2 (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya bazu musamman a Hubei da yankunan da ke kewaye da shi.
A matsakaita, lokaci tsakanin bayyanar COVID-19 da lokacin da aka gano cutar ya kai kwanaki 5 (2-9).
A matsakaita, ya ɗauki kwanaki 4.8 (3.0-7.2) kafin ya fara nuna alamun cutar.
Matsakaicin mutuwar mutum na farko ya kasance 9.5 (4.8-13) tun lokacin da aka gano shi.
Ƙididdigar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar ƙimar
Yawan masu kamuwa da cutar ya karu sosai kafin 23 ga Janairu, 2020, daidai da lokacin da yawancin mutane ke tafiya kafin bikin bazara na kasar Sin.
Adadin tabbatar da cutar ya kasance 1.44% (95% CI: 1.10-1,86%), kuma yawan mutuwar a cikin yawan marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Babban haɗarin COVID-19 guda uku sune jinsi (maza), shekaru (≥60), da kuma matsanancin cutar huhu.
Kwayoyin cuta na CoVs babban nau'in ƙwayoyin cuta ne waɗanda ke da ƙwayoyin RNA guda ɗaya.
Ana iya rarraba su zuwa nau'ikan guda huɗu, alpha, beta, gamma, da delta. A cikin waɗannan nau'ikan, ƙwayoyin cuta na CoVs na alpha da beta sune mafi saurin kamuwa da mutane.
A cikin SARS-CoV da MERS-CoV, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Ana gano RNA na kwayar cutar kuma ana shigar da shi cikin kwayar halitta; bayan kwayar cutar ta kwayar halitta ta kwayar halitta, RNA na kwayar halitta tare da glycoproteins da ƙwayoyin nucleocapsid suna samar da ƙwayoyin cuta waɗanda ke haɗuwa da ƙwayoyin plasma don samar da kwayar cutar.
An gano tsarin halittar SARS-CoV-2 na farko a ranar 10 ga Janairu, 2020.
SARS-CoV-2 an gano sabon nau'in beta-CoV wanda ya dace da kwayoyin halittar 99,98% a cikin kwayoyin halitta 10 da aka kama a farkon barkewar cutar a kasuwar kayan kifin Huanan da ke Wuhan.
SARS-CoV-2 yana da kwayoyin halitta da suka fi kama da SARS-CoV fiye da MERS-CoV.
A cikin microscope na lantarki don nazarin yaduwar cutar, an gano ɓangarorin SARS-CoV-2 a cikin ɓangarorin da suka lalace sosai na epithelium na numfashi na mutum.
A cikin mutane, an gano cewa kwayar cutar ACE2 tana da tasiri a cikin SARS-CoV-2 da SARS-CoV.
Amma furotin S na SARS-CoV-2 yana haɗuwa da kwayar halittar mutum ta ACE2 a hankali fiye da SARS-CoV, wanda ya dace da ra'ayin cewa SARS-CoV-2 yana kamuwa da marasa lafiya da ƙarancin cutar fiye da SARS-CoV.
SARS-CoV-2 na iya zama sabon ɗan gajeren furotin da aka samar ta hanyar furotin orf3b da furotin da aka gano wanda aka samar ta hanyar furotin orf8.
Bayan haka, a cikin SARS-CoV-2 an gano cewa cutar ta kamu da cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar.
A ranar 18 ga Fabrairun 2020, Zhou da abokan aikinsa sun ba da rahoton samfurin microscopy na lantarki wanda ke amfani da yanayin zafi mai ƙarancin zafi (cryo-EM) na cikakken ƙwayar ACE2 na mutum a ma'aunin 2.9 Å a cikin tsarin amino acid B0AT1.
An gano cewa wannan sarkar, tare da fasalin buɗewa da rufewa, an haɗa ta a matsayin nau'i biyu kuma tsarin ACE2-B0AT1 na iya haɗa sunadarai biyu na S, wanda ke nuna alamun bayyanar cutar CoV.
B0AT1 na iya kasancewa cikin gwajin maganin rigakafin SARS-CoV-2.
Dabbar da aka samo asali daga ita ta fara kamuwa da cutar
An san cewa SARS-CoV da MERS-CoV duka sun samo asali ne daga bera kuma daga nan ne aka yada su ga mutane ta hanyar ƙudaje da raƙuma.
Ta hanyar kwatanta asalin SARS-CoV-2 da sauran CoVs, an gano cewa kwarkwata ce asalin SARS-CoV-2 saboda sabon kwayar cutar tana da kusan kashi 96% na kama da kwayar cutar SARS guda biyu da ke da alaƙa da kwarkwata bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma dabba da ta fara kamuwa da cutar ta taimaka wa kwayar cutar ta kamu da mutane har zuwa lokacin da ba a san yadda za ta iya yaduwa ba, kuma ba a san yadda za ta iya yaduwa ba.
Ji da abokan aikinsa sun ce maciji na iya zama tushen kamuwa da cutar ga mutane ta hanyar kwari da ke haifar da ɓoyewar S-protein.
A cewar binciken, masu bincike a Guangzhou, China, sun ce ƙwari, dabbobi masu shayarwa masu ƙarancin ƙwari waɗanda likitocin gargajiya ke amfani da su a China, na iya zama farkon masu kamuwa da SARS-CoV-2 saboda kusan 99% na kamawar kwayoyin halitta da aka gano a cikin kwayar cutar CoV na ƙwari da SARS-CoV-2.
Duk da haka, bambancin kashi 1% a cikin kwayoyin halittar biyu har yanzu yana da girma; don haka ana jiran sakamakon da ke ba da tabbaci (Fig. 33).
Yawancin halaye na SARS-CoV-2 ba a san su ba tukuna.
Kwayoyin SARS-CoV da MERS-CoV na iya rayuwa na tsawon awanni 48 a cikin yanayin zafi, har zuwa kwanaki 5 a cikin yanayin zafi na yau da kullun ƙasa da 20 ° C da zafi tsakanin 40% da 50%.
SARS-CoV-2 na iya samun halaye iri ɗaya.
An tabbatar da cewa SARS-CoV-2 ba ya jure wa hasken rana da zafin jiki na 56 ° C na minti 30; ether, ethanol 75%, kayan tsabtace jiki waɗanda ke ɗauke da chlorine, peracetic acid, chlorophorum, da sauran abubuwan da ke cikin mai, amma ba corregisin ba, waɗanda zasu iya kashe kwayar cutar yadda ya kamata.
A cikin yanayin, yawancin mutane ba su da kariya ga SARS-CoV-2 kuma suna da saukin kamuwa da sabon kwayar cutar.
A halin yanzu, babu wani bincike mai zurfi game da yadda jiki yake jurewa SARS-CoV-2.
Saboda haka, muna amfani da binciken da aka yi a baya kawai akan wasu ƙwayoyin cuta na CoV, musamman SARS-CoV da MERS-CoV (Draw (Draw 4).4).
A mafi yawan lokuta, bayan kamuwa da cutar, ƙwayar cuta tana gano ta ta hanyar masu karɓar ƙwayar cuta (PRR) waɗanda suka haɗa da masu karɓar regitins na C, masu karɓar TLR, masu karɓar NLR da masu karɓar RLR.
A cikin hanyoyi daban-daban, kwayar cutar tana haifar da zazzabi, kumburi na ƙwayoyin cuta, da kuma tarin ƙwayoyin cuta na I (IFN) waɗanda aka ƙirƙira don magance cutar wanda ke rage yaduwar kwayar cutar da kuma sake haifar da cutar.
Duk da haka, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta zama mai hana rigakafi.
Bayan ɗan lokaci, tsarin rigakafin jiki ya fara yin tsayayya da kwayar cutar.
Kwayoyin T sun hada da CD4+ da CD8+ T cells wadanda ke taka muhimmiyar rawa wajen kare jiki.
Kwayoyin CD4+ T suna ƙarfafa ƙwayoyin B don samar da ƙwayoyin cuta waɗanda zasu iya hana cutar, sannan ƙwayoyin CD8+ T suna kashe ƙwayoyin cuta.
Kwayoyin T masu taimakawa suna samar da cytokines masu taimakawa don taimakawa kare kwayoyin.
Amma CoVs na iya lalata aikin T-cell wanda ke haifar da mutuwar T-cell.
Tsarin rigakafi na jini wanda ya ƙunshi masu haɗuwa kamar C3a da C5a da kuma rigakafi suna da amfani wajen magance kamuwa da ƙwayoyin cuta.
Alal misali, an cire ƙwayoyin cuta daga mai haƙuri wanda ya warke daga cutar MERS-CoV.
Ƙari ga haka, yawan ƙwayar cuta tana sa ƙwayoyin jiki su yi yawa kuma hakan yana iya sa huhu da sauran gabobin jiki su lalace sosai, kuma wasu gabobin jiki su daina aiki, har ma su mutu.
SARS-CoV-2 ya kamu da cutar a cikin farkon kamuwa da cutar, wanda ya fi shafar tsofaffi da ke fama da wasu cututtuka da yawa da kuma mata masu ciki.
Sau da yawa, mutanen da ke da ƙwayoyin cuta da yawa ko kuma waɗanda ke da rashin lafiyar jiki suna da haɗarin kamuwa da cutar fiye da sauran mutane.
Matsakaicin lokacin SARS-CoV-2 kafin bayyanar cututtuka yana tsakanin kwanaki 1 zuwa 14, kuma mafi yawan lokuta tsakanin kwanaki 3 zuwa 7 bisa ga nazarin 425 na farko a Wuhan.
Koyaya, binciken marasa lafiya 1,099 ya nuna cewa tsawon lokacin bayyanar cututtuka shine kwanaki 3 gaba ɗaya kuma yana tsakanin 0 zuwa 24 days.
Wani bincike na kwanan nan, kamar yadda aka ambata a sama, ya nuna cewa tsawon lokacin bayyanar cututtuka shine kwanaki 4.8 (3.0-7.2) dangane da ƙididdigar marasa lafiya 8,866.
Yana da mahimmanci ga hukumomin kiwon lafiya su tsara lokacin keɓewa daidai gwargwado dangane da ainihin lokacin da ake buƙata don bayyanar cututtuka, don haka hana mutane masu cutarwa amma marasa alamun cutar daga cutar wasu.
A al'adance, ana buƙatar keɓewar kwanaki 14 ga mutanen da ke da alaƙa da cutar ko waɗanda ke da kwayar cutar.
Idan aka kara wa'adin killacewa zuwa kwanaki 24?
Yawan zazzabi shine farkon alamun COVID-19, wanda zai iya kasancewa babu wata alama ko kuma ya kasance tare da wasu alamun kamar tari mai zafi, wahalar numfashi, ciwon gida, zazzabi, ciwon kai, ciwon makogwaro, mura mai yawa, ciwon kirji, fitsari, zawo da amai.
Wasu marasa lafiya sun sami wahalar numfashi ko ƙarancin iskar oxygen a cikin jini mako guda bayan kamuwa da cutar.
Marasa lafiya masu tsanani sun sami ciwo mai tsanani na numfashi, ƙananan jini, cututtukan acidic da haemorrhage.
Marasa lafiya da ke da zazzabi ko alamun zazzabi mai tsanani, koda kuwa ba su da wata cuta ta huhu, ya kamata a fara gwada su don cutar a farkon lokacin.
Binciken ƙididdigar marasa lafiya a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cutar ya kasance 98% na zazzabi, 76% na tari mai zafi, 55% na matsalolin oxygen da 3% na zazzabi; 8% na marasa lafiya da ke buƙatar na'urar numfashi.
An sami irin wannan binciken a cikin binciken biyu na kwanan nan akan kamuwa da cutar cikin iyali da kuma kamuwa da cutar ta hanyar marasa alamun cutar.
Kamar wannan binciken, binciken da aka yi a cikin 2012 na masu kamuwa da cutar ya nuna cewa masu cutar MERS-CoV sun sami zazzabi (98%), tari mai zafi (47%) da rashin iskar oxygen (55%) a matsayin alamun farko.
Amma kashi 80% na masu buƙatar na'urar numfashi sun fi na COVID-19 da yawan mutuwar MERS fiye da COVID-19.
Ana kuma lura da zawo (26%) da ciwon makogwaro (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, zazzabi (99%-100%), tari mai tsami (29%-75%), matsalolin iskar oxygen (40%-42%), zawo (20-25%) da ciwon makogwaro (13-25%) an lura da su a matsayin manyan alamun bayyanar cututtuka tare da kusan 14%-20% na marasa lafiya da ke buƙatar na'urar numfashi.
A ranar 14 ga Fabrairu, yawan mutuwar COVID-19 ya kasance 2% lokacin da aka tabbatar da cutar a duniya ya kai 66,576.
Kamar dai da wannan kwayar cutar, yawan mutuwar SARS ya kai kashi 10% na mutane 8,096 da aka tabbatar a watan Nuwamba 2002.
A cikin MERS, bisa ga binciken kamuwa da cutar a watan Yunin 2012, yawan mutuwar ya kai kashi 37% na mutane 2,494 da aka tabbatar da cutar.
A cikin binciken da aka yi a baya, ƙimar ƙwayoyin cuta na asali (R0) don SARS-CoV-2 ya kasance mafi girma daga 6.47, ƙimar ƙwayoyin cuta na 95% (CI) ya kasance 5.71-7.23, yayin da R0 don SARS-CoV kawai ya kasance tsakanin 2 da 4.
Kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamun cututtuka, yawan mutuwa da R0 an nuna su a cikin tebur Tebur 1.1.
A cikin waɗannan lokuta, cutar SARS-CoV-2 tana da ƙarancin kisan gilla fiye da MERS-CoV da SARS-CoV.
A cikin wannan yanayin, cutar SARS-CoV-2 ta fi ƙarfin kamuwa da cutar MERS-CoV da SARS-CoV.
Sau da yawa masu fassara suna bayyana a cikin iyali ɗaya ko taro ɗaya ko motar ɗaya kamar jirgin ruwa da suke tafiya.
Sau da yawa, masu cutar suna tafiya ko zama a lardin Wuhan ko wasu yankuna da ke fama da cutar ko kuma sun kasance cikin hulɗa da masu cutar ko marasa lafiya a cikin makonni biyu da suka gabata kafin kamuwa da cutar.
Koyaya, an gano cewa mutane na iya kamuwa da cutar ba tare da alamun cutar ba har tsawon makonni biyu kuma marasa lafiya da suka warke kuma aka sallame su daga asibiti na iya ci gaba da kamuwa da cutar, wanda ke nuna buƙatar ƙara lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin farin jini (musamman ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Misali, mafi ƙarancin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Matsayin ƙwayoyin cuta da ƙwayoyin cuta sun ƙaru a cikin jini a cikin wasu marasa lafiya, kuma tarin sunadarai da ake kira erythroid sun ƙaru a cikin jini a cikin yawancin marasa lafiya.
A cikin marasa lafiya masu tsanani, yawan D-dima, cutar fibrin da ke cikin jini, ya karu, kuma yawan kwayoyin halitta ya ragu.
Matsalolin da ke tattare da karɓar allurar kirji suna faruwa a yawancin masu cutar COVID-19 kuma ana nuna su ta hanyar ɓoyayyen ɓoyayyen ɓoye ko ƙarancin ƙwayar cuta (GGO) na huhu.
Sau da yawa marasa lafiya suna da hauhawar jini, cututtukan huhu da kuma mummunan cututtukan numfashi (ARDS).
A cikin yanayin ciwon numfashi mai tsanani (ARDS), zafin jiki, tarin ruwa da kuma zubar da huhu suna haifar da rikicewar iska.
Rashin aiki na nau'ikan pinemosites na I da II yana rage yawan ƙwayoyin da ke rage sararin samaniya tsakanin jini kuma yana sa ƙwayoyin suyi koyi da su, don haka rage ƙarfin huhu don yin aiki kuma ƙara haɗarin rashin aiki.
Saboda haka, mummunan sakamako na radiation na kirji galibi yana haɗuwa da tsananin cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar COVID-19 ya nuna zazzabin pinemositis, kumburi na ƙwayoyin huhu, ƙwayoyin cuta na ƙwayoyin cuta na numfashi, da ƙwayoyin cuta masu haɗuwa da ƙwayoyin cuta a cikin huhu na mai cutar da ta mutu, wanda ya dace da asalin kamuwa da cutar ta ARDS, kuma yayi kama da na SARS da MERS.
Gano RNA na SARS-CoV-2 RNA ta hanyar hanyar RT-PCR na dakin gwaje-gwaje an yi amfani dashi azaman babban ma'auni don gwajin COVID-19.
Koyaya, saboda yawan adadin sakamakon gwajin da ba daidai ba, wanda zai iya haifar da yaduwar cutar, an fara amfani da alamun a cikin gwaji (ba wai kawai a cikin RT-PCR ba) a China a ranar 13 ga Fabrairu, 2020.
Wannan ya kasance daidai da gwajin SARS.
Saboda haka, haɗuwa da tarihin cututtuka, bayyanar cututtuka, gwaje-gwajen gwaje-gwaje da sakamakon binciken MRI yana da mahimmanci kuma yana da mahimmanci don tabbatar da ingancin bincike.
A ranar 14 ga Fabrairu, 2020, ƙungiyar da Feng Zhang ke jagoranta ta bayyana wata yarjejeniya don amfani da tsarin CRISPR na SHERLOCK don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA na SARS-CoV-2 a cikin kewayon 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 kwafi a kowace microliter na abin da aka saka) ta amfani da ma'aunin mai a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki masu mahimmanci ba.
Akwai fatan cewa wannan sabon tsarin zai iya haɓaka ingancinsa sosai idan aka gwada shi a cikin gwajin asibiti.
Saboda rashin sanin sabon CoV, likitoci na iya kasancewa a kusa da marasa lafiya na COVID-19 a farkon lokacin gwaji yayin da suke gwada magungunan da aka bayar ko waɗanda ake so kafin magance sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan ƙwayoyin cuta (Table (Table 2).2).
Wannan ya haɗa da magungunan da za a iya amfani da su tare da maganin rigakafi, maganin rigakafi, maganin kumburi, furotin da aka samo daga marasa lafiya, maganin gargajiya na kasar Sin, da kuma maganin cututtukan zuciya.
An yi niyyar amfani da ƙwayar da aka samo daga marasa lafiya da suka warke don magance cutar.
Kamfanonin harhada magunguna suna aiki da shi don samar da rigakafi da alluran rigakafi da ke magance cutar.
SARS-CoV-2 yana fara cutar da huhu da farko kuma yana iya cutar da, a ƙananan, sauran kwayoyin da ke aiki da ACE2 a matsayin mai cutarwa ga koda.
Duk da haka, rashin aiki da rashin aiki na numfashi sune manyan matsalolin lafiya da kuma manyan abubuwan da ke haifar da mutuwa.
Don haka, taimakon numfashi yana da mahimmanci don rage alamun cututtuka da ceton rayuka kuma ya haɗa da ƙarin iskar oxygen gaba ɗaya, ƙarin iskar oxygen, shigar da injin numfashi mai ƙarfi da kuma yin amfani da injin numfashi don daidaita yanayin cutar.
Marasa lafiya da ke da alamun ciwon numfashi mai tsanani ya kamata su sami maganin ECMO, wanda shine madadin hanyar numfashi ta zuciya da huhu don magance waɗanda ke da ciwon zuciya ko ciwon numfashi.
Bugu da ƙari, kula da aikin koda, rigakafi da maganin cututtuka na gaba ɗaya da ƙananan jini, da kuma kula da aikin gabobin jiki masu mahimmanci suna da fa'ida ga marasa lafiya da SARS-CoV-2.
An san cewa haɓakar cytokine yana haifar da tsananin rigakafi a cikin marasa lafiya na SARS da MERS.
Ƙarfafawar cytokine shine tsarin amsawar rigakafi na jiki wanda aka bayyana ta hanyar bayyanar cytokines daban-daban kamar TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan cytokines suna haifar da ƙwayoyin rigakafi don sakin ƙwayoyin cuta da yawa waɗanda ba su da mahimmanci kuma suna da mahimmanci ga ARDS da kuma rashin aiki na kwayoyin halitta.
Rage rigakafi yana da amfani wajen magance haɓakar cytokine, musamman a cikin marasa lafiya masu tsanani.
Corticosteroids da tosislizumab, mai hana IL6 rigakafi mai ƙwayar cuta guda ɗaya, an yi amfani da su don magance haɓakar cytokine.
Sauran magungunan rigakafi don magance haɓakar cytokine sun haɗa da rage ƙarfin tsarin rigakafin T-cell; hana IFN-γ, IL-1, da TNF; hana JAK; maganin rigakafi; rage alamun cytokine 4; da magungunan da ke hana HDAC.
Magungunan ƙwayoyin cuta, kamar magungunan rigakafi, an yi amfani da su sosai don magance SARS don rage tsananin tasirin rigakafi.
Koyaya, shan magungunan ƙwayoyin cuta da yawa ba su da tasiri a cikin huhu da suka zama mummunan rauni a cikin marasa lafiya tare da SARS da COVID-19.
Maimakon haka, yana iya haifar da matsaloli masu tsanani, musamman cutar sankarar bargo (AVN), wanda ke da tasiri sosai ga maganin cutar.
Koyaya, ana ba da shawarar cewa ƙananan allurai na corticosteroids a cikin marasa lafiya masu cutar COVID-19 waɗanda ke da tsananin rauni a cikin ɗan gajeren lokaci kuma ana kiyaye su a hankali.
A lokacin da aka rubuta wannan rahoton, an gano maganin rigakafi a cikin mutum guda.
Amma allurar remdesivir, mai kama da nucleotide, ta tabbatar da amfani ga Ba'amurke da ke fama da COVID-19.
Remdesivir wani sabon maganin rigakafin cutar ne wanda Gilead ta samar don magance cututtukan da ke haifar da cutar Ebola da Marlburg.
Daga baya, an nuna cewa remdesivir yana da ikon hana sauran ƙwayoyin RNA, gami da MERS da SARS.
Bisa ga abin da aka ambata, Gilead ta ba da maganin ga China don gwaji biyu a cikin mutane da ke fama da cutar SARS-CoV-2, wanda ke da tsammanin sakamako.
Bugu da ƙari, baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin an nuna su don magance marasa lafiya da ke da alamun rashin ƙarfi na numfashi.
Zazzabi, zawo, amai, ƙonewa da sauran matsaloli masu tsanani na iya faruwa yayin haɗuwa da lopinavir/ritonavir.
Ya kamata a lura da hulɗar waɗannan magungunan tare da sauran magungunan da ake amfani da su a cikin marasa lafiya.
An cire plasma daga marasa lafiya da suka warke ta hanyar aikin rigakafi
Tarin jini daga mutanen da suka warke daga cututtuka masu yaduwa don magance cututtukan da ke kama da su ko don hana mutane kamuwa da cutar ya daɗe.
Haka ne, marasa lafiya masu lafiya galibi suna da adadin ƙwayoyin cuta masu yawa a cikin jini.
Masu rigakafi sunadarai ne na antibody (Ig) waɗanda ƙwayoyin B ke samarwa don magance ƙwayoyin cuta da sauran ƙwayoyin cuta waɗanda ke gano kwayoyin cuta guda ɗaya kuma suna kashe su kai tsaye.
Dangane da abin da aka ambata, ana iya cire plasma daga jinin rukunin marasa lafiya da suka warke daga COVID-19 sannan a yi musu allurar rigakafi a cikin marasa lafiya 10 masu tsanani.
Alamun sun fara sauƙaƙa a cikin awanni 24, tare da raguwar kumburi da ƙwayoyin cuta da kuma karuwar iskar oxygen a cikin jini.
Amma gwaji da kuma bayyana su na da muhimmanci domin samar da damar amfani da su a cikin marasa lafiya da yawa kafin a samar da wasu magunguna.
Bugu da ƙari, saboda tasirin maganin, wasu daga cikin illolin da ke tattare da ƙwayar cuta dole ne a bincika su da hankali.
Alal misali, rigakafi zai iya sa jikin mutum ya yi tsayayya da cutar kuma ya sa a yi amfani da sinadarin cytokine, wanda zai iya zama guba mai haɗari.
Yawancin lokaci, ƙwayoyin rigakafi suna da ƙarancin jini kuma ana buƙatar ƙarin sinadarin plasma don kula da marasa lafiya masu tsanani.
Ba abu mai sauƙi ba ne don samar da ƙwayoyin cuta na musamman da sauri don magance cutar ta duniya.
Saboda haka, yana da mahimmanci kuma mai mahimmanci a cire ƙwayoyin B daga marasa lafiya da suka warke sannan a bincika lambobin kwayoyin cuta na rigakafi mai ƙarfi ko kuma a gwada rigakafin rigakafi mai ƙarfi don daidaita su da sunadarai masu mahimmanci na kwayar cutar.
Ta haka ne za mu iya ƙarfafa ƙarfin jikinmu.
An yi amfani da maganin gargajiya na kasar Sin (TCM) don magance cututtuka daban-daban a kasar Sin tsawon dubban shekaru.
Amma aikinsa ya dogara ne akan haɗuwa da magunguna daban-daban a cikin yanayin da ya dace da tsarin bincike na TCM.
Yawancin magungunan da ke da amfani ba a san su ba ko kuma ba a san su sosai ba saboda yana da wuyar sarrafa su da kuma sarrafa su ko kuma yawan abubuwan da ke cikin su.
A halin yanzu, saboda rashin takamaiman maganin COVID-19, TCM ya zama ɗayan mahimman hanyoyin kula da marasa lafiya tare da alamun rashin lafiya da na matsakaici ko marasa lafiya da suka warke.
Misali, an gano cewa digo na Shu Feng Jie Du da Lian Hua Qing Wen na iya zama da amfani wajen magance COVID-19.
An lura da yawan warkewar marasa lafiya na COVID-19 a larduna da yawa na kasar Sin waɗanda suka yi amfani da TCM a cikin kashi 87% na marasa lafiya na gida, kamar Gansu (63.7%), Ningxia (50%) da Hunan (50%), yayin da a lardin Hubei, wanda ya yi amfani da TCM a kusan kashi 30% na marasa lafiya na COVID-19, an sami ƙarancin dawo da lafiya (13%).
Amma wannan ƙididdiga ce mai mahimmanci saboda akwai wasu abubuwan da ke shafar kamar yawan marasa lafiya da rashin lafiya da za a yi la'akari da su a cikin gwajin.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun ba da rahoton wani bincike da ke kwatanta maganin da ke amfani da magungunan Turai da Amurka kawai da haɗin WM da TCM.
Sun gano cewa lokacin da ake buƙata don dawo da zafin jiki, warkar da bayyanar cututtuka da kuma kwantar da asibiti ya fi guntu a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai.
Abin sha'awa, ƙimar ƙarancin alamun bayyanar cututtuka (daga mai laushi zuwa mai tsanani) ya bayyana a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (7.4% zuwa 46.2%) da ƙananan mutuwar a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (8.8% zuwa 39%).
Koyaya, inganci da ingancin TCM har yanzu suna jiran ƙarin bincike a kan mutane da yawa da cibiyoyi.
Zai zama da kyau a nuna yadda magungunan ke aiki da kuma bayyana ainihin abubuwan da ke cikin magungunan TCM da ke da amfani ko dai a matsayin mai amfani ko a hade idan ya yiwu.
Masu fama da cutar COVID-19 da ake zargi ko tabbatar da su sau da yawa suna da tsananin tsoron kamuwa da cutar da ke haifar da mutuwa, yayin da waɗanda aka keɓe suna da rashin jin daɗi, kaɗaici da fushi.
Hakanan, alamun kamuwa da cuta kamar zazzabi, rashin numfashi, tari da kuma tasirin magunguna kamar rashin bacci na corticosteroids na iya haifar da damuwa da rikicewar hankali.
A farkon barkewar cutar SARS, an gano cututtukan kwakwalwa daban-daban da suka haɗa da damuwa, damuwa, tsoro, rikicewa, rikicewa, damuwa, da ƙoƙarin kashe kansa.
Binciken tuntuɓar mutum da keɓaɓɓun keɓewa a matsayin ɓangare na matakan COVID-19 na hukumomin kiwon lafiya na ƙasa na iya haifar da ƙarin damuwa da laifi game da tasirin kamuwa da cuta, keɓewa da nuna bambanci daga dangi da abokai.
Saboda haka, dole ne a ba da sabis na lafiyar hankali ga masu cutar COVID-19, waɗanda ake zargi da kamuwa da cutar da kuma waɗanda ke da alaƙa da su da kuma sauran mutanen da ke buƙatar taimako.
Kulawa da lafiyar kwakwalwa ya kamata ya kasance tare da kafa ƙungiyoyin kula da lafiyar kwakwalwa na ma'aikatun daban-daban, ingantaccen tsarin musayar bayanai na yau da kullun da ingantaccen bayani game da cutar SARS-CoV-2 da tsarin kulawa da lafiya da kuma amfani da kayan aiki da aikace-aikacen fasaha don nisantar kusanci.
Alluran rigakafi masu inganci suna da mahimmanci don hana kamuwa da cuta tsakanin dabbobi masu cutar da mutane masu cutar da wasu dabbobi ko mutane waɗanda ƙila suna da cutar kuma galibi suna aiki tare da maganin rigakafi don magance cututtukan da sabbin ƙwayoyin cuta ke haifarwa.
An riga an yi ƙoƙari don samar da alluran rigakafi na S-protein don samar da rigakafi na dogon lokaci ko haɓaka ƙarfin jiki ga SARS-CoV.
An gwada alluran rigakafi da ke amfani da ƙwayoyin cuta da aka raunana akan dabbobi don SARS.
Amma fa'idar alluran rigakafi a cikin dabbobi ko tsofaffi masu lafiya da kuma rigakafin kamuwa da ƙwayoyin cuta na dabbobi ba za a iya gano su ba har sai an gudanar da bincike na asibiti.
Wannan na iya zama saboda an daina cutar SARS shekaru 17 da suka gabata kuma babu wani sabon kamuwa da cutar.
A gefe guda, ƙananan cututtukan MERS suna ci gaba da bayyana a Gabas ta Tsakiya kuma cutar tana yaduwa zuwa wasu yankuna saboda ƙwayoyin cuta da ke ci gaba da cutar da mutane a yankunan da cutar ta fi yaduwa.
An tsara matakan rigakafin MERS ta hanyar amfani da ƙwayoyin cuta masu ƙarancin ƙarfi, DNA parasimides, kwayoyin cuta, ƙananan ƙwayoyin cuta, ƙwayoyin cuta masu kama da ƙwayoyin cuta da ƙwayoyin cuta masu ɓoyewa kuma an gwada wasu daga cikin waɗannan matakan akan dabbobi.
Samun allurar rigakafin SARS-CoV-2 mai inganci da aminci ga mutanen da ke da ƙarancin rigakafi yana da mahimmanci da gaggawa don magance cutar.
Amma yana da wahala a magance wannan matsalar saboda tsayi mai yawa (kimanin watanni 18) da ake buƙata don samar da allurar rigakafi ta hanyar maye gurbin CoVs.
A matsayin sabon kamuwa da cuta, COVID-19 ya fara nuna yiwuwar warkewa a cikin dubunnan masu cutar.
Sau da yawa, marasa lafiya suna samun sauƙi ba tare da wata matsala ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da yawan kamuwa da cuta da mutuwa a cikin marasa lafiya masu tsanani.
Don haka, samar da hanyoyin kula da cutar yana da mahimmanci don tabbatar da asibitoci da cibiyoyin kiwon lafiya suna iya amfani da ayyukansu yadda yakamata ko kuma a wuraren da ba su da isasshen kayan aiki.
Dangane da binciken asibiti na yau, waɗannan abubuwan masu zuwa na iya tasiri ko haɗuwa da maganin marasa lafiya na COVID-19 (Table (Table 33)):
Shekaru: Shekaru sune mahimmin ma'auni don kimanta cutar SARS, kamar yadda yake ga COVID-19.
COVID-19 ya fi shafar mutanen da ke tsakanin shekaru 30 zuwa 65 kuma kashi 47.7% sun haura shekaru 50 a cikin binciken da aka yi da marasa lafiya 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da suka nemi shiga dakunan jinya suna da ƙarin cututtuka da matsaloli kuma sun fi tsofaffi fiye da waɗanda ba su nemi ba (tsakanin shekaru 66 zuwa 51), wanda ke nuna cewa shekaru yana da tasiri a cikin yawan masu cutar COVID-19.
Jima'i: An bayyana cewa maza sun fi kamuwa da SARS-CoV-2 (0.31/100,000) fiye da mata (0.27/100,000).
Cutar cututtuka da rikice-rikice: Marasa lafiya na COVID-19 waɗanda ke buƙatar zuwa dakunan jinya sau da yawa suna da cututtukan zuciya masu rauni da ke haifar da rashin ƙarfi.
Rashin aikin zuciya ya zama babban dalilin mutuwar marasa lafiya na SARS.
An gano cewa SARS-CoV-2 na iya haɗuwa da ƙwayoyin cuta na ACE2 na ƙwayoyin cuta na ƙwayoyin cuta, wanda ke haifar da rikicewar rashin haske a cikin marasa lafiya na COVID-19.
Ya kamata a lura cewa shekaru da yanayin rashin lafiya suna da alaƙa mai ƙarfi kuma suna iya yin tasiri.
Sakamakon gwaje-gwaje na musamman: Matsayin CRP a cikin jini yana nuna tsananin kumburi ko cututtukan tsoka kuma an nuna cewa yana iya zama ɗayan abubuwan da ke da tasiri a cikin maganin cutar, karɓar magani da kuma murmurewar marasa lafiya.
An kuma gano alaƙar da ke tsakanin ƙimar CRP da tsufa da kuma cutar COVID-19.
Bugu da ƙari, ƙididdigar ƙwayoyin cuta na LDH, AST, ALT, da CK na iya zama alamar sakamako na magani.
Wadannan kwayoyin suna bayyana a cikin kwayoyin halitta daban-daban, musamman a cikin zuciya da kuma cikin kwakwalwa, kuma ana sake su idan akwai lalacewar sassan jiki.
Saboda haka, yawanci suna nuna matsalolin zuciya ko duhu.
Muhimman alamomi: Ana buƙatar yin amfani da allurar rigakafi da alamun bayyanar cututtuka na ɗan lokaci tare da sauran matsalolin da ke tattare da shirin magani da matsalolin COVID-19.
Amfani da maganin anti-inflammatory: Kamar yadda aka ambata a sama, maganin anti-inflammatory shine maganin rigakafi wanda aka fi amfani dashi azaman magani na kari don magance cututtukan cututtuka don rage tsananin tasirin tsarin garkuwar jiki.
Saboda yawan amfani da corticosteroids a cikin marasa lafiya a cikin SARS mai tsanani, yawancin marasa lafiya sun sami sauƙi tare da cututtukan ƙashi tare da nakasa na dindindin da rashin lafiya.
Saboda haka, idan ya cancanta, masu cutar COVID-19 ya kamata su sha ƙananan allurai na maganin ƙonewa a cikin ɗan gajeren lokaci.
Tashin hankali: Kamar yadda aka ambata a sama, a lokacin annobar COVID-19, yawancin marasa lafiya sun sami gajiya mai tsanani sakamakon keɓewa na dogon lokaci da baƙin ciki mai tsanani da kuma asarar dangi na kusa.
Yana da mahimmanci a ba da shawara ta hankali da tallafi na dogon lokaci ga waɗannan marasa lafiya don taimaka musu su warke daga gajiya da dawowa cikin rayuwar yau da kullun.
Dangane da nazarin marasa lafiya da aka yi har zuwa yau, COVID-19 ya bayyana yana da alamun bayyanar cututtuka daban-daban da SARS.
Bayan kamuwa da cututtukan numfashi na kirji, SARS-CoV-2 na iya shiga cikin hanyoyin numfashi na makogwaro da hanci kuma yana haifar da alamun rashin ƙarfi ko rashin bayyanar cututtuka a farkon lokacin kamuwa da cuta, kamar yadda yake tare da sauran CoVs da ke haifar da mura.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon kwanaki ko lokacin da alamun cutar suka bayyana suna iya samun adadin kwayar cutar a cikin aikin yau da kullun, wanda ke sa ya zama da wahala a magance cutar.
Amma an gano cewa kamuwa da SARS-CoV yana faruwa ne a lokacin da marasa lafiya ke da rauni, saboda yawancin masu kamuwa da cutar ba su da lafiya a farkon kwanaki.
Wannan shine dalilin da ya sa cutar ta COVID-19 ta fi ta SARS tsanani da kuma wahala.
A halin yanzu, akwai matakan da yawa a cikin kasar Sin kamar su dokar hana fita a Wuhan da biranen da ke kewaye da ita da kuma keɓewa na kusan dukkanin jama'a don hana yaduwar SARS-CoV-2.
Duk da cewa waɗannan matakan sun haifar da mummunan tasirin tattalin arziki da sauran sassan ƙasar, yawan sabbin cututtukan yana raguwa, wanda ke nuna cewa annobar tana komawa baya.
Wani misali mai ban sha'awa shine cewa annobar za ta ƙare a watan Maris, sannan lokacin dawo da al'ada zai ɗauki tsakanin watanni 3 zuwa 4.
Amma wasu masana ba su da wannan ra'ayin.
Paul Hunter da abokan aikinsa sun gano cewa COVID-19, wanda ya fi SARS yaduwa, ba zai ƙare a cikin 2020 ba.
A cikin wannan yanayin, cutar SARS-CoV-2 ta fi yawa a cikin duniya fiye da kowace cuta da ta gabata.
Wani rukunin Kanada ya ba da rahoton cewa an gano SARS-CoV-2 a cikin ƙirji da makogwaro na marasa lafiya da suka warke makonni 2 bayan an sallame su daga asibiti, wanda ke nuna cewa sabon kwayar cutar na iya sake dawowa kamar mura ta yau da kullun.
Amma akwai alamun da ke nuna kyakkyawan fata a China dangane da raguwar yawan sabbin masu cutar, wanda ke nuna cewa matakan da aka dauka na iya yin tasiri.
Da farko, an yi hasashen cewa mutane miliyan ɗaya za su kamu da cutar Ebola kuma mutane 500,000 za su mutu.
Amma saboda tsauraran matakan killace mutane, an shawo kan cutar.
A cikin yanayin SARS-CoV, yana yiwuwa cewa mutane da ke kamuwa da SARS-CoV-2 suna raguwa kuma suna ƙarewa ko kuma suna zama ƙwayoyin cuta masu saurin mutuwa.
Kwatanta cutar ta COVID-19 da SARS da MERS an samo su a cikin zane (Figure 55).
SARS-CoV-2 yana yaduwa ta hanyar tari ko hancin mutum, kuma yana iya yaduwa ta hanyar taɓa abubuwa masu dauke da kwayar cutar.
An kuma gano kwayar cutar a cikin bayan gida, wanda ke nuna cewa akwai wata sabuwar hanyar watsawa ta hanyar taɓa bakin mutum a bayan gida.
Wani bincike na kwanan nan da aka yi kan marasa lafiya 138 ya nuna cewa kashi 41% na marasa lafiya na iya kamuwa da cutar ta hanyar kamuwa da cuta a asibiti, gami da marasa lafiya 17 da suka kamu da wasu cututtuka da likitoci 40.
Saboda haka, ana buƙatar ƙarin hankali don kare mutane, musamman likitoci, ma'aikatan zamantakewar al'umma, dangin marasa lafiya, abokan aiki, da masu tafiya waɗanda zasu iya haɗuwa da marasa lafiya ko masu kamuwa da cuta.
Hanya ta farko da za a iya amfani da ita don rage haɗarin kamuwa da cuta ita ce sanya abin rufe fuska; amfani da abin rufe fuska na likita da abin rufe fuska na N95 (jerin # 1860s) yana taimakawa hana yaduwar kwayar cutar.
Masks na likita suna taimakawa wajen hana ruwa daga mai cutar daga iska ko kuma taɓawa daga wasu.
Amma kawai abin rufe fuska na N95 (sashi na # 1860s) na iya kare mutum daga shan kwayar cutar a cikin iska mai nisa daga 10 zuwa 80 nm, wanda kashi 5% na kwayar cutar ke iya wucewa; SARS-CoV-2 yayi daidai da SARS-CoV a girma kuma duka suna kusan 85 nm.
Saboda akwai wasu abubuwa da zasu iya shiga cikin abin rufe fuska na likita guda biyar, likitocin da ke hulɗa da marasa lafiya a kai a kai dole ne su sa N95 (jerin # 1860s) a maimakon abin rufe fuska na likita.
Baya ga sanya abin rufe fuska, likitoci suna buƙatar sanya rigunan da aka tsara don rage haɗarin kamuwa da cutar.
Kwayar cutar za ta iya kamuwa da mutum ta hanyar baki.
A ranar 22 ga Janairun 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; wanda ke nufin cewa kwayar cutar ta shiga jikinsa ta fuskarsa.
Saboda haka, dole ne likitoci su saka abin rufe fuska ko kuma tabarau da za su iya ganin mutum yayin da suke kula da marasa lafiya.
Ga mutane gabaɗaya da ke zaune a cikin yankuna masu cutar ko waɗanda ke iya kamuwa da cutar, yana da mahimmanci kowa ya wanke hannayensu akai-akai da sabulu mai ƙwayoyi, ƙoƙarin keɓewa da zama a gida da kuma guje wa hulɗa da mutanen da ke da cutar.
Nesa da mutum ya kamata ya kasance tsakanin mutum da mai haƙuri ya zama mita 1.5.
Waɗannan ayyukan suna da tasiri sosai wajen rage haɗarin kamuwa da cutar da hana yaduwar kwayar cutar.
Ko da yake SARS-CoV-2 ya zo ga mutane a matsayin sabon kwayar cuta, yawancin kamanceceniyarsa da SARS-CoV kamar yadda aka sanar a ranar 7 ga Janairu 2020 ya kamata ya sa China ta kasance mai matukar damuwa saboda tunaninta game da barkewar cutar SARS a 2003.
Koyaya, a ranar 19 ga Janairun 2020, shugaban Hukumar Kula da Cututtuka ta Wuhan ya ba da tabbacin cewa sabon kwayar cutar ba ta da saurin yaduwa kuma ba ta da saurin yaduwa daga mutum zuwa mutum, don haka sarrafawa da kawar da cutar ba matsala ba ce.
Wannan sakon ya rage damuwar jama'a sosai, musamman a lokacin da ake shirin bikin bazara na kasar, kuma damar da ake da ita na hana cutar a Wuhan ta ragu.
Cibiyoyin Kula da Cututtuka na kasar Sin na iya koyon darasi daga wannan mummunan yanayin kuma su yi canje-canje masu mahimmanci a nan gaba.
Misali, waɗannan cibiyoyin suna buƙatar (1) yin hankali sosai wajen ba da sanarwar jama'a saboda jama'a suna kula da kowane kalma kuma suna daidaita halayensu da yanke shawara; (2) don haka suna iya bin diddigin bayanai na musamman da asibitoci ke bayarwa da yanke shawara maimakon jiran rahotanni na likita ko hukuma; (3) don ɗaukar ƙarin matakan da za su iya hana cutar daga farawa maimakon ƙoƙarin kwantar da hankalin jama'a; da (4) shirya tarurrukan horo na musamman akai-akai don taimakawa jama'a su ƙara fahimtar cutar da kuma gwadawa da haɓaka dabarun magance ta a lokuta daban-daban.
Cutar COVID-19 ta barke ne sakamakon sabon kwayar cutar SARS-CoV-2 wanda ya fara a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya bazu ko'ina cikin China da kuma wasu ƙasashe 50 a duniya a lokacin da muke rubuta wannan rahoton.
Saboda kamanceceniya tsakanin cutar da SARS-CoV da bayyanar cututtuka tsakanin COVID-19 da SARS, cutar COVID-19 ta haifar da tunanin dawowar SARS.
Amma akwai wasu bambance-bambance masu banbanci tsakanin COVID-19 da SARS, waɗanda ke da amfani ga rigakafin cutar da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa kuma yana shafar maza fiye da mata, kuma tsufa da yawan mutuwa ma sun fi girma a cikin tsofaffi fiye da matasa.
SARS yana da yawan mace-mace fiye da COVID-19 (10,91% zuwa 1,44%).
Masu cutar COVID-19 suna yada kwayar cutar yayin da ba su da alamun cutar, yayin da masu cutar SARS galibi suna yada cutar a lokacin da suka kamu da cutar, wanda ke sa hana yaduwar COVID-19 ya fi SARS wahala.
Wannan shine dalilin da yasa SARS-CoV-2 ke yaduwa cikin sauri da kuma girma fiye da SARS-CoV.
Ana iya samun cutar a cikin wasu marasa lafiya na COVID-19 ta hanyar gwajin RNA da aka yarda da SARS-CoV-2.
A gefe guda, marasa lafiya da suka warke suna iya sake samun kwayar cutar.
Duk waɗannan suna ƙara haɗarin yaduwar kwayar cutar.
Duk da wannan matakin da aka ɗauka a cikin binciken COVID-19, yawancin mahimman tambayoyi masu zuwa har yanzu ba a amsa su ba:
Daga ina ne SARS-CoV-2 ya samo asali?
Ko da yake akwai kusan kusan 96% na kamanceceniya tsakanin SARS-CoV-2 da wasu ƙwayoyin cuta guda biyu na SARS-like waɗanda suka samo asali daga barbashi, ba za mu iya tabbatar da cewa SARS-CoV-2 ya samo asali ne daga barbashi ba.
Wane dabba ne ya fara kamuwa da cutar daga dabba mai cutar, kamar su kwarkwata, kuma ya tura ta ga mutane?
Idan ba mu san amsoshin tambayoyi 1 da 2 ba, ba za mu iya dakatar da yaduwar kwayar cutar ba, kuma cutar za ta iya sake dawowa a kowane lokaci.
Ko da yake gwaje-gwaje na kwayoyin halitta da na kwayoyin halitta sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya kwayar cutar ke shiga cikin ƙwayoyin cuta na oxygen kuma yana haifar da canje-canje masu zuwa na cututtuka?
Shin kwayar cutar tana haɗuwa da kwayoyin ACE2 a wasu sassan jiki?
Har sai mun sami amsoshin waɗannan tambayoyin, ba za mu iya gano cutar da sauri ba kuma ba za mu iya magance ta ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar cutar ke canzawa yayin da take yaduwa daga mutum zuwa mutum?
Shin za ta zama annoba ta duniya, ko kuma za ta ɓace kamar SARS ko kuma za ta sake dawowa kamar mura?
Neman amsoshin waɗannan tambayoyin da sauran su yana da mahimmanci amma yana iya ɗaukar lokaci.
Amma duk abin da ya faru, ba mu da wani zaɓi sai dai mu kawo ƙarshen annobar da wuri-wuri kuma mu mayar da mutane ga al'ada.
Dabbobi sun kamu da cutar coronavirus ga mutane
A cikin shekaru dubu da suka gabata, yawancin kwayoyin halitta sun canza daga kwayoyin halitta zuwa kwayoyin halitta.
Kafin 2003, an san cewa wasu CoVs guda biyu masu kamuwa da mutane (HCoVs) suna haifar da rashin lafiya mai sauƙi, kamar mura.
A cikin wannan yanayin, cutar SARS da MERS sun haifar da wasu canje-canje a cikin yanayin da cutar HCoV ke iya zama mai haɗari da haɗari ga rayuwa.
Cutar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ta sake haifar da ƙarin labarai game da CoVs kuma ta ba da mamaki saboda yawan yaduwar cutar amma ƙananan kamuwa da cuta idan aka kwatanta da takwaransa SARS-CoV.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
Yawancin HCoVs sun samo asali ne daga ƙuda kuma ba sa haifar da cututtuka.
An kuma gano cewa wasu daga cikin waɗannan ƙwayoyin cuta sun kamu da cutar a cikin dabbobi.
Sanin dabbobin da ke kewaye da su yana da tasiri kai tsaye wajen hana kamuwa da cututtuka daga mutane.
Binciken hulɗar dabbobi da CoVs na iya zama da amfani wajen gano yadda CoVs ke haifar da cututtuka ga mutane.
A cikin wannan bita, muna taƙaita ilimin da ake da shi game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su daga asalin dabbobi da kuma yadda suke yaduwa tsakanin jinsuna.
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa fiye da yadda aka saba gani.
Ana nazarin cutar CoV 2019 (COVID-19) a halin yanzu a wannan matakin.
Bugu da ƙari, ana nuna takaddun da ake buƙata don watsa kwayar cutar da tasirin maye gurbin kwayar cutar akan cutar.
Kwayar cutar Corona (CoVs) tana cikin iyali Coronaviridae, ƙungiyar ƙwayoyin cuta na RNA masu ƙarancin ƙwayoyin cuta da ƙwayoyin cuta.
Waɗannan ƙwayoyin cuta suna da manyan kwayoyin halitta masu nauyin kilo 26 zuwa 32 a cikin ƙwayoyin RNA waɗanda ake kira CoVs saboda ƙirarsu ta kama da kambi a cikin microscope na lantarki.
A cikin tsarin kwayoyin halitta, CoVs suna da kwayoyin halitta marasa rarrabuwa waɗanda ke da alaƙa da juna.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna da manyan ƙananan ƙwayoyin cuta guda biyu (ORF1a da ORF1b), wanda ke haifar da sunadarai masu amfani da pp1a da pp1ab.
Ana kuma gyara sunadarai masu amfani da daban zuwa sunadarai 16 da ba su da daidaituwa, da ake kira nsp1~16.
Sauran ɓangaren kwayoyin halitta ya ƙunshi ORFs na sunadarai masu kama da juna, ciki har da kai (S), ƙwayoyin cuta (E), ƙwayoyin cuta (M), da kuma nucleoprotein (N).
Yawancin ƙwayoyin cuta masu kama da ƙwayoyin cuta suna samuwa ta hanyar ƙwayoyin cuta daban-daban.
Dangane da bambance-bambance a cikin tsarin furotin, CoVs an rarraba su zuwa nau'ikan 4 (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV), tare da beta-CoVs suna da yawancin HCoVs kuma an rarraba su zuwa iyalai 4 (A, B, C, da D).
A cikin wannan yanayin, ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
A cikin dubunnan shekaru, CoVs sun kasance masu saurin kamuwa da nau'ikan ƙwayoyin cuta daban-daban kuma wasu daga cikinsu sun zama ƙwayoyin cuta masu saurin kamuwa da cuta ga mutane.
A halin yanzu, an san CoVs guda bakwai na mutum (HCoVs).
A cikin waɗannan, HCoV-229E da HCoV-NL63 suna cikin alpha-CoVs.
Wasu beta-CoVs guda biyar sun haɗa da HCoV-OC43, HCoV-HKU1, coronavirus mai saurin kamuwa da cutar mura (SARS-CoV), coronavirus mai saurin kamuwa da cutar mura ta Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 galibi suna haifar da alamun rashin lafiya, kamar mura ko zazzaɓi.
A gefe guda, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 sune ƙwayoyin cuta masu saurin kamuwa da cuta, suna haifar da mummunan cututtukan cututtukan huhu na kirji a cikin yawancin marasa lafiya waɗanda ke da haɗarin kamuwa da cututtukan numfashi mai tsanani (ARDS) da kuma cututtukan huhu.
An gano asalin asalin HCoV-229E na farko, B814, a cikin ɓoyayyen hanci na marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
A cikin wannan yanayin, yawancin masu cutar sun kasance masu saurin kamuwa da cutar, amma a cikin yanayin, yawancin masu cutar sun kasance masu saurin kamuwa da cutar.
A cikin wannan yanayin, yawancin mutane suna da tabbacin cewa cutar HCoVs ba ta da wata illa har sai barkewar SARS.
Cutar SARS ta 2003 ta kasance ɗaya daga cikin bala'o'i mafi muni a tarihin kwanan nan, tare da mutuwar mutane 8,000 da kusan kashi 10 cikin ɗari.
Shekaru goma bayan haka, annobar mura ta Gabas ta Tsakiya (MERS) ta zama sanannen annoba a yankin Larabawa kuma wani lokacin ta bazu zuwa wasu sassan duniya.
Sabon HCoV 2019 (2019-nCoV), wanda aka sake masa suna SARS-CoV-2, shine sanadin cutar coronavirus ta 2019 (COVID-19) ta yanzu, wacce ta kashe mutane 3,120 kuma ta kamu da sama da mutane 91,000 a ranar 2 ga Maris, 2020.
An daɗe ana faɗakar da mutane cewa duniya ta shirya don barkewar cutar SARS-CoV-2 ta gaba.
Dukkanin HCoVs bakwai sun samo asali ne daga barbashi, beraye ko dabbobin gida.
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa a cikin ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
Cutar COVID-19 ta haifar da mummunan sakamako ga kiwon lafiya, ilimi, zamantakewa da ɗabi'a a China da duniya.
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa a cikin dabbobi.
Wannan zai iya taimakawa ko sauƙaƙa ganowa na SARS-CoV-2, wanda ya fara kamuwa da cutar kuma ya haifar da yaduwar cutar, wanda zai iya haifar da tasiri mai mahimmanci don hana yaduwar gaba.
A cikin wannan bita, muna ba da taƙaitaccen tarihin asalin HCoVs na dabbobi, yadda suke yaduwa tsakanin jinsuna daban-daban da kuma yadda suke haifar da cuta.
A cikin wannan labarin, an bayyana cewa cutar ta HCoV ta haifar da wasu cututtuka da yawa a cikin dabbobi.
Hakanan muna nazarin juyin halittar HCoVs inda yawan yaduwar cutar yakan haifar da raguwar ƙarfin kamuwa da cuta.
A cikin wannan yanayin, muna kuma nazarin ƙarshen annobar SARS-CoV-2 ta yanzu.
An san CoVs a cikin dabbobi tun daga ƙarshen 1930s.
A cikin wannan yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin yanayi mai kyau, a cikin yanayin yanayi mai kyau.
A cikin shekaru goma da suka gabata, an gano HCoVs bakwai.
Bayanan da aka samu a cikin tarihin gano HCoVs (Table 1) sun ba da bayanai da kuma yadda mutane ke amsawa.
An fara gano wani nau'in HCoV-229E a cikin hanyoyin numfashi na marasa lafiya da ke fama da cututtukan numfashi na hanci da hanci a cikin 1966, kuma daga baya ya daidaita don girma a cikin ƙwayoyin huhu na WI-38.
A cikin waɗannan lokuta, cutar ta kamu da cutar ta hanyar cutar da ake kira HCoV-229E.
A cikin shekarun da suka gabata, cutar ta kamu da cutar a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Alamun asibiti na cutar HCoV-OC43 suna da kamanceceniya da HCoV-229E, wanda ba za a iya rarrabe shi da cutar da wasu ƙwayoyin cuta na numfashi kamar su cutar mura ta tsuntsaye da cutar mura ta yau da kullun ke haifarwa ba.
A cikin yanayin da ba a san ko wane irin cutar ba, cutar ta iya zama a cikin yanayin da ba a san ko wane irin cutar ba.
A yadda aka saba, lokaci da ake bukata don nuna alamun cutar ga duka ƙwayoyin cuta biyu bai kai mako ɗaya ba, sannan kuma cutar ta ci gaba har zuwa makonni biyu.
A cikin binciken da aka yi a kan masu son rai, an gano cewa mutanen da ba su kamu da cutar HCoV-229E ba sun kamu da mura mai sauƙi.
Wasu marasa lafiya da ke da matsalar rashin lafiyar jiki sun kamu da cutar cututtukan huhu na chestnut.
SARS, wanda aka fi sani da mummunan mura, shine farkon cutar HCoV da aka fara bincike sosai a tarihin ɗan adam kuma an gano ta ne daga SARS-CoV, HCoV na uku da aka gano.
An fara gano cutar SARS a ƙarshen 2002 a lardin Guangdong na China.
Cutar SARS ta sami mutane 8,096 da suka kamu da cutar tare da mutuwar 774, kuma ta bazu zuwa ƙasashe da nahiyoyi da yawa.
Baya ga masu kamuwa da cutar mai tsanani, an nuna cewa kowane mai cutar zai iya kamuwa da cutar kamar yadda mutum biyu ke iya, lokacin bayyanar cututtuka yana tsakanin kwanaki 4 zuwa 7 kuma cutar ta fi tsanani a rana ta 10.
Masu cutar SARS-CoV sun fara fama da ciwon gida, ciwon kai, zazzabi, rashin jin daɗi da rawar jiki, sannan wahalar numfashi, tari da kuma matsalolin numfashi masu tsanani a matsayin alamun bayyanar cututtuka.
Rage ƙwayoyin cuta, rashin ingancin gwajin ƙwayar cuta da ƙaruwa mai ƙarfi na creatinine sune matsalolin SARS a cikin dakin gwaje-gwaje.
Ana kuma ganin mummunan lalacewar iska (DAD), yaduwar ƙwayoyin epithelial da haɓakar ƙwayoyin rigakafi a cikin marasa lafiya na SARS.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa a cikin dakunan gaggawa da kuma amfani da na'urar numfashi.
Baya ga hanyoyin numfashi na kirji, wasu gabobin jiki daban-daban kamar jijiyoyin jiki, jijiyoyin jiki da kodan suma suna iya kamuwa da cutar a cikin waɗannan marasa lafiya masu tsanani, galibi tare da karuwar kwayar cutar cytokine, wanda zai iya haifar da mutuwa musamman a cikin marasa lafiya da ke fama da matsalar rashin lafiyar jiki.
An fara gano kwayar cutar a cikin wani ɓangaren huhu na mai cutar da aka fara ganowa wanda ya yi tafiya zuwa Hong Kong daga Guangzhou.
A cikin wannan yanayin, ƙwayoyin cuta na farko da aka gano a cikin duniya sun kasance masu haɗari.
An gano HCoV-NL63 a cikin jariri ɗan wata 7 a cikin Netherlands a ƙarshen 2004.
An fara gano shi a cikin yara, tsofaffi da marasa lafiya masu fama da cututtukan jiki tare da cututtukan numfashi.
HCoV-NL63 yana haifar da zafin hanci, ja da launin ido, zafin ido da kuma boronchioritis.
Wani bincike mai zaman kansa ya gano kwayar cutar a cikin samfurin hanci da aka ɗauka daga ɗan wata 8 mai cutar asma a Netherlands.
Ko da yake an gano shi a cikin Netherlands, amma a zahiri yana ko'ina cikin duniya.
HCoV-NL63 ana zaton yana haifar da kusan kashi 4.7% na cututtukan numfashi na yau da kullun, kuma yana da mahimmanci a farkon bazara, hunturu da bazara.
HCoV-NL63 yana da alaƙa da rhinitis wanda ke haifar da tari a cikin makogwaro da hanci.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 da haihuwa wanda aka kwantar da shi a asibiti da cutar huhu da bronchiolitis a Hong Kong.
Bugu da ƙari, cutar ta kamu da cutar sankarar bargo da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
Dukkanin HCoVs huɗu suna da bambancin yanayi kuma gabaɗaya ba su da sauyi don haifar da cututtukan ƙwayoyin cuta masu saurin yaduwa, duk da cewa akwai haɗari da ba a san su ba kamar ƙarancin kwayar cutar HCoV-NL63, wanda aka gano kwanan nan yana haifar da mummunan cututtukan huhu a cikin kasar Sin.
A cikin yanayin da ya dace, waɗannan HCoVs suna da ƙarancin ƙwayoyin cuta ko ƙarancin ƙwayoyin cuta idan sun sami damar yaduwa da kuma kasancewa cikin mutane.
An fara gano MERS-CoV a cikin 2012 a cikin huhu na wani mai shekaru 60 da haihuwa mai fama da cutar sankarar koda a Saudi Arabia.
Yayin da yawancin marasa lafiya da aka gano ta hanyar gwaje-gwaje na gwaji daga Gabas ta Tsakiya ne, an gano wasu masu kamuwa da cutar daga wasu ƙasashe a Turai da Tunisia.
Wani annobar cutar da ta fi muni a Koriya ta Kudu a shekarar 2015 inda aka tabbatar da mutane 186.
Alamun asibiti na MERS suna kama da na SARS, wanda ke nuna ciwon zazzabi mai zafi.
Bayan SARS, marasa lafiya na MERS sun sami mummunan rauni na koda, wanda ya kasance mafi ƙarancin MERS a cikin cututtukan HCoV.
Fiye da 30% na marasa lafiya suna da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A ranar 14 ga Fabrairu, 2020, an gano fiye da marasa lafiya 2500 a cikin gwaje-gwajen gwaji tare da yawan mace-mace da kashi 34.4%, wanda ya sa MERS-CoV ya zama ɗayan ƙwayoyin cuta masu saurin mutuwa da aka sani.
Daga tsakiyar 2019 zuwa ƙarshen Disamba, an gano wasu mutane da ke fama da cutar sankarar bargo da aka saba da ita tare da kamuwa da SARS-CoV-2 a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta bayyana cutar sankarar bargo mai saurin kamuwa da cutar SARS-CoV-2 a matsayin babbar matsalar lafiyar jama'a ta duniya da ke haifar da cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duniya, tare da mutuwar kashi 3.4%.
A wannan matakin, yawan mace-macen a Hubei, China ya kai kashi 4.2%, kuma a wajen lardin ya kai kashi 1.2%.
SARS-CoV-2 yana haifar da cututtukan mura masu tsanani kamar SARS-CoV da MERS-CoV, tare da zazzabi, tari da wahalar numfashi.
Wasu marasa lafiya suna fama da cutar shanyewar jiki.
Cutar zazzabin jini tana daya daga cikin alamun cutar da ke da tsanani kuma tana iya sa mutum ya kamu da rashin lafiya da sauri, wanda hakan ke haifar da ciwon numfashi mai tsanani.
Ko da yake SARS-CoV da SARS-CoV-2 suna da kamanceceniya ta kusan kashi 82% a cikin tsarin nucleotide, suna da rassa daban-daban a cikin asalin bishiyar.
SARS-CoV-2 ya bayyana yana da ƙarancin kamuwa da cuta amma yana da yawa fiye da SARS-CoV da MERS-CoV.
An gano wasu mutane marasa alamun cutar SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar cutar a duniya.
A cikin wannan yanayin, SARS-CoV-2 yana da alamun da ke nuna bambancin da ke tsakanin kwayoyin HCoVs.
A cikin wannan yanayin, cutar ta kamu da cutar a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
A cikin wannan yanayin, SARS-CoV-2 yana bin tsarin HCoVs guda shida.
Na biyu, tsananin alamun COVID-19 yana tsakanin SARS-CoV da HCoVs huɗu masu rarrabuwa ta hanyar yanayin ƙasa (watau HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, SARS-CoV-2 yana nuna alamun da ke faruwa a cikin yanayin HCoVs na al'ada, kamar rashin bayyanar cututtuka, rashin ƙarfi ko rashin bayyanar cututtuka.
Hakanan, ƙananan ƙarancin cututtukan COVID-19 na iya kasancewa a lokacin barkewar cutar SARS-CoV, kodayake ƙimar ta ɗan ƙasa.
A cikin waɗannan lokuta, yawancin masu cutar sun kasance masu saurin kamuwa da cutar, amma a cikin waɗannan lokuta, cutar ta fi yawa.
A gefe guda, yanayin yaduwar SARS-CoV-2 yana da ƙarancin ƙarancin HCoVs.
A gefe guda, har yanzu ana buƙatar bincika ko yadda SARS-CoV-2 ke yaduwa yana raguwa bayan shiga cikin mutane kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 ta hanyar gwajin kwayar halitta.
A cikin wannan yanayin, a cikin yanayin da ba a san ko cutar ta cutar ba, cutar ta SARS-CoV-2 tana da tasiri sosai a cikin jiki.
Hakanan yana da mahimmanci a bincika musamman ko SARS-CoV-2 na iya bayyana a cikin yanayi daban-daban kamar yadda yake tare da HCoVs masu ɗaukar jinsuna dangane da yanayin.
Koyaya, halaye na SARS-CoV-2 gami da yanayin yaduwarsa, yiwuwar kamuwa da cuta da kuma ci gaba da yaduwa bayan haɗuwa da mutane zai taimaka wajen kawo ƙarshen annobar COVID-19 mai gudana.
A cikin wannan yanayin, HCoVs suna da ƙananan alamun da ke nuna cewa sun dace da mutane.
A gefe guda, yana yiwuwa cewa mutane ne kawai ke iya daidaitawa da waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyu na iya tsira daga ɓarkewar cutar HCoV da ta gabata.
A cikin wannan yanayin, cutar ta kamu da cutar ta hanyar cutar HCoVs.
Don ci gaba da rayuwa, kwayar cutar coronavirus ta mutum (HCoV) tana samar da ƙarin adadin kwayoyin don haifar da canji wanda ke lalata furotin mai kare kwayar cutar wanda ke hana ta haɓaka.
Saboda haka, yayin da cutar SARS-CoV-2 ke ci gaba da yaduwa da kuma kamuwa da mutane da yawa, akwai yiwuwar cewa za ta iya zama mai saurin kamuwa da cutar.
Idan ya zama ruwan dare, zai yi wuya a hana yaduwar cutar a cikin mutane ta hanyar keɓewa ko wasu matakan.
A cikin shekaru da yawa, nau'ikan CoV guda huɗu masu yaduwa a waje da asibiti suna tafiya cikin mutane, suna haifar da tari a cikin mutanen da ke da rigakafi.
Ba lallai ba ne ƙwayoyin cuta su kasance a cikin dabbobi.
A gefe guda, ƙwayoyin cuta masu saurin kamuwa da cuta na SARS-CoV da MERS-CoV ba su da cikakkiyar dacewa da jikin mutum, wanda ke sa kamuwa da cutar ga mutane ya zama ɗan gajeren lokaci.
Suna buƙatar ci gaba da haɓaka a cikin dabbobi masu ɗauke da ƙwayoyin cuta da ke jiran su isa ga mutane marasa ƙarfi ta hanyar ɗaya ko fiye da dabbobi masu cin abinci da masu yawa.
SARS-CoV-2 yana da kamanceceniya da SARS-CoV/MERS-CoV da HCoVs huɗu masu yaduwa a waje da asibiti.
A cikin wannan yanayin, cutar ta kamu da cutar a cikin gida, kuma a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida, a cikin gida.
A cikin waɗannan lokuta, cutar ta kamu da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta hanyar kamuwa da cutar ta SARS-CoV ko MERS-CoV.
Har yanzu ba a san ko zai iya zama mai kyau ga mutane ba kuma ya yi tafiya cikin mutane ba tare da wata dabba ba.
Kafin a fara magana game da asalin HCoV, yana da kyau a tattauna ma'anar da halayen dabbobi da HCoVs ke juyawa, hulɗa da su, mazaunin, ci gaba da kuma yawan haifuwa.
A cikin wannan yanayin, HCoVs suna da yawa a cikin dabbobi, amma a cikin dabbobi, HCoVs suna da yawa a cikin dabbobi.
Kwayar cutar ta dabba ta al'ada ce kuma ba ta haifar da cutar a cikin dabbar da ke ciki.
A cikin wannan yanayin, dabba mai ɗaukar hoto yana riƙe da kwayar cutar HCoV kuma yana ci gaba da kasancewa.
A cikin waɗannan lokuta biyu, dabbobi masu dauke da kwayar cutar suna dauke da kwayar cutar HCoV ko kwayar cutar da ke haifar da ita.
A gefe guda, HCoVs da suka fito da sabon abu a cikin dabbobi masu shayarwa kafin ko kusa da cutar ga mutane ba su da cikakkiyar ma'ana kuma galibi suna haifar da cuta.
Wannan kwayar cutar tana iya zama mai saurin kamuwa da cutar ga mutane kuma yana iya zama mafi saurin kamuwa da cutar da ke sa kwayar cutar ta kara girma da sauri kuma ta kamu da mutane ta hanyar kara yawan kamuwa da cutar ga mutane.
A cikin wannan yanayin, cutar ta HCoV ta zama mai saurin kamuwa da cuta a cikin jikin mutum.
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa fiye da yadda ake tsammani.
A wannan yanayin, dabba da ke cikinsa ta zama dabba da aka haifa ta hanyar halitta.
Rahoton annoba ya nuna cewa wanda ya fara kamuwa da cutar SARS ya kamu da ita a lokacin farauta.
Bayan haka, gwaje-gwajen jini sun nuna cewa masu sayar da dabbobi suna da ƙarancin rigakafi ga SARS-CoV IgG fiye da sauran mutane.
A cikin waɗannan lokuta, cutar ta SARS-CoV ta fi yawa fiye da kowace cuta da ta gabata.
Wannan ya tabbatar da cewa SARS ya ci gaba da kasancewa bayan ya kashe duk sinadarin zinc a kasuwa.
Koyaya, an ba da shawarar cewa ƙwayoyin cuta a cikin daji ko wuraren da ba a taɓa haɗuwa da dabbobi a cikin kasuwar da aka gwada su don rashin SARS-CoV, wanda ke nufin cewa ƙwayoyin cuta na iya zama dabbobi waɗanda SARS-CoV ke girma da yawa amma ba zai iya rayuwa tare da su ta hanyar halitta ba.
Musamman, yayin da kashi 80% na nau'ikan dabbobi a kasuwannin Guangzhou ke da ƙwayoyin cuta masu hana SARS-CoV, babu shakka cewa yawancin ƙananan nau'ikan SARS-CoV na iya girma da haɓaka sosai.
Duk waɗannan sun bayyana ba za su iya cutar da SARS-CoV ba.
A cikin waɗannan lokuta, cutar SARS-CoV-2 ta haifar da cutar da ke haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wannan ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙun ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
Wannan da sauran CoVs a cikin jemage suna da kashi 88-92% na tsarin kwayar cutar SARS-CoV.
Binciken ya tabbatar da sabon ra'ayi cewa kwarkwata da ke dauke da kwayar cutar da ba ta girma ba suna haifar da cututtuka ga mutane.
Yawancin SARS CoV-kamar (SL-CoVs) an gano su a cikin jemage, amma babu ɗayan ban da WIV1 da aka ɗauka a matsayin kwayar cutar.
An san cewa ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta ta ƙwayar cuta.
WIV1 da aka samo daga samfurin ƙwayar cuta ta ƙwari yana amfani da ACE2 na bargo, ƙwari da ɗan adam don shiga cikin jiki.
Abin mamaki, ƙwayar cutar SARS ta iya hana cutar WIV1.
A halin yanzu, WIV1 ya bayyana cewa ya samo asali ne daga SARS-CoV na bera, wanda ya kasance kashi 95% na kowa a cikin kwayar halitta.
Ko da yake waɗannan ƙwayoyin cuta biyu suna da alaƙa da juna, ana tsammanin cewa WIV1 ba shine mai haifar da SARS-CoV ba kuma cewa kwari ba shine tushen SARS-CoV ba.
Bayanin kwayoyin halitta na kwayar cutar ya sanya MERS-CoV cikin rukuni ɗaya tare da CoV-HKU4 da CoV-HKU5 na bera.
Koyaya, a cikin waɗannan lokuta, yawancin masu cutar sun kasance masu saurin kamuwa da cutar, kuma yawancin masu cutar sun kasance masu saurin kamuwa da cutar.
Wannan ƙwayoyin cuta na RNA polymerase na MERS-CoV yana da kamanceceniya da kwayar cutar beta-CoV da aka gano a Turai da Afirka.
A halin yanzu, babu wani kwayar cutar MERS-CoV mai rai a cikin kwarkwata.
MERS-CoV da wani kwayar cutar CoV-HKU25 mai kama da ta barawo suna da daidaito na kashi 87% kawai a cikin samfurin.
Saboda haka, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙun ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
A gefe guda, binciken Gabas ta Tsakiya ya nuna cewa raƙuma suna da ƙwayoyin cuta masu cutarwa musamman MERS-CoV, kamar raƙuma daga Gabas ta Tsakiya a yawancin ƙasashen Afirka.
A cikin wannan yanayin, a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
Hakanan ya kamata a ambaci a matsayin mafi ƙarancin alamun cutar amma mafi girma daga raƙuman da aka gano a cikin raƙuman da aka yi amfani da su don kamuwa da MERS-CoV.
Musamman, raƙuma masu cutar sun fitar da cutar ba kawai ta hanyar numfashi ba amma ta hanyar bayan gida, wanda shine babban hanyar watsa kwayar cutar daga bats.
Duk da haka, akwai wasu tambayoyi da ake da su yayin da yawancin mutanen da aka tabbatar da cutar MERS ba su taɓa saduwa da raƙuma ba kafin bayyanar cututtukan, ana iya ɗaukar su a matsayin kamuwa da mutane ko kuma ba a san inda suka samo asali ba kuma wataƙila wasu nau'ikan dabbobi ba su da MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na kwayoyin halitta na CoV RaTG13 na bera wanda aka samo daga ƙwayoyin cuta.
A cikin yanayin SARS-CoV da MERS-CoV, bambancin yanayin tsakanin SARS-CoV-2 da RaTG13 ya yi yawa sosai don ba za a iya danganta su da asalin asali ɗaya ba.
A cikin waɗannan lokuta, cutar SARS-CoV-2 tana da yawa fiye da yadda ake tsammani.
Da alama cewa dabbobin da ke da SARS-CoV-2 suna cikin daji da ake siyarwa a Kasuwar Kasuwancin Kiwon Lafiyar Ruwan Huanan, inda yawancin cututtukan COVID-19 na farko suka fito, wanda ke nuna yiwuwar cewa dabbobin sun kamu da mutane.
Yawancin binciken da aka yi kwanan nan game da tsarin metagenome sun nuna cewa ƙananan ƙwayoyin cuta masu haɗari da aka sani da mura suma suna iya kasancewa asalin beta-CoV da ke da alaƙa da SARS-CoV-2.
Waɗannan sabbin kwayoyin CoV na rigakafi suna da 85-92% na kwayar cutar SARS-CoV-2.
Duk da haka, suna da alaƙa da RaTG13 wanda ya kai kusan 90% a matakin isomers.
Yana cikin ƙananan rukuni biyu waɗanda ke da alaƙa da SARS-CoV-2 a cikin juyin halitta, ɗayan yana da furotin mai ɗaure ƙwayoyin cuta (RBD) wanda yayi kama da SARS-CoV-2 a kashi 97,4% ta hanyar tsarin amino acid.
A cikin yanayin da ya bambanta, RBDs na SARS-CoV-2 da RaTG13 sun bambanta sosai, kodayake suna da kamanceceniya sosai dangane da alaƙar kwayoyin halitta.
Binciken farko na cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan SARS-CoV-2
Wannan binciken ya yi amfani da hanyoyin da aka tsara da kuma rarrabewa don samar da ɗaya daga cikin tsarin kwayoyin halitta wanda ya ƙunshi kashi 86.3% na yawan kwayoyin cutar.
A cikin wannan yanayin, cutar SARS-CoV-2 ta fi yawa a cikin dabbobi fiye da yadda ake tsammani.
A halin yanzu, babu wata hujja da ta tabbatar da cewa SARS-CoV-2 ya samo asali ne daga kwayar cuta ta hanyar kai tsaye saboda bambancin yanayin SARS-CoV-2 da SARS-CoV-2 ya danganta da kwayar cuta ta beta-CoV.
Hakanan, matsakaicin matsakaici tsakanin SARS-CoV-2 da RaTG13 ya fi gajeren matsakaici tsakanin SARS-CoV-2 da SARS-CoV-2 wanda ke da alaƙa da beta-CoV mai kamuwa da cutar.
Hakanan, a cikin nau'ikan da aka samo asali, SARS-CoV-2 yana da ƙarancin ƙwayoyin cuta da ƙwayoyin cuta.
A cikin RBD, an gano alamun alaƙa tsakanin SARS-CoV-2 da kwayar cutar, SARS-CoV-2 da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 suna da alaƙa ta hanyar haɗin jini.
Ana tsammanin cewa babban bambancin tsakanin RBD na SARS-CoV-2 da ke tattare da beta-CoV mai kama da SARS-CoV-2 yana haifar da canji na zaɓi.
Wani aikin kuma shine canza kwayar halitta tsakanin SARS-CoV-2 da ke da alaƙa da beta-CoV mai ɗaukar hoto da RaTG13 zuwa cikin jinsunan daji na uku.
A cikin yanayin canji, ana yin canjin kwayar halitta a cikin beta-CoVs.
Har ila yau, an yi nazarin kwayoyin halitta don tabbatar da ingancin kwayoyin SARS-CoV-2.
A cikin waɗannan lokuta, yawancin kwayoyin cutar sun kasance masu haɗari, amma a cikin waɗannan lokuta, yawancin kwayoyin cutar sun kasance masu haɗari.
A cikin waɗannan lokuta, yawancin kwayoyin halitta suna da alamun da ke nuna cewa cutar ta kamu da cutar a cikin kwayoyin halitta.
An ba da rahoton cewa an gano CoV na bera mai suna ARCoV.2 (Appalachian Mountain CoV) a cikin barkonon sauro na Arewacin Amurka wanda ya nuna alaƙa da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa ta asali da wani CoV na bera, wanda aka kira Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da ake zargin cewa raƙumi yana dauke da kwayar cutar.
Don ƙarin bayani, ilimin da ake da shi game da dabbobi da aka sani da kawo HCoVs an taƙaita su a cikin Figure 1 da Table 2.
Binciken kwayoyin halittar kwayar cutar ya ba da tabbacin cewa akwai alamun watsawa tsakanin jinsunan HCoV a tarihi.
A cikin shekarun 1890, cutar ta kamu da cutar da ke tattare da cutar sankara da kuma cutar sankara da kuma cutar sankara.
A cikin wannan yanayin, cutar ta kamu da cutar a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
An gano alpha-CoV a cikin jemage mai kama da HCoV-229E.
A cikin waɗannan, akwai alpha-CoV mai kama da ƙwayoyin cuta.
Yawancin shaidu suna ba da shawarar cewa kamuwa da cutar daga bera zuwa mutum.
Na farko, mutane da ba masu fata ba suna haɗuwa da ƙwari da yawa a cikin gidajen da suke.
Amma, mutane ne suka fi yawan kamuwa da ƙwari.
A cikin wannan yanayin, cutar ta kamu da cutar ta hanyar cutar da ake kira alpha-CoV.
Daga nan, an gano alpha-CoV daga arupaga a cikin daji.
Saboda haka, babu shakka cewa kwayar cutar HCoV-229E ta haɗu da alpha-CoV a cikin ɗan adam.
A taƙaice, kwarkwata suna kawo cutar hauka, Ebola, Nipah, da Hendra ga mutane.
Saboda haka, ba abin mamaki bane cewa kwarkwata na iya ɗaukar kwayar cutar HCoV-229E cikin sauƙi ga mutane.
A gefe guda, yayin da alpha-CoVs ke da alaƙa da kwayar HCoV-229E, ƙwayoyin cuta da raƙuma waɗanda ƙila sun haɓaka ƙwayoyin cuta kuma sun kamu da cutar ga mutane suna da alaƙa da MERS-CoV.
MERS-CoV misali ne mai kyau na yaduwar kwayar cutar tsakanin jinsuna daga bera zuwa raƙumi da raƙumi zuwa ɗan adam.
An san asalin MERS-CoV a cikin ƙuda lokacin da aka fara gano shi kuma an tabbatar da shi ta hanyar binciken da aka yi a baya.
Kwayoyin cuta sun kasance mafi yawan ƙwayoyin cuta na dabbobi a cikin kwayar halitta da kuma watsawa tsakanin dabbobi.
Tsayi, kwanciyar hankali, kusanci da ƙarfin tashi sune abubuwan da ke sa kwarkwata su zama manyan 'masu watsa kwayar cutar'.
A gefe guda, MERS-CoV ya shiga raƙuma shekaru da yawa da suka gabata.
Ya saba da raƙuman da suka canza daga dabbobi masu shayarwa zuwa dabbobi masu cutar da ke zaune cikin aminci da yanayi.
A cikin waɗannan dabbobi, MERS-CoV yana haifar da rashin lafiya mai sauƙi kuma yana ci gaba da juyawa a hankali.
A cikin wannan yanayin, cutar MERS-CoV tana da haɗari sosai kuma ba ta iya kamuwa da mutane saboda rashin saurin yaduwa.
A cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
A cikin wannan yanayin, cutar ta beta-CoV ta kasance mafi muni a cikin ƙwayoyin cuta.
Hakanan, a cikin waɗannan nau'ikan, ana iya samun cutar SARS-CoV-2 mai kama da beta-CoV, amma ba ta da kama da SARS-CoV.
A cikin wannan yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin yanayi mai kyau.
Da farko, ƙudaje na iya zama masu ɗaukar kwayar cutar da ke da alaƙa da SARS-CoV-2 wanda ke canzawa zuwa SARS-CoV-2.
Mutane za su iya zama tare da wasu ta hanyar aikin gona da kuma hakar ma'adinai.
Na biyu, ƙwayoyin cuta na iya zama ɗaya daga cikin mafi yawan ƙwayoyin cuta da ke haifar da cutar da ke haifar da cutar SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar yanka da cin naman dabbobin daji.
Ana iya yin zargin cewa yawancin dabbobi masu shayarwa da dabbobi masu gida suna da kwayar cutar SARS-CoV-2.
Nazarin da aka yi a kan dabbobin gida da na daji sun nuna cewa suna da ƙwayoyin cuta.
Na uku, ana iya samun ra'ayoyi game da maye gurbi da daidaitawa na SARS-CoV-2 a cikin nau'ikan dabbobi na uku waɗanda suka haɗu da ƙudaje da raƙuma.
A cikin wannan yanayin, cutar SARS-CoV-2 ta fi yawa a cikin mutane fiye da kashi biyu cikin ɗari.
Bugu da ƙari, a cikin nau'ikan da ke da alaƙa da ƙwayar cuta, abubuwa uku a gefen kwayar cutar suna da mahimmanci don sauƙaƙe CoV zuwa wasu nau'ikan.
Da farko dai, yawan canjin yanayin ne a cikin wasu sassan RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta masu ɗauke da RNA guda ɗaya, maye gurbin CoV yana cikin matsakaita ko mafi girma kuma matsakaicin canjin kwayar halitta shine ~10-4 a kowace shekara don kowane kwayar halitta 2, dangane da matakin haɓakar CoV a cikin sabon dabba da aka kamu.
CoV yana da enzymes da ke canza RNA, yana share abubuwan da ke haifar da sauye-sauye masu yawa ko kuma ba su wanzu.
A cikin maganin antibody, Remdesivir an san shi da hana haɓakar CoV ta hanyar enzymes da ke hana RNA polymerase.
Remdesivir yana ɗaya daga cikin magungunan da aka gwada a cikin likitoci don maganin SARS-CoV-2.
Duk da haka, yawancin CoVs sun canza kusan miliyan ɗaya fiye da dabbobi da ƙwayoyin cuta ke girma a cikinsu.
Hakanan, sauye-sauye yawanci suna da yawa idan CoVs ba su dace da yanayin dabbobin da suke girma ba.
A cikin kwatancen SARS-CoV mai canzawa sosai, an gano ƙananan canjin SARS-CoV-2, wanda ya sa ya zama mai saurin daidaitawa ga mutane.
An ce ya riga ya saba da wata dabba da ta fi kusa da mutum.
Bayan SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya saba da zama a cikin raƙumi.
Saboda haka, ba zai yiwu ba cewa maye gurbin kwayoyin halitta zai sa kayan wasa da magungunan da ke rage ƙarfin SARS-CoV-2 su zama marasa ƙarfi da sauri.
Na biyu, babban RNA na kwayoyin halittar CoVs yana amfani da wasu hanyoyin canzawa ta hanyar maye gurbin kwayoyin halitta da kuma canza tsarin kwayoyin halitta; don haka, yana haɓaka yiwuwar canzawa zuwa kwayoyin halittar da ke cikin su, wanda ke da fa'ida ga haɓakar sabbin CoVs lokacin da ya dace.
Wannan yana da alaƙa da tsarin RNA wanda ya haifar da furotin da kuma tsarin aikinsa na 3 na kwayoyin halitta.
Na uku, CoV yana canzawa kuma sau da yawa yana samar da ƙarin RNA ta hanyar canjin kwayoyin halitta da ake buƙata.
A cikin kwayoyin halitta, sauye-sauyen kwayoyin halitta galibi suna faruwa yayin da RNA na CoV ke tafiya zuwa ƙwayoyin halitta.
RNA mai kama da juna da kuma tsarin kwayoyin halitta na iya canza kwayoyin halitta don samar da sabon CoV.
An gano canjin kwayar halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoVs masu kama da dabbobi kamar SL-CoV da batCoV-HKU9 a cikin jemage.
Hadin kan kwayoyin cuta da dabbobi a cikin yaduwar cuta
Baya ga ƙwayoyin cuta uku da aka ambata a sama, hulɗar ƙwayoyin cuta da dabbobi masu shayarwa wani abu ne mai mahimmanci don watsawa tsakanin jinsuna.
A cikin wannan yanayin, SARS-CoV ya zama mai sauya yanayin yanayin da ya nuna cewa yana da zaɓi mai kyau na yanayin jiki wanda kwayar cutar ke shiga cikin yaduwar dabbobi.
Dangane da nazarin kwatancen SARS-COV na ɗan adam da na ɗan adam, an yi imanin cewa SARS-CoV yana da saurin daidaitawa ga jikin da yake ciki, musamman canjin RBD na furotin S.
A cikin yanayin, RBD na CoV S-protein yana da alaƙa da ƙwayoyin cuta masu karɓa kuma an zaɓi shi ta hanyar ƙin ƙwayoyin cuta.
A cikin SARS-CoV, RBD yana cikin matsayi na 318 zuwa 510 a cikin amino acid na S1, yana ba shi damar haɗawa da ACE2 na mutum kuma shine tushen shigar da kwayar cutar.
RBD na SARS-CoV na iya gano ACE2 mai karɓar ƙwayoyin cuta na dabbobi daban-daban, gami da bera, ƙuda, beraye, ƙuda, wanda ke haifar da ƙwayoyin cuta na dabbobi.
A takaice, ragowar amino acid guda 6 ne kawai aka gano a cikin bambancin kwayoyin halitta tsakanin mutane da ƙwayoyin cuta a cikin RBD kuma 4 daga cikinsu suna da wani yanki mai ɗaurewa ga mai karɓar kwayar cutar ACE2.
A cikin wannan yanayin, SARS-CoV yana da ƙananan kwayoyin halitta da ke haifar da ƙananan kwayoyin halitta.
A wasu kalmomin, canza waɗannan amino acid biyu na iya zama mahimmanci don sauya kwayar cutar zuwa jikin mutum.
Yana da ban sha'awa cewa SARS-CoV-2 yana karɓar kwayar halitta iri ɗaya da mai karɓar SARS-CoV.
A cikin kashi 30% na bambance-bambance tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein, yana nuna alaƙar da ke tsakanin S-protein da ACE2 na ɗan adam na iya zama maye gurbi.
A zahiri, binciken cryo-EM ya nuna kusan 10 - 20 sau da yawa mafi ƙarfi na haɗin ACE2 na ɗan adam zuwa S-protein na SARS-CoV.
Hakanan yana da ban sha'awa don tabbatar da ko akwai wasu ƙwayoyin cuta masu karɓar kwayar cutar da aka yi amfani da su don cutar SARS-CoV-2.
A cikin wannan yanayin, HCoV-NL63 yana da alaƙa da ACE2 amma a wani ɓangaren S-protein.
Akwai wasu ƙwayoyin cuta masu karɓar HCoV, kamar aminopeptidase N na HCoV-229E, da sialic acid mai ɗauke da acetyl 9-O na HCoV-OC43.
Wannan yana iya bayyana yadda kwayar cutar CoV ke daidaitawa da jikin mutum wanda ya kamu da cutar daga dabbobi da suka girma.
Bayan ƙwayoyin cuta, ƙwayoyin cuta na HCoVs suna da tasiri a kan ƙwayoyin cuta na HCoVs.
Bambancin ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
HCoVs suna canza yanayin yanayin su kuma suna lalata sunadarai masu kare kwayar cutar don su iya cutar da wasu dabbobi.
Saboda haka, dole ne a ci gaba da gano da kuma bayyana abubuwan da ke tattare da kwayoyin halitta a cikin wannan haɗin gwiwar mai mahimmanci tsakanin ƙwayoyin cuta da dabbobi.
A cikin wannan yanayin, a cikin yanayin da aka tsara, ƙwayoyin cuta na SARS-CoV-2 suna da ƙarancin ƙwayoyin cuta.
Bayyanar sabon kwayar cutar HCoV: Asalinsa
A cikin waɗannan lokuta, yawancin kwayoyin cutar sun kasance masu haɗari ga ƙwayoyin cuta na mutum.
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa fiye da yadda ake tsammani.
A cikin wannan yanayin, HCoVs suna da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Misali: Samun ko rasa kwayoyin halitta masu samar da sunadarai suna da ikon canza yanayin kwayar cutar sosai.
A cikin furotin mai nuna alama na SARS-CoV, ana tsammanin ORF8 yana da mahimmanci a cikin tsarin mutum, yayin da ƙwayoyin cuta na SARS-CoV da ke da alaƙa da ƙwari waɗanda aka ware suna bayyana don yin furotin daban na ORF8.
An gano isomers 29 a cikin kwayar halittar SARS-CoV a farkon cutar ɗan adam.
Wannan kwayar cutar tana rage ORF8 zuwa ORF8a da ORF8b kuma ana tsammanin yana iya daidaitawa da maye gurbin da ke haifar da maye gurbin dabbobi.
Hakanan an san SARS-CoV don canza kwayoyin halittar alpha da gamma-CoVs, inda yawancin kwayoyin da aka canza an sanya su cikin furotin RNA polymerase.
An kuma gano wasu canje-canje a cikin nsp9, yawancin nsp10, da kuma ɓangarorin nsp14.
A wani ɓangare, cutar MERS-CoV ta haifar da sauye-sauyen kwayoyin halitta tsakanin nau'ikan ƙwayoyin cuta daban-daban guda biyu waɗanda suka faru a cikin raƙuman Saudi Arabiya.
Bayan SARS-CoV da MERS-CoV, an kuma lura da aikin gyaran kwayar halitta a cikin wasu HCoVs, inda HCoVs ke canza CoVs na wasu dabbobi a cikin takamaiman kwayoyin halittar su.
Ya kamata a lura cewa zaɓin da ba na halitta ba zai iya haifar da canje-canje na bazuwar cikin kwayoyin halittar kwayar cutar, wanda zai haifar da fitowar kwayar cutar daga yankin da aka zaɓa, kamar ƙwayoyin cuta na kwayar cutar.
Wani misali na wannan aikin shine rashin kwayar ORF4 a cikin HCoV-229E wanda ke haifar da cire ainihin binomial.
A cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
A ƙarshe, juyin halittar sabbin ƙwayoyin cuta na HCoVs yana haifar da matsalolin rashin rayuwa a cikin dabbobi masu yawa.
Ba a lura da rashin bayyanar cututtuka ko ƙananan alamun cutar lokacin da kwarkwata suka kamu da CoV, wanda ke nuna alaƙar CoV da ƙwari.
A cikin yanayin kwayoyin halitta, ƙudaje suna da ƙwarewa sosai ga CoV.
Misali: Rashin ingancin kwayoyin rigakafi a cikin kwarkwata yana rage yawan kamuwa da cutar CoV.
Kuma ƙwayoyin ƙwayoyin cuta na halitta a cikin jemage sun daina aiki saboda ƙarin ƙwayoyin ƙwayoyin cuta na kwayar cutar NKG2/CD94 da ƙarancin ƙwayoyin ƙwayoyin cuta na kwayar halitta na I.
Hakanan, yawan adadin kwayoyin oxygen (ROS) wanda ke haifar da yawancin ayyukan kwayoyin cuta na iya hana CoV daga yin aiki da wasu kwayoyin kuma yana tasiri ga gyaran aikin enzyme mai canza kwayoyin halitta, don haka zaɓar kwayoyin cutar da ke haifar da cututtuka yayin da suka shiga cikin sabon dabba.
Wasu kwayoyin halittar da ke haifar da cutar CoV suma suna canzawa, suna samar da sabon furotin ko sassansa wanda ke ba da damar dabba ta daidaita da kwayar cutar.
Saboda haka, ba daidaituwa bane cewa an gano sabbin ƙwayoyin cuta guda uku na HCoV a cikin shekaru ashirin da suka gabata.
CoVs ba sa haifar da cututtuka ko alamu masu sauƙi a cikin dabbobin gida kamar su rodents da raƙuma.
Suna iya canzawa sosai ba tare da tsayayya da rigakafin da suke girma ba.
Wannan shine dalilin da yasa dabbobi masu dauke da kwayar cutar ba su nuna alamun cutar ba kuma suna haifar da rashin lafiya mai tsanani a cikin mutane.
Babban alamun cututtuka galibi ana haifar dasu ne ta hanyar haɓakar rigakafi da sakin cytokines da yawa, kuma yayin da rigakafin cutar ke ƙaruwa, cutar ta ci gaba da lalacewa.
Wannan ya bambanta da dabbobi marasa alamun cuta, inda ƙwayoyin cuta suka samo asali daga CoV mai canzawa.
Bambancin ƙwayoyin cuta na iya zama da amfani wajen magance cutar SARS-CoV-2.
Sunadaran rigakafin ƙwayoyin cuta suna da ƙarfi a cikin ƙudaje.
Saboda haka, samar da maganin rigakafin kwayar cutar ta I aƙalla a lokacin kamuwa da SARS-CoV-2 zai zama mai amfani.
Hakanan, ƙwayoyin ƙwayoyin cuta na NLRP3 ba su da tasiri a cikin ƙuda.
Dangane da waɗannan ra'ayoyin, hana NLRP3 tare da MCC950 zai iya zama da amfani a cikin maganin COVID-19.
A cikin wannan yanayin, cutar SARS-CoV-2 ta kasance a cikin yanayin da ya dace da cutar SARS-CoV da MERS-CoV.
A cikin yanayin da ya dace, cutar ta kamu da cutar a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
A cikin waɗannan lokuta, an gano cewa ƙwayoyin cuta da sauran dabbobi masu kasuwa suna da kwayar cutar da ke kama da SARS-CoV, amma babu wani kwayar cutar SARS-CoV-2 da aka gano.
An gano beta-CoV na mahaifa wanda yayi kama da SARS-CoV-2, yana nuna cewa mai yiwuwa mai yiwuwa mai yiwuwa ya kasance dabba mai shayarwa ko kuma beta-CoV na mahaifa yana cikin ɓangaren kwayoyin halitta wanda ke haɗuwa da SARS-CoV-2.
Duk da shakku, babu wata hujja da ta nuna cewa SARS-CoV-2 ya samo asali ne ta hanyar mutum ko kuma ta hanyar haɗari.
An sake bayyana CoVs saboda sabon fitowar SARS-CoV-2.
Binciken CoV a cikin jemage da sauran dabbobi ya canza ra'ayinmu game da yadda dabbobi masu ɗauke da HCoV ke cutar da mutane.
A cikin wannan yanayin, cutar SARS-CoV ta fi yawa a cikin mutane fiye da a cikin mutane.
A cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
Hakanan, ya kamata a cire kayan kwalliya daga kasuwar dabbobi don hana kamuwa da wasu dabbobi, bisa ga binciken asalin beta-CoV na kayan kwalliya wanda ke da alaƙa da SARS-CoV-2.
Amma yadda mutane ke watsa SARS-CoV-2 daga tsuntsaye da sauran dabbobi masu shayarwa ya kamata a bayyana a cikin binciken da ke gaba.
A gefe guda, MERS-CoV ya daɗe yana rayuwa a cikin raƙuma.
Rakuma manyan dabbobi ne da ke jigilar nama, madara, ulu da kuma kayan ado ga mazauna yankin.
An fi yaduwa a Gabas ta Tsakiya da Afirka.
Saboda haka, ba za a iya sadaukar da dukkan raƙuman ba don yaƙi da cutar MERS, kamar yadda aka yi a kasuwar dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana sake barkewar cutar MERS, ana buƙatar ɗaukar matakan kariya da kuma samar da allurar rigakafin MERS-CoV.
Idan ba mu iya kawar da waɗannan ƙwayoyin cuta ba, sabon nau'in ƙwayoyin cuta na iya bayyana kuma su haifar da annoba.
Akwai wasu CoVs da ke kama da dabbobi da ke yawo a cikin gandun daji.
Musamman, CoVs a cikin ƙuda suna da ƙarfin aiki daban-daban.
A nan gaba, CoV zai iya kamuwa da dabbobi kuma ya canza, yana haifar da sabon nau'in CoV wanda zai iya zama mai saurin kamuwa da cuta ko kuma mai saurin mutuwa.
Dole ne a dakatar da cin namun daji a wasu sassan kasar Sin tare da kauce wa kusanci da dabbobi ba dole ba.
Saboda ci gaba da rikice-rikice da SARS, MERS da COVID-19 ke haifar, ana buƙatar ingantaccen tsarin sarrafawa don waɗannan ƙwayoyin cuta.
A takaice dai, akwai ƙwayoyin cuta da yawa a duniya a cikin tarihi.
Suna zama a cikin gidajen da suke har sai sun sami damar fita.
Kodayake kwarkwata suna da halaye da yawa da ke haifar da yaduwar kwayar cutar, ana iya rage haɗarin haɗuwa da mutane da kwarkwata da sauran nau'ikan namun daji idan an koya wa mutane su guji kusantar su.
Ci gaba da lura da dabbobi masu shayarwa yana da mahimmanci don ƙarin fahimtar yanayin CoV da kuma yanayin dabbobi, wanda ke da amfani wajen hana dabbobi kamuwa da mutane da kuma hana barkewar cutar nan gaba.
A ƙarshe, mafi kyawun hanyar hana ƙwayoyin cuta a cikin dabbobi shine fahimtar yadda ƙwayoyin cuta da dabbobi ke rayuwa.
Har yanzu akwai wasu nau'ikan dabbobi da ba a san asalin SARS-CoV-2 ba.
Da farko, idan kwari suna cutar da kwari da cutar SARS-CoV-2, yana da ban sha'awa don gano dalilin da yasa kwari da kwari ke rayuwa a cikin yanayin da ya dace.
Na biyu, idan kwari suna watsa kwayar cutar ga mutane kai tsaye, ya kamata a tabbatar da yadda mutane ke hulɗa da kwari.
Na uku, idan dabba ta uku tana aiki kamar dabba mai girma, ta yaya ta ke aiki tare da wasu dabbobi kamar mutane, jemage da dabbobi masu rarrafe?
A ƙarshe, idan yawancin dabbobi masu shayarwa sun haɗa da dabbobin gida waɗanda ke da yiwuwar kamuwa da SARS-CoV-2, dole ne a sanya su cikin kulawa da kuma kula da yadda suke watsa cutar.
Ko dai daga cikin bera, ƙwari, ko wasu dabbobi masu shayarwa, ana tsammanin SARS-CoV-2 ko ƙwayoyin cuta masu saurin haifuwa za su bayyana a cikin dabbobi masu shayarwa a nan gaba.
Ci gaba da binciken waɗannan dabbobi zai bayyana hanyar juyin halittar SARS-CoV-2 a cikin dabbobi, wanda zai taka muhimmiyar rawa wajen rigakafi da magance COVID-19 a cikin mutane.
Ana buƙatar sabunta ƙa'idodin gwaji don COVID-19 masu cutar da ake zargi da kumamasu cutar da aka tabbatar
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta ba da umarnin gaggawa wanda ke ba da shawarwari game da ganewar asali da magani na sabon cutar coronavirus ta 2019 (2019-nCoV), kuma umarnin sun ba mu ƙwarewa da ingantaccen bayani game da yadda za mu magance cutar a duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce, kuma fahimtarmu da iliminmu game da ita suna ci gaba da ƙaruwa a hankali bisa ga binciken da ke gudana da ayyukan likita; don haka hanyoyin bincike da magani suna ci gaba da sabuntawa.
A cikin wannan wasiƙar, mun amsa ga wata shawara game da manufofinmu kuma mun gabatar da sababbin ka'idoji don tantancewa masu cutar da ake zargi da kuma masu cutar da aka tabbatar bisa ga sabon jagorar tantancewa da magani na COVID-19 (mataki na bakwai) wanda kwamitin kiwon lafiya na Jamhuriyar Jama'ar Sin ya fitar.
A watan Disamba na 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da annoba, wanda yanzu ake kira cutar coronavirus ta 2019 (COVID-19) kuma an sanya sunan cutar a matsayin cutar cututtukan numfashi mai tsanani ta coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin cutar da ke addabar duniya.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta tsara jagororin gaggawa kuma an buga su a cikin binciken likita na soja a kan yanar gizo a ranar 06 ga Fabrairu, 2020.
Tun da aka fito da shi, ya jawo hankalin mutane da yawa.
Amma yana da mahimmanci a lura cewa COVID-19 sabuwar cuta ce, kuma ra'ayoyinmu da iliminmu suna ci gaba da ƙaruwa bisa ga binciken da ke gudana da ayyukan likita; saboda haka, hanyoyin bincike da magani suna ci gaba da sabuntawa.
Misali, Jagoran Ganowa da Kula da COVID-19 wanda Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya bayar tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, ya fitar da kundin littattafai bakwai tare da wasu manyan canje-canje.
Kuma manufofinmu sun karɓi ra'ayin Zhou da sauransu, waɗanda suka ƙirƙiri tsarin ƙididdigar ƙididdiga mai sauƙi bisa ga ƙwarewar likita.
Ayyukan su sun ƙara sabon tabbataccen hujja ga manufofinmu kuma sun ba da haske mai amfani game da wannan annoba ta duniya.
Muna goyon bayan aikin da suke yi kuma muna yaba musu.
Koyaya, waɗannan matakan dole ne a sake sabunta su dangane da sabbin jagororin bincike da magani na COVID-19 (gwajin Mataki na Bakwai) da kuma sabon binciken.
Kamar yadda aka bayyana a cikin kundin na bakwai (3 ga Maris 2020) tabbatar da yiwuwar cutar dole ne ya haɗu da ɗayan halayen tarihin cutar da alamun bayyanar cututtuka guda biyu don cikakken bincike, ko kuma ya haɗu da alamun bayyanar cututtuka guda uku idan tarihin cutar ba shi da tabbas:
Tarihin cutar: (1) Tafiya ko zama a Wuhan da kewayenta, ko kuma haɗuwa da wasu masu cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) haɗuwa da waɗanda ke da cutar SARS-CoV-2 (tare da gwajin kwayar nucleic acid); (3) haɗuwa da masu zazzabi ko alamun zazzabi daga Wuhan da kewayenta, ko kuma haɗuwa da wasu masu cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) haɗuwa da waɗanda ke da cutar a cikin gida (fiye da mutane 2 da ke da rashin lafiya ko alamun cutar a cikin makonni 2 da suka gabata, kamar gida, makaranta, ofis, da sauransu).
Alamun cututtuka: (1) zazzabi ko rashin numfashi; (2) tare da alamun COVID-19; (3) yawan adadin farin jini wanda ke nuna yawan al'ada, ba ya ƙaruwa ko raguwa a matakin farko.
Gwajin tabbataccen cutar ya kamata ya dogara ne akan wanda ake zargi da cutar yana nuna ɗayan waɗannan alamun cutar ko kuma yanayin jini: (1) Gwajin PCR na ainihi wanda ya nuna cutar SARS-CoV-2; (2) jerin abubuwan da ke cikin kwayar cutar da ke nuna alaƙa da sabon coronavirus da aka sani; (3) nuna rashin lafiyar ƙwayoyin IgM da IgG na SARS-CoV-2 a cikin gwajin ƙwayar cuta; ko canjin kwayar IgG na SARS-CoV-2 daga marasa lafiya zuwa marasa lafiya, ko kuma karuwa a cikin yanki fiye da sau 4 a cikin lokacin murmurewa a cikin yanayin mai tsanani.
Mun lura cewa an samo samfurin kwayar halittar nucleic acid a cikin numfashi ko samfurin jini lokacin da aka ƙara shi zuwa kundin na biyu (Janairu 18, 2020) da na uku (Janairu 22, 2020).
An ƙara ganewar asali ta hanyar gwajin jini a cikin bugu na huɗu (27 ga Janairu 2020) da na biyar (8 ga Fabrairu 2020); sannan an ƙara alamun jini a cikin fitowar ta bakwai.
Waɗannan canje-canjen suna dogara ne akan ci gaba da bincike na masu bincike don ingantaccen ganowa na acidic acid don saurin bincike, da kuma samfurin numfashi wanda ya haɗa da samfurin jini, wanda ke ba da damar samar da samfura daban-daban, da kuma tallafawa samar da takamaiman ƙwayoyin cuta a cikin ƙa'idodin da aka kafa.
Bugu da kari, akwai alamun da yawa da ke tunatar da mu mu kula da marasa lafiya masu rashin lafiya da ke da alamun cutar.
Saboda haka, ana buƙatar sake fasalin jadawalin Zhou da sauransu, kamar yadda suka rarraba mutumin da ba shi da alamun cutar a matsayin "mai haɗari".
Hakanan za'a iya yin la'akari da tsarin ƙididdiga a cikin sauran ayyukan likita da bincike.
A ƙarshe, muna fatan za a sami ƙarin alamun kai tsaye kuma muna gayyatar masu karatu su ba da ra'ayoyinsu.
Game da gwajin "masu cutar da ake zargi" da "masu cutar da aka tabbatar", muna ba da shawarar bin da bin sabbin ƙa'idodin ƙasashensu.
Ƙungiyarmu za ta kuma sabunta manufofinmu a kan lokaci don bayar da taimako.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar, mafi girma a rana ɗaya.
A jiya, Bangladesh ta tabbatar da sabbin mutuwar COVID-19 guda biyar a ranar.
Wannan shi ne adadin mutane da suka mutu a rana daya sakamakon cutar.
A jiya, Cibiyar Kula da Cututtuka, Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton adadin masu cutar da suka hada da 114 da suka kamu da cutar da kuma 33 da suka warke a gida.
Jimlar wadanda suka mutu sun kai 17.
A cikin wani rahoto da aka watsa ta yanar gizo, Darakta na IEDCR, Dr Meerjady Sabrina Flora, ta ce cikin wadanda suka mutu akwai maza hudu da mace daya.
A cewar Dr. Meerjady, mutane biyu da suka mutu sun haura shekaru 60, biyu suna tsakanin shekaru 51 zuwa 60 da daya yana tsakanin shekaru 41 zuwa 50.
Ya kuma bayyana cewa biyu daga cikin wadanda suka mutu daga cutar sun fito ne daga Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani ma'aikacin asibiti ya shaida wa Anadolu Agency, wata jaridar kasar, cewa daya daga cikin wadanda suka mutu Jalal Saifur Rahman, Shugaban Hukumar Yaki da Cin Hanci da Rashawa ta Bangladesh, wanda ake kula da shi a Asibitin Kuwait Maitree.
A ranar Lahadi, a cikin wani bidiyo da aka watsa ta yanar gizo, Ministan Sufuri na Bangladesh Obaidul Quader ya ce an dakatar da zirga-zirgar jama'a na tsawon lokacin da aka tsara har zuwa wannan Asabar.
An shirya dakatar da zirga-zirgar jiragen sama daga ranar 26 ga Maris zuwa Asabar, 4 ga Afrilu.
Har ila yau, an ba da izinin jigilar kayayyaki na yau da kullun, gami da magunguna, kayan wuta da abinci.
An gano farkon cutar COVID-19 a Bangladesh a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da matar ɗayan.
A ranar 9 ga watan Maris, an warkar da mutane uku.
SARS-CoV-2 ya riga ya harba mutane sama da miliyan a duniya.
A ranar Alhamis, jimlar adadin masu kamuwa da cutar coronavirus ta SARS-CoV-2 ya zarce miliyan ɗaya a duk duniya, a cewar bayanan Jami'ar Johns Hopkins.
Aƙalla mutane dubu 52 sun mutu sakamakon COVID-19, cutar da kwayar cutar coronavirus ke haifarwa.
An sanar da wannan adadi a ranar da Malawi ta sanar da mutum na farko da ya kamu da cutar coronavirus kuma a Zambia mutum na farko da ya mutu daga cutar coronavirus.
A ranar Alhamis, Koriya ta Arewa ta bayyana cewa tana ɗaya daga cikin ƙasashe kaɗan da suka rage marasa cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta sanar da cewa an tabbatar da mutane 1,051,635, daga cikinsu akwai mutane 79,332 da suka kamu da cutar a cikin awanni ashirin da takwas kafin karfe 10 na yammacin Turai ta tsakiya (08:00 GMT) a ranar 4 ga Afrilu.
A Amurka, an bayar da rahoton sama da mutane 244,000 da suka kamu da cutar coronavirus, kuma an samu mutuwar mutane 5,900.
CBS News ta ruwaito cewa mutane 1,000 sun mutu a Amurka a ranar Laraba daga cutar coronavirus, bisa ga bayanan Jami'ar Johns Hopkins.
A duniya, ƙasashe sun ba da sanarwar tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, Sergei Sobyanin, magajin garin Moscow ya tsawaita dokar hana fita har zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa Rasha za ta ci gaba da biyan albashi har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kara kwanaki 15 ga dokar ta baci, ta samu kuri'u 215 a kuri'u 10 da daya a kuri'u daya.
Saudiyya ta kara wa'adin karfe uku na dare zuwa rana guda a cikin biranen alfarma na Makka da Madina; a baya an yi hakan daga karfe 3:00 na yamma zuwa 6:00 na safe.
Thailand na shirin kafa dokar hana fita daga karfe 22:00 zuwa 04:00.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jiharsa ta tsawaita dokar hana fita har zuwa 1 ga Mayu.
Shagunan Australiya sun kafa iyakacin adadin takarda mai tsabta da mutum zai iya saya.
A daren Asabar zuwa Lahadi, shagunan Woolworths da Coles na Ostiraliya sun rage adadin takarda zuwa biyu kuma an rage adadin takarda a kowane shago a duk faɗin ƙasar.
A ranar Litinin, ALDI ta kuma ba da umarnin kada a wuce fakitin guda.
An buga adadin a matsayin saƙo a wurin biya da kuma shafin Facebook na shagon.
An ce masu amfani da kayayyakin sun sayi takarda mai tsabta a cikin adadi mai yawa saboda tsoron COVID-19 lokacin da ake buƙatar keɓewa.
A ranar Laraba, Woolworths ya rage adadin takarda mai tsabtace gida zuwa fakiti ɗaya a kowane tsari.
Canje-canjen da aka yi a baya sun hana kowa wucewa ta hanyar shirya takarda mai tsabta guda huɗu da aka sanya ta hanyar shagunan Woolworths da Coles a ranar 4 da 5 ga Maris.
A cikin sanarwar manema labarai ta watan Maris, Coles Store ya bayyana cewa, a ƙarƙashin ƙa'idodin da aka kafa na ƙuntatawa na fakitin takarda mai tsabta guda huɗu, yawancin shagunan suna ƙarancin kaya bayan sa'a ɗaya da aka yi musu oda, kuma ya bayyana sayan a matsayin "ba a taɓa gani ba", yayin da ALDI ta sanar a Facebook a ranar Talata cewa "ba zato ba tsammani".
Sayarwa ta "ƙaru sosai" a makon da ya gabata, a cewar wani mai magana da yawun Woolworths.
Costco a Canberra ya rage adadin zuwa fakitin takarda biyu a makon da ya gabata.
Don ci gaba da rage ƙarancin takarda, Coles Store ya ba da umarnin manyan fakiti ga masu siyarwa kuma ya ƙara yawan sayayya, kuma Woolworths ya ba da umarnin ƙarin takarda, yayin da ALDI ta kawo kaya don wasan kwaikwayon na ranar Laraba da aka fara siyarwa.
Russell Zimmerman, shugaban zartarwa na Kungiyar Kasuwancin Australiya, ya ce 'yan kasuwa na iya ƙara yawan kaya, amma dokokin da majalisar ta kafa game da manyan motocin kaya sun sa hakan ya zama da wahala.
Ya yi imanin cewa farashin kayayyaki zai karu yayin da masu ba da bashi ke ƙoƙarin biyan bukatun abokan ciniki, tare da ba su tallafi kaɗan.
A ranar Talata, ALDI ta sanar da cewa saboda sayayya ta ƙare da wuri, wasu shaguna ba za su iya ba da talla a ranar Laraba ba.
A wani rahoto da aka bayar a News.com.au, Dr Gary Mortimer, masanin kasuwanci a Jami'ar Fasaha ta Queensland, ya ce shagunan suna adana kaya da daddare.
Ya kuma bayyana cewa takardar bayan gida abu ne da ke cikin fakiti, wanda ke haifar da karancin kayayyaki a cikin shaguna, kuma idan aka sayar da su, suna barin sarari da yawa a kan ɗakunan ajiya, suna ƙara haifar da jin cewa kayayyaki sun ƙare.
Russell Zimmerman na ABC News ya ce: "Coles da Woolworths suna tunanin cewa samun ƙarin kayayyaki a kan ɗakunan ajiya kamar takarda mai tsabta da magungunan kashe ƙwayoyin cuta da yawa zai rage tsoro".
Kamfanin da ke sarrafa takarda mai tsabtace jiki mai amfani da Who Gives a Crap ya ce kayayyakin sun ƙare a cikin shagon ranar Laraba.
Kamfanin Kimberly-Clark wanda ke kera kayan wanki na Kleenex da Solaris Paper wanda ke kera takarda mai tsabtace jiki na Sorbent sun yi ikirarin cewa za su kasance a aiki 24/7 don wadatar da kasuwa, in ji News.com.au.
Domain.com, wani gidan yanar gizon sayar da gidaje, ya ba da sanarwar cewa masu siyar da gidaje za su ba da takaddun tsabtace gida kyauta ga masu fara amfani da gidan a cikin gidan sayar da kayayyaki na Melbourne, inda aka yi amfani da ƙananan kayan aiki saboda abokan ciniki suna da hutun ranar aiki da ta yi daidai da ƙarshen mako.
A ranar Alhamis, NT News, jaridar da ake buga a Darwin, ta ƙara shafuka takwas waɗanda za a iya yanke su don amfani da su azaman takarda mai tsabta.
Shagunan ba sa son yin doka, a cewar rahoton ABC Australia na ranar 3 ga Maris, inda ya ce ba su da niyyar yin doka kan sayayya.
Russell Zimmerman ya ci gaba da cewa, wasu kayayyaki da aka fi sayarwa sun hada da abin rufe fuska, maganin kashe kwari, abinci mai bushe, sabulu da kuma kayan wanke hannu.
Haka ma a waje da Ostiraliya, inda a daren Lahadi kantin sayar da kayayyaki na intanet na Ocado na Burtaniya ya rage takardar bayan gida ta Andres zuwa fakiti biyu na takarda 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba.
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana cutar COVID-19 ta yanzu ta coronavirus SARS-CoV-2 a matsayin annoba.
Duk da cewa kalmar "annoba" tana nufin yaduwar cutar a cikin ƙasashe da yawa, ba musamman tsananin cutar ba, WHO ta ba da shawarar cewa gwamnatoci su shiga cikin aikin magance ta:
"Kowace ƙasa na iya canza yanayin annobar.
Tedros Adhanom Ghebreyesus, Darakta Janar na WHO ya ce: "Kasashe suna ganowa, gwaji, magani, keɓewa, karɓar masu kamuwa da cutar da kuma ƙarfafa mutane su kiyaye kansu".
"Muna matukar damuwa da yadda cutar ke yaduwa da sauri da kuma rashin daukar matakan dakile ta.
A cewar Dokta Tom Frieden, tsohon Darakta na Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, wannan annobar "ba ta taɓa faruwa ba".
A cikin wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce: "Baya ga mura, babu wata kwayar cuta ta numfashi da ta fi wannan girma da ta zama annoba a duniya".
Ghebreyesus ya yi magana a cikin wata sanarwa, inda ya ce: Ba mu taɓa ganin annobar coronavirus ba.
Ya kara da cewa: "Ba mu taba ganin wata annoba da za a iya magance ta ba".
Wannan yaduwar cutar ta biyo bayan shawarar da Hukumar Lafiya ta Duniya ta yanke a watan Janairu ta ayyana cutar a matsayin babbar matsalar kiwon lafiya ta duniya.
Babban daraktan Cibiyar Kula da Cututtuka da Cututtuka ta Amurka, Dr. Anthony Fauci, ya ce: "A bayyane yake cewa cutar ta kara tsananta lamarin".
A ranar Alhamis, kamfanin dillancin labarai na Associated Press ya ba da rahoton cewa aƙalla mutane 126,000 sun kamu da COVID-19 a duniya, tare da mutuwar sama da 4,600.
Cutar annobar coronavirus ta 2019 20 annobar annobar annobar cutar coronavirus ta 2019 (COVID-19), wacce kwayar cutar coronavirus mai saurin kamuwa da cutar mura (SARS-CoV-2) ke haifarwa.
A watan Disamba na 2019, an gano barkewar cutar a Wuhan, China; an ayyana ta a matsayin bala'in kiwon lafiya na duniya a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin cutar a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, kusan mutane miliyan 1.61 sun kamu da COVID-19 a cikin ƙasashe da yankuna 210, kuma kusan 97,000 daga cikinsu sun mutu.
Kimanin mutane 364,000 ne suka warke.
Yawan mace-macen ya kai kashi 4 cikin dari a kasar Sin, yayin da a duniya ya kai kashi 13.04 cikin dari a Aljeriya da kashi 0.8 cikin dari a New Zealand.
Alamomin sun hada da zazzabi, tari da kuma numfashi mai wuya.
Babban alamun cututtuka sun haɗa da tashin hankali da kuma matsalolin numfashi.
Alamun cutar na iya farawa a cikin kwanaki biyar bayan kamuwa da cutar, amma zai iya wucewa daga kwana biyu zuwa goma sha huɗu.
Babu allurar rigakafi ko magani da aka sani don cutar.
Babban aikin kulawa shine magance alamun cutar da taimakawa mai cutar. Sharuɗɗan kariya sun haɗa da wanke hannu, rufe baki lokacin tari, nisantar mutum da wasu, da lura da keɓewa daga mutanen da ake zargi da kamuwa da cutar.
Shugabannin duniya sun yi aiki da dokar hana zirga-zirga, keɓewa, keɓewa, kula da cutar a wuraren aiki da rufe cibiyoyi don magance cutar.
Cutar ta haifar da rikicewar tattalin arziki da zamantakewar al'umma, tare da jinkirta ko dakatar da ayyukan wasanni, addini, siyasa da al'adu da kuma ƙarancin kayayyaki a duniya wanda ya haifar da ƙarancin masu sayayya saboda tsoron cutar.
Makarantu da jami'o'i sun rufe a matakin ƙasa ko na yanki a cikin ƙasashe 193, wanda ya shafi kusan kashi 99.4 na ɗaliban duniya.
Labaran jita-jita game da cutar sun bazu a kan layi, tare da rahotannin tashin hankali ko nuna bambanci ga baƙi musamman Sinawa, mutanen Gabas da kudu maso gabashin Asiya, da sauran mutanen da suka fito daga yankunan da cutar ta fi yawa.
Sakamakon rage zirga-zirga da rufe manyan masana'antu, gurɓataccen iska da gurɓataccen iska sun ragu.
A ranar 31 ga Disamba, 2019, Ma'aikatar Kiwon Lafiya a Wuhan, China (babban birnin lardin Hubei) ta ba da rahoton wasu cututtukan cutar sankarar bargo da ba a sani ba, kuma a farkon Janairu 2020, an fara gwajin.
An gano cewa cutar ta samo asali ne daga kasuwar sayar da kayan abincin teku ta Huanan, inda ake zargin cewa cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da cutar da aka sani da SARS-CoV-2, sabon kwayar cutar da aka gano tana da kamanceceniya da coronavirus na bat, bat, da SARS-CoV. Mutumin da aka fara ganowa da alamun cutar ya kamu ne a ranar 1 ga Disamba, 2019, kuma mutumin ba shi da alaƙa da waɗanda ke cikin wannan kasuwar da aka yi watsi da su.
An kuma fara samun wasu mutane a watan Disamba na 2019, inda kashi biyu bisa uku ke da alaƙa da wannan tushen.
A ranar 3 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba wanda jaridar South China Morning Post ta wallafa ya ce an gano cutar a ranar 17 ga Nuwamba, 2019, wanda ya fara faruwa ne a wani mutum mai shekaru 55 a lardin Hubei, wanda zai iya zama na farko.A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa sabon kamuwa da cutar ya ragu a China amma ya karu sosai a Italiya, Iran da Koriya ta Kudu, tare da yawan sabbin masu kamuwa da cutar a wajen China ya zarce sabbin masu kamuwa da cutar a cikin kasar Sin a karon farko.
Wataƙila akwai wasu cututtukan da ba a sanar da su ba; musamman waɗanda ke da alamun rashin lafiya.
Har zuwa 26 ga Fabrairu, an ba da rahoton ƙananan adadin masu kamuwa da cutar a tsakanin matasa, tare da waɗanda ke ƙasa da shekaru 19 da ke da kashi 2.4% na yawan kamuwa da cutar a duniya.Shugaban kimiyya na gwamnatin Burtaniya, Patrick Vallance, ya ce kashi 60% na yawan mutanen Burtaniya na iya kamuwa da cutar kafin a ba su allurar rigakafi.
Cutar ta shafi yawan mutanen da aka tabbatar da cutar COVID-19 a cikin gwajin, kuma an tabbatar da gwajin bisa ga ƙa'idodin gwamnati.
Har zuwa 23 ga Maris, babu wata ƙasa da ta gwada kashi 3% na yawanta, kuma ƙasashe da yawa kamar Italiya, Netherlands, Spain, da Switzerland sun ba da umarnin kada a gwada waɗanda ke da alamun rashin lafiya.
Binciken da aka fitar a ranar 16 ga Maris ya nuna cewa a ranar 23 ga Janairu, kashi 86% na masu cutar COVID-19 a China ba su da asali, yayin da marasa lafiya da ba a tantance su ba sun kai kashi 79% na waɗanda aka tantance.
Binciken ƙididdigar da aka fitar a ranar 30 ga Maris ya nuna cewa adadin masu kamuwa da cutar a Italiya ya fi na da aka bayar.
Sabbin cututtukan (R0) na COVID-19 sun kasance daga 1.4 zuwa 2.4.
Binciken da Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka suka buga ya kammala cewa adadin zai iya zama 5.7.
Yawancin masu cutar COVID-19 suna warkewa.
A cikin marasa lafiya, lokacin farawa daga bayyanar cututtuka zuwa mutuwa tsakanin kwanaki 6 zuwa 41, amma mafi yawan lokuta kwanaki 14.
Ya zuwa ranar 10 ga Afrilu, 2020, kusan mutane 97,000 sun mutu daga COVID-19.
A China, har zuwa 5 ga Fabrairu, kashi 80% na mutanen da suka mutu sun haura shekaru 60, kuma kashi 75% suna da wasu cututtuka na yau da kullun ciki har da cututtukan zuciya da ciwon sukari. Adadin mutuwar da aka bayar a hukumance daga cutar ta COVID-19 galibi ya kasance daga mutanen da aka gwada tabbatacce ga COVID bisa ga ƙa'idodin gwamnati.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma fiye da yadda aka bayyana, saboda ba ya haɗa da mutuwar da ba a bincika ba, misali: mutuwar gida, a gidajen kulawa, da sauransu.
Wasu rahotanni daga Italiya sun nuna cewa adadin mutuwar a lokacin annobar ya fi adadin mutuwar COVID da aka bayar da rahoton a cikin kashi 4-5.
"Mujalissar Hukumar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta ce:" Mun san cewa yawan mutuwar da aka bayar ba daidai bane da ainihin adadin mutuwar, kuma wannan ya yi daidai da rahotannin da aka bayar cewa ba a ba da cikakken adadin mutuwar cutar a Amurka ba. Yawancin lokaci ana ba da cikakken adadin mutuwar a lokacin annoba kamar annobar 2009 H1N1 na mura. An tabbatar da mutuwar mutum na farko a ranar 9 ga Janairu, 2020.
A ranar 1 ga watan Fabrairu, mutuwar farko a waje da China ta faru a Philippines, kuma mutuwar farko a waje da Asiya ta faru a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, mutane sama da dozin biyu sun mutu a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, sama da ƙasashe da yankuna arba'in sun ba da rahoton mutuwar a duk nahiyoyi sai Antarctica.
Waɗannan ƙididdigar sun bambanta daga yanki zuwa lokaci, kuma ana danganta su da ƙididdigar da aka ɗauka, ayyukan cibiyoyin kiwon lafiya, yanayin rashin lafiya, lokacin da cutar ta ƙare da yanayin al'umma kamar shekaru, jinsi, da lafiyar jama'a.
Dangane da bayanan Jami'ar Johns Hopkins, matsakaicin mutuwar cutar ya kai kashi 6.0% (97,039/1 617,204) har zuwa 10 ga Afrilu 2020.
Adadin yana canzawa daga yanki zuwa yanki.
A China, yawan mace-macen da ke mutuwa ya ragu daga kashi 17.3% (masu alamun cutar a ranar 1 ga Janairu, 2020) zuwa kashi 0.7% (waɗanda ke da alamun cutar bayan 1 ga Fabrairu, 2020).Sauran ma'aunin sun haɗa da yawan mace-macen (CFR), wanda ke nuna adadin waɗanda suka kamu da cutar da suka mutu, da kuma yawan kamuwa da cutar (IFR), wanda ke nuna adadin waɗanda ke kamuwa da cutar (ko ba a gwada su ba) da suka mutu daga cutar.
Waɗannan ƙididdigar ba su dogara da ƙima ba kuma suna bin wasu mutane daga kamuwa da cutar zuwa wadata ko mutuwa.
Jami'o'i da yawa sun yi ƙoƙari su ƙididdige wannan adadi na mutane.
Cibiyar Kula da Alamar Alamar Jami'ar Oxford ta ce yawan kamuwa da cutar ya kasance tsakanin 0.1% da 0.39%.
Ƙididdigar da ke sama a cikin wannan rukunin sun dace da sakamakon gwajin COVID-19 na farko na mutane da aka yi wa allurar rigakafi a Jamus da kuma ƙididdigar binciken da ke nuna yawan mutuwar da aka yi a cikin gwajin.
Hukumar Lafiya ta Duniya ta ce cutar za a iya hana ta.
Ba a san lokacin yaduwar cutar da kuma tsawon lokacin cutar ba kuma yana iya bambanta daga yanki zuwa yanki.
Maciej Boni na Jami'ar Jihar Penn ya ce: Ba tare da sarrafawa ba, cututtukan cututtuka galibi suna zuwa da ƙarfi kuma suna raguwa lokacin da masu cutar suka mutu.
Amma yana da wuya a yi hasashen abin da zai faru a nan gaba.
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin, Zhong Nanshan, ya ce "ana iya kawo karshen annobar a watan Yuni" idan dukkan kasashen duniya suka bi umarnin WHO don hana yaduwar cutar.
A ranar 17 ga Maris, Adam Kucharski na Makarantar Kiwon Lafiya da Magungunan Yankin Gashi ta London ya yi hasashen cewa SARS-CoV-2 zai iya yin yaduwa daga wuri zuwa wuri, mai yiwuwa na tsawon shekara ɗaya ko biyu.
A cewar wani bincike na Kwalejin Imperial wanda Neil Ferguson ya jagoranta, dole ne a kiyaye keɓewar jama'a da sauran matakan "har sai an sami allurar rigakafi (a cikin watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce: "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar, saboda yawan kamuwa da ita, za ta iya zama cikakke kuma zai iya zama cuta ta yanayi, ta sake dawowa kowace shekara".
Sake dawowa da kwayar cutar mai saurin yaduwa zai dogara ne da rashin lafiyar mutum da kuma maye gurbin kwayar cutar.
Alamun COVID-19 na iya zama marasa ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Mafi yawan alamun cututtukan cututtuka sune zazzabi (88%) da tari mai zafi (68%).
Alamomin da ba a saba gani ba sune gajiya, tari, rashin wari, wahalar numfashi, ciwon tsoka da tsoka, ciwon makogwaro, ciwon kai, sanyi, amai, tari mai zub da jini, fitsari ko launin shuɗi. WHO ta ce kusan mutum ɗaya cikin shida zai kamu da cutar kuma ya sami matsalar numfashi.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da alamun bayyanar cututtuka kamar matsalolin numfashi, ciwo ko ciwon kirji, tashin hankali na lokaci-lokaci, wahalar tashi, kumburi a fuska ko lebe, waɗanda ke da waɗannan cututtukan ana ba da shawarar neman taimakon likita nan da nan idan alamun ba su ragu ba. Ci gaban cutar na iya haifar da ciwon huhu mai tsanani, matsalolin numfashi mai tsanani, zubar jini na ciki, matsalolin acid na jiki, da mutuwa.
Idan wasu masu kamuwa da cutar ba su da alamun cutar, idan ba su da alamun cutar amma sakamakon gwajin ya nuna cewa suna da cutar, masu binciken sun ba da shawarar cewa a kula da waɗanda ke da alaƙa da waɗanda aka tabbatar da cutar sosai don tabbatar da rashin cutar.
China ta ce yawan marasa alamun cutar ya kai kashi 44 cikin dari.
Lokacin bayyanar cututtuka na yau da kullun (lokacin tsakanin kamuwa da cuta da bayyanar cututtuka) yana daga kwana ɗaya zuwa 14; yawanci kwanaki kaɗan. Misali mai ban mamaki shine cewa yawan mutanen da ke da cutar COVID-19 waɗanda suka rasa ƙamshi daga 30% zuwa 15% a baya.
Wasu daga cikin hanyoyin da cutar ke yaduwa ba a san su ba tukuna.
Ana ganin cewa cutar tana yaduwa ne ta hanyar kusanci da ruwa wanda ke faruwa idan mutum ya tari, ya yi fitsari ko kuma ya kusanci wani a cikin mita 1 zuwa 2.
Bincike ya nuna cewa yin tari ba tare da rufe fuska ba zai iya sa ruwa ya yi zurfi na ƙafa 15 zuwa 15.
Wasu sun ce ana iya kamuwa da cutar ta hanyar ɓarkewar jini na dogon lokaci, wanda zai iya fitowa yayin magana.
Ruwa yana iya shiga cikin hanci ko baki daga mutane da ke kusa da su ko kuma numfashi zuwa cikin huhu.
Wasu ayyukan likita kamar su CPR da CPR na iya haifar da wannan ruwan numfashi zuwa cikin iska kuma ya haifar da yaduwar cutar ta iska.
Hakanan ana iya yadawa ta hanyar taɓa wani abu mai cutar kamar fata da kuma taɓa fuska, hanci, ko baki.
Duk da cewa akwai damuwa cewa ana iya yaduwa ta hanyar hasken rana, ana ganin cewa wannan haɗarin yana da ƙarancin gaske.
Gwamnatin China ta musanta cewa SARS-CoV-2 yana yaduwa ne daga bayan bayan mai cutar zuwa bakin mai cutar. Kwayar cutar tana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya yaduwa kafin bayyanar cututtuka da kuma lokacin kamuwa da cutar.
Mutane da aka yi wa gwaji a cikin kwanaki uku kafin su soma nuna alamun cutar suna iya kamuwa da cutar kafin su soma nuna alamun cutar.
Akwai rahotanni kaɗan na rashin alamun cutar da aka tabbatar a cikin dakin gwaje-gwaje, amma an gano cutar da ba ta nuna alamun cutar a wasu ƙasashe yayin binciken bin diddigin cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ba da shawarar cewa ba a san yadda cutar ke yaduwa ba, mai kamuwa da cutar zai iya yaɗawa zuwa mutane biyu ko uku. Kwayar cutar tana iya rayuwa na awanni ko kwanaki a wani wuri.
Musamman, kwayar cutar na iya rayuwa har zuwa kwanaki uku a kan filastik (poropyrene) da kwanaki 304 a kan ƙarfe mai ƙarfe, kwana ɗaya a kan kwali da har zuwa kwanaki huɗu a kan ƙarfe na jan ƙarfe.
Koyaya, yanayin ya bambanta dangane da yanayin zafi da zafin jiki. An gwada dabbobin gida da sauran dabbobin gida don COVID-19.
Babu wata hujja da ta nuna cewa dabbobi na iya yada cutar ga mutane, kodayake hukumomin Burtaniya sun ba da shawarar cewa mutane su wanke hannayensu bayan sun taɓa dabbobi da kuma bayan sun taɓa wuraren da mutane masu cutar za su iya aiki.
Kwayar cutar coronavirus mai saurin kamuwa da cutar (SARS-CoV-2) wata sabuwar kwayar cuta ce, wacce aka samo daga mutane uku da ke fama da cutar zazzabin cizon sauro da ke da alaƙa da cutar mura ta Wuhan.
Dukkanin siffofin sabon SARS-CoV-2 sun yi kama da na coronavirus. A waje da jikin mutum, ana kashe kwayar cutar ta sabulu na gida wanda ke lalata kumburi da rufe shi. SARS-CoV-2 yana da kamanceceniya da asalin SARS-CoV.
An yi zaton cewa ya fito ne daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa coronavirus yana cikin rukuni ɗaya da Betacoronavirus, wanda ke cikin Sarıbekovirus (dangin B) kuma dukansu sun samo asali ne daga barbashi.
Ya yi daidai da kashi 96% na sauran kwayoyin halittar kwayar cutar coronavirus na bat (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike a China sun gano bambancin amino acid guda daya a cikin tsarin kwayoyin halittar kwayoyin halitta tsakanin kwayar cutar da aka samo daga tsutsa da kuma kwayar cutar da aka samo daga mutane.
A halin yanzu, kwatancen kwayoyin halitta ya nuna cewa har zuwa kashi 92% na kwayoyin halittar coronavirus na SARS-CoV-2 a cikin ƙudaje bai isa ya tabbatar da cewa ƙudaje sun kamu da cutar ba.
Ana iya tantance kamuwa da kwayar cutar a cikin yanayin farko, yayin da za a iya tabbatar da tabbataccen gwajin ta hanyar rRT-PCR na gwajin gwaji na kwayoyin cuta ko CT.
Nazarin PCR da CT da aka yi a Wuhan ya nuna cewa CT ya fi nuna yanayin kwayar cutar fiye da PCR, kodayake ba a bayyana shi sosai ba, wasu fasalulluka na wannan hanyar a cikin dakin gwaje-gwaje suna da alaƙa da wasu hanyoyin bincike na cutar hawan jini da sauran cututtuka.
Ya zuwa watan Maris na 2020, Kwalejin Nazarin Magunguna ta Amurka ta ce: CT ba za a yi amfani da shi ba don ganewa ko amfani dashi azamanbabbanbinciken COVID-19.
WHO ta buga wasu takaddun shaida don nazarin RNA na SARS-CoV-2, tare da na farko da aka buga a ranar 17 ga Janairu.
Gwajin yana amfani da hanyar gwajin rRT-PCR na lokaci-lokaci.
Ana iya yin gwajin ne daga samfurori da aka samo daga numfashi ko jini.
Yawancin lokaci, ana samun sakamako a cikin sa'o'i ko kwanaki.
Ana yin gwajin ne ta hanyar amfani da allurar hanci, kodayake ana iya amfani da allurar hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna aiki da gwajin jini don gano ƙwayoyin cuta.
Har zuwa 6 ga Afrilu 2020, babu ɗayan waɗannan hanyoyin da aka tabbatar da samar da ƙididdigar da ta dace don amfani da su a wurare da yawa.
A cikin Amurka, gwajin jini na Cellex an amince da shi azaman magani na gaggawa amma ana amfani dashi ne kawai a cikin dakunan gwaje-gwaje masu izini.
Ana amfani da CT don bincika mutanen da ke nuna alamun ciki har da rashin cutar GGO ko ruwa a cikin huhu.
Ƙungiyar Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Magungunan Maguna.
Saboda alaƙar da ke tsakanin cutar da cutar adenovirus, gwajin ƙarfe wanda ba a tabbatar da shi ta hanyar PCR ba zai iya nuna ainihin kamuwa da COVID-19 ba.
Wani babban binciken da aka gudanar a China ya kwatanta sakamakon gwajin kirji ta hanyar CT da PCR kuma ya nuna cewa yayin da gwajin ba shi da cikakkiyar ganewar asali, yana da sauri kuma yana nuna yanayin kwayar cutar, wanda zai iya zama kyakkyawan tsarin bincike na annoba.
An tsara tsarin CNN wanda ke da hankali na wucin gadi don gano yanayin hoto na kwayar cutar ta hanyar amfani da na'urar da CT.
Matakan da za a dauka don hana yaduwar cutar sun hada da tsabtace jiki, wanke hannu, kauce wa taɓa fuska, hanci ko baki ba tare da wanke hannu ba, da yin tari ko hancin tare da tawul da kuma zubar da tawul ɗin nan da nan zuwa ma'aji.
Ana ba da shawarar masu kamuwa da cutar su sanya abin rufe fuska a wuraren taron jama'a.
Matakan nisantar kusanci suna da mahimmanci don hana yaduwar cutar. Yawancin gwamnatoci sun hana ko kuma sun ba da shawarar mutane su guji tafiye-tafiye marasa mahimmanci zuwa ko daga ƙasashe da yankunan da cutar ta ɓarke.
Amma, a wurare da dama a duniya, cutar ta kai ga yaduwar mutum zuwa mutum.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma, kuma wasu al'ummomi ba su san inda cutar ta samo asali ba ko yadda ta kamu. Ana ba da shawarar masu ba da sabis na kiwon lafiya waɗanda ke kula da wanda ke da wataƙila yana da cutar su bi ƙa'idodin kiyayewa na yau da kullun, ƙa'idodin nisantar kusanci, da kuma rufe fuska. Binciken abokan hulɗa yana da mahimmanci ga ma'aikatun kiwon lafiya don gano asalin kamuwa da cutar da hana sake yaduwa.
Amfani da bayanan wurin wayar salula na gwamnati ya haifar da damuwar sirri wanda Amnesty International da wasu kungiyoyi sama da 100 suka ba da sanarwar neman dakatar da wannan tsarin sa ido.
An ƙirƙiri aikace-aikace daban-daban ko kuma an ba da shawarar yin amfani da su ta hanyar son rai, sannan a ranar 7 ga Afrilu 2020, ƙungiyoyin masana sama da dozin suna neman mafita mafi aminci ga sirri kamar amfani da fasahar Bluetooth don adana bayanan wayar hannu da aka haɗa.
Masu amfani da waɗannan wayoyin suna karɓar saƙo idan sun kasance kusa da wanda aka gwada don COVID-19. Akwai wasu bayanan da ba daidai ba game da yadda za a hana kamuwa da cutar; misali, shafa hanci da shafa bakin bakin ba ya kashe kwayar cutar.
Babu allurar rigakafin COVID-19, amma akwai kamfanoni da yawa da ke samar da ita.
Wanke hannu yana da mahimmanci don hana yaduwar cututtuka.
CDC ta ba da shawarar cewa mutane su wanke hannayensu akai-akai da sabulu da ruwa na aƙalla dakika ashirin; musamman bayan sun fita daga bayan gida ko kuma idan hannayensu sun kasance masu lalatattu, kafin cin abinci, bayan yin tari, tari ko hancin mutum.
Wannan saboda lokacin da cutar ta fita daga jikin mutum, sabulu na gida yana kashe ta, yana da ikon karya shingen da ke rufe kwayar.
CDC ta kuma ba da shawarar yin amfani da tsabtace hannu wanda ya ƙunshi kashi 60% na alkali idan sabulu da ruwa ba su samuwa.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa kada a taɓa fuska, hanci, ko baki da hannayen da ba su da tsabta.
Kwayoyin cuta suna cikin wurare daban-daban waɗanda za a iya kashe su ta hanyar maganin da aka tsara (a cikin minti ɗaya bayan haɗuwa da maganin kashe ƙwayoyin cuta a kan ƙarfe mai ƙarfe), gami da 6271% na ethanol, 50100% na isopropanor, 0,1% na sodium hypochlorite, 0,5% na hydrogen peroxide da 0,27,5% na povidone iodine.
Sauran magungunan, kamar su benzarkonium chloride da chorohexisidine gurukonate, ba su kashe ƙwayoyin cuta yadda ya kamata.
CDC ta ba da shawarar cewa duk wuraren da ake zargi ko tabbatar da cutar COVID a cikin ɗakunan aiki ko wuraren kula da yara, kamar ofisoshi, dakunan wanka, wuraren taruwa, na'urorin lantarki na yau da kullun kamar su allunan, kayan aiki, kwamfutocin rubutu, wayoyin salula da ATM da marasa lafiya ke amfani da su, ya kamata a yi musu maganin kashe ƙwayoyin cuta.
Cibiyoyin kiwon lafiya suna buƙatar mutane su rufe hanci da baki da gashin hannu ko kuma tawul lokacin da suke tari ko hancin kuma su zubar da tawul ɗin nan da nan.
Abun rufe fuska na likita shine mafi kyawun zaɓi ga masu kamuwa da cutar, saboda sanya abin rufe fuska yana hana yawan ruwa da ke fitowa daga magana, hancinsa da tari.
Hukumar Lafiya ta Duniya ta fitar da jagororin lokacin da kuma yadda za a sanya abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin kwayar cuta a Jami'ar Leeds, Sanya abin rufe fuska yana rage yawan shafawa a fuska, inda cutar ta fi yawaita shiga idan ba a wanke hannaye yadda ya kamata ba. Ana kuma amfani da abin rufe fuska ta hanyar kula da mai cutar.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa mutanen da ba su da lafiya su sa abin rufe fuska ne kawai idan suna da haɗarin kamuwa da cutar, kamar kula da mutumin da ke da COVID-19, kuma sun yarda cewa sanya abin rufe fuska yana hana mutane taɓa fuska.
Kasashe da dama sun fara karfafawa 'yan kasarsu gwiwa su sanya abin rufe fuska.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na masana'anta da ba na likita ba.A takaice, China ta ba da shawarar cewa mutanen da ba su da lafiya su yi amfani da abin rufe fuska na likita da aka yi amfani da su musamman idan sun kusanci wasu a nesa da ƙasa da mita 1.
Hong Kong ta bukaci mutane su sanya abin rufe fuska na likita yayin tafiya ko kuma a wuraren taron jama'a.
Jami'an kiwon lafiya a Thailand za su ƙarfafa mutane su yi amfani da abin rufe fuska na masana'anta a gida kuma su wanke su kowace rana.
A Jamhuriyar Czech da Slovakia an hana fita waje ba tare da rufe baki da hanci ba.
A ranar 16 ga Maris, Vietnam ta bukaci kowa ya sanya abin rufe fuska a wuraren da jama'a ke taruwa don kare kansa da kuma kare wasu.
Gwamnatin Ostiraliya ta ba da umarnin cewa duk wanda ya shiga kantin sayar da abinci dole ne ya sanya abin rufe fuska.
Isra'ila ta bukaci dukkan mazauna kasar da su sanya abin rufe fuska a wuraren da jama'a ke taruwa.
A ranar 1 ga Afrilu, Taiwan, wanda ke samar da abin rufe fuska sama da miliyan goma a kowace rana, ta bukaci fasinjojin jiragen kasa da bas na birni da su sanya abin rufe fuska.
Panama ta kafa dokar rufe fuska a duk lokacin da ka fita waje, kuma ta bukaci a kera abin rufe fuska na gida ga waɗanda ba za su iya sayen abin rufe fuska na gida ba.
Ana amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa nesa (wanda aka fi sani da nisantar mutum) ya ƙunshi ayyukan da aka tsara don hana kamuwa da cutar don rage yaduwar kwayar cutar da kuma nisantar mutane.
Matakan sun hada da keɓewa, dakatar da zirga-zirga da rufe makarantu, wuraren aiki, filayen wasa, wuraren wasan kwaikwayo ko shaguna.
Mutane na iya yin amfani da matakan kariya ta hanyar zama a gida, rage zirga-zirga, guje wa taron jama'a, yin gaisuwa ta hanyar da ba ta dace ba, da kiyaye nesa.
A halin yanzu, kasashe da yawa suna ba da umarni ko kuma suna buƙatar mutane a cikin yankunan da ke fama da cutar su guji kusanci.
Matsakaicin adadin taron jama'a da hukumomin gwamnati da cibiyoyin kiwon lafiya na Amurka ke buƙata an rage shi da sauri daga mutane 250 (idan an san cewa babu cutar COVID-19 a yankin) zuwa 50, sannan an rage zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron mutane fiye da biyu. Tsofaffi da waɗanda ke da wasu cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da rashin lafiyar jiki waɗanda ke da haɗarin kamuwa da cututtuka da matsalolin kiwon lafiya sun ba da shawarar CDC su zauna a gida idan za su iya kamuwa da cutar daga takwarorinsu. A ƙarshen Maris, 2020, WHO da sauran cibiyoyin kiwon lafiya sun fara maye gurbin amfani da kalmar "keɓewa" da "tsayawa nesa", suna bayyana cewa an yi niyya don kiyaye haɗin kai yayin da ake buƙatar nisantar da mutane.
Amfani da kalmar "keɓewa" ya sa mutane su yi tunanin keɓewa, maimakon ƙarfafa su su ci gaba da kasancewa tare da wasu ta wasu hanyoyi. Wasu daga cikin hukumomin sun ba da jagororin da suka dace game da jima'i a lokacin annobar.
Waɗannan ƙa'idodin sun haɗa da yin jima'i tare da abokin tarayya wanda ba shi da cutar ko alamun cutar.
Keɓewa a gida ya zama dole ga mutanen da aka gwada sun kamu da COVID-19 ko kuma ake zargin suna da cutar.
Cibiyoyin kiwon lafiya sun ba da cikakkun jagororin game da mafi kyawun keɓewa. Yawancin ƙasashe sun ba da umarni ko kuma sun bukaci duk waɗanda ke zaune a wuraren da cutar ta kamu da keɓewa.
An ba da umarnin keɓewa mai ƙarfi ga waɗanda ke cikin rukunin haɗarin kamuwa da cutar.
Masu yuwuwar haɗuwa da wani mai cutar COVID-19 da waɗanda suka yi balaguro kwanan nan zuwa ƙasashe ko yankuna masu cutar da aka ba da shawarar keɓewa na kwanaki 14 daga ranar ƙarshe da za su iya haɗuwa da cutar.
Matakan kula da annoba sun haɗa da hanawa ko hanawa da rage yaduwar cutar.
Ana yin rigakafi a farkon lokacin barkewar cutar kuma ana nufin bin diddigin da keɓewar mutane da kuma samar da ƙarin matakan rigakafi da rigakafin rigakafin cutar don hana cutar daga ci gaba da yaduwa zuwa sauran al'ummomi.
Lokacin da ba za a iya hana yaduwar cutar ba, to ana mai da hankali kan rage yaduwar: ana ɗaukar matakan rage yaduwar cutar da rage tasirin cutar ga cibiyoyin kiwon lafiya da al'umma.
Ana iya ɗaukar matakan hanawa da rage yaduwar cutar a lokaci guda.
Dakatar da annobar yana buƙatar tsauraran matakan dakile annobar ta hanyar rage yawan sabbin kamuwa da cutar zuwa ƙasa da 1.
Yana rage matsalolin ayyukan kiwon lafiya na cunkoso da yawan marasa lafiya da kuma samar da isasshen lokaci don neman allurar rigakafi da magani.
Hanyoyin kula da cutar ba tare da maganin ba sun haɗa da magance cutar ta hanyar ɗaukar matakan kariya na mutum kamar tsabtace jiki, sanya abin rufe fuska da keɓewa; matakan tsaro na al'umma kamar rufe makarantu da dakatar da ayyukan jama'a; buƙatar wayar da kan jama'a da amsawa; da matakan muhalli kamar share wuraren aiki.An ɗauki wasu matakan gaggawa don magance cutar a China lokacin da cutar ta fara bayyana kamar rufe dukkan biranen da tsauraran ƙa'idodin hana zirga-zirga.
Sauran ƙasashe ma sun ɗauki matakan da suka dace don hana yaduwar cutar.
Koriya ta Kudu ta fara gwajin mutane da kewaye da keɓewa da kuma sanar da tafiye-tafiye na masu kamuwa da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda ke keɓe kansu kuma ta sanya manyan tarar waɗanda ba su yi hakan ba.
Taiwan ta kara samar da abin rufe fuska da kuma hukunta masu amfani da kayan aikin likita. Kamar yadda Burtaniya da Amurka suka nuna cewa rage yawan kamuwa da cutar (rage yawan kamuwa da cutar ba zai hana yaduwar cutar ba) da kuma hana shi (rage yawan sabbin kamuwa da cutar) duk suna da manyan matsaloli.
Matakan rage yawan kamuwa da cuta na iya rage yawan masu buƙatar kula da lafiya da kashi biyu bisa uku da rage yawan mutuwar da rabi, amma ba zai hana dubban mutane mutuwa ba yayin da cibiyoyin kiwon lafiya ke ci gaba da karɓar yawan marasa lafiya.
Dakatar da cutar zai zama mafi kyau amma ya kamata a ci gaba da yin shi har sai cutar ta sake yin yaduwa a cikin mutane (ko har sai an sami allurar rigakafi, dangane da abin da ya faru a baya), kuma cutar za ta sake dawowa idan an sauƙaƙe matakan.
Matsayi mai tsawo na hana yaduwar cutar yana da tasirin zamantakewa da tattalin arziki.
Babu takamaiman maganin da aka amince da shi don rage tasirin COVID-19, amma ana ci gaba da aikin don inganta shi, gami da nazarin magungunan gargajiya don rage tasirin kwayar cutar.
Shan magungunan mura da yawa da shan ruwa da kuma hutawa na iya taimakawa wajen rage alamun cutar.
Saboda rashin lafiya, ana buƙatar maganin oxygen, maganin ruwa, da taimakon numfashi.
Yin amfani da magungunan steroid na iya sa ka rashin lafiya.
Yawancin magunguna da aka amince da su don magance wasu cututtukan ƙwayoyin cuta ana nazarin su don maganin COVID-19.
WHO ta ba da sanarwar cewa: magungunan gargajiya dagida na iya rage tsananin alamun cutar SARS-CoV-19.
Ƙara iyawa da daidaitawa don kula da bukatun cibiyoyin kiwon lafiya don kula da marasa lafiya na COVID-19 waɗanda WHO ta bayyana a matsayin manyan matakan magance cutar.
ECDC da ofishin yanki na WHO na Turai sun ba da jagororin ga asibitoci da masu ba da sabis na kiwon lafiya na farko don sauya abubuwan da aka yi amfani da su a cikin ayyukan wasu hukumomi, kamar mayar da hankali kan ayyukan dakin gwaje-gwaje don gwajin COVID-19, dakatar da ayyukan likita da ba dole ba, keɓewa da keɓewar waɗanda ke da cutar COVID-19, da haɓaka ƙarfin sabis na kulawa ta gaggawa ta hanyar horar da likitoci da haɓaka yawan masu ba da iska da gadaje.
Akwai bambance-bambance da yawa game da asalin kamuwa da cutar (wanda aka fara gano cutar).
An fara gano sabon kamuwa da cutar coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata guda, yawan masu kamuwa da cutar coronavirus a Hubei ya karu.
Yawancin lokuta, masu kamuwa da cutar suna da alaƙa da kasuwar sayar da abinci na teku ta Huanan wanda ke sayar da dabbobi masu rai, kuma wasu rahotanni sun nuna cewa kwayar cutar ta samo asali ne daga wasu daga cikin waɗannan dabbobin; a wasu kalmomin, ta samo asali ne daga dabbobi. An gano marasa lafiyar da cutar sankarar bargo daga wani abu da ba a sani ba a ranar 26 ga Disamba kuma an kula da su ta hanyar Dr. Zhang Jixian na Asibitin Lardin Hubei, in ji Wuhan Jianghan CDC a ranar 27 ga Disamba.
A ranar 30 ga Disamba, ƙungiyar likitocin asibitin Wuhan ta sanar da abokan aikinta game da "SARS mai kama da coronavirus".
Likitoci takwas, ciki har da Li Wenliang, sun fuskanci tuhuma daga 'yan sanda saboda yada jita-jita, yayin da wani, Ai Fen, ya fuskanci tsawatawa daga shugabanninsa saboda bayyana batun.
Hukumar Kiwon Lafiya ta Wuhan ta fitar da sanarwar a ranar 31 ga Disamba ta sanar da WHO.
Hukumomin kiwon lafiya sun sami rahoto game da wasu cututtukan cutar sankarar bargo a Wuhan, wanda ya haifar da fara gwajin a farkon watan Janairu. A farkon barkewar cutar, yawan masu cutar ya ninka kusan kowane kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, kwayar cutar ta yadu zuwa wasu lardunan China, tare da taimakon sabbin hanyoyin zirga-zirgar jiragen kasa zuwa China da kuma Wuhan a matsayin cibiya da cibiyar zirga-zirgar jiragen kasa zuwa larduna daban-daban.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton kusan sabbin kamuwa da cutar 140 a rana guda, gami da biyu a Beijing da daya a Shenzhen.
Bayan haka, bayanan da aka bayar daga gwamnati sun nuna cewa mutane 6,174 sun kamu da cutar a ranar 20 ga Janairu, 2020. Ya zuwa ranar 26 ga Maris, Amurka ta zarce China da Italiya a matsayin mafi yawan masu kamuwa da cutar a duniya. Ya zuwa ranar 9 ga Afrilu, 2020, an bayar da rahoton sama da mutane miliyan 1.61 a duniya; tare da mutuwar sama da 97,000 da warkewa sama da 364,000.
Kimanin ƙasashe da yankuna 200 sun sami aƙalla mutum ɗaya da ke fama da cutar.
Saboda annobar a Turai, ƙasashen yankin Schengen sun rage tafiye-tafiye da kuma aiwatar da matakan rigakafin cutar a kan iyakoki.
Kasashe sun aiwatar da matakan kariya na gida kamar kariya (wanda aka fi sani da tsare-tsare na gida).Kamar yadda na 2 ga Afrilu, kusan mutane miliyan 300 ko kusan kashi 90% na yawan jama'a suna cikin irin wannan dokar hana fita a Amurka, kuma sama da miliyan 50 a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu da mutane biliyan 1.3 a Indiya suna cikin dokar hana fita.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin irin wannan tsarin zaman gida, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu, kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An fara gano mutum na farko da ya kamu da COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; rahotanni marasa tushe sun nuna cewa an gano mutum na farko a ranar 17 ga Nuwamba.
Dr. Zhang Jixian ya lura da marasa lafiya da ke fama da cutar zazzabin cizon sauro a ranar 26 ga Disamba, asibitin da yake aiki ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwajin asali na kwayoyin halitta da aka yi wa marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa SARS yana da alaƙa da coronavirus.
Hukumar Kula da Lafiya ta Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba.
Hukumar Lafiya ta Duniya ta samu wannan bayanin a ranar.
A cikin sanarwar, 'yan sanda sun gargadi likitocin Wuhan game da " yada jita-jita " game da cutar.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara bayyana cewa babu "tabbacin tabbatacce" na kamuwa da cutar daga mutum zuwa mutum.
A ƙarshen watan Janairu, gwamnatin China ta sanar da ƙaddamar da wani babban kamfen, wanda Babban Sakataren Jam'iyyar Kwaminis ta China, Xi Jinping, ya bayyana a matsayin "yaƙin da ya kamata mutane su yi" don hana yaduwar cutar.
A cikin abin da aka bayyana a matsayin "warewar mutane mafi girma a tarihin ɗan adam", an dakatar da takunkumin hana zirga-zirga da aka ba da sanarwar a ranar 23 ga Janairu daga Wuhan, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi kusan mutane miliyan 57.
An dakatar da zirga-zirgar jama'a a cikin gari.
An soke bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi na Huoshenshan, wanda aka gina a cikin kwanaki 10.
An gina wasu asibitoci a baya kamar asibitin Leishenshan don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitocin da aka gina, kasar Sin ta kuma mayar da wasu gine-gine 14 a Wuhan, kamar su dakunan taro da filayen wasa zuwa asibitocin wucin gadi.A ranar 26 ga Janairu, gwamnati ta ba da ƙarin umarni don magance cutar COVID-19, gami da ba da umarnin kiwon lafiya ga matafiya da tsawaita hutun bikin bazara.
Jami'o'i da makarantu a kasar sun rufe.
Yankunan Hong Kong da Macau sun ɗauki matakai daban-daban; musamman, waɗanda suka shafi makarantu da jami'o'i.
An dauki matakan yin aiki daga nesa a yankuna daban-daban na kasar Sin.
An fara aiwatar da dokar hana zirga-zirga a ciki da wajen Hubei.
An sauya hanyar sufuri ta jama'a kuma an rufe gidajen tarihi na wucin gadi a China.
An sanya takunkumin hana zirga-zirgar jama'a a birane da yawa, inda aka ce kusan mutane miliyan 760 (fiye da rabin yawan jama'a) an ba da umarnin su zauna a gida.Bayan barkewar cutar a watan Maris, hukumomin kasar Sin sun dauki tsauraran matakai don hana cutar "shigowa cikin kasar" daga wasu ƙasashe.
Misali, Beijing ta kafa dokar keɓewa ta kwanaki 14 ga duk baƙi da ke shiga birnin.A ranar 23 ga Maris, mutum ɗaya daga China ya shiga cikin ƙasar a cikin kwanaki biyar da suka gabata, ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an shawo kan yaduwar cutar daga cikin mutane zuwa cikin gida kuma yanzu an sarrafa cutar a kasar Sin.
A ranar 26 ga Maris, 2020, Ma'aikatar Harkokin Wajen ta kasar Sin ta sanar da cewa an dakatar da masu shigowa da visa ko izinin zama daga ranar 28 ga Maris, ba tare da ba da takamaiman lokacin da dokar za ta ƙare ba.
Masu son shiga kasar Sin dole ne su nemi takardar izinin shiga a ofishin jakadancin kasar Sin ko ofishin jakadancin kasar Sin.
A ranar 30 ga watan Maris, gwamnatin kasar Sin ta bukaci cibiyoyin kasuwanci da masana'antu su sake budewa, tare da bayar da tallafin kudi don dawo da cibiyoyin kasuwanci. Majalisar dokokin kasar ta ayyana ranar makoki ta kasa da mintuna uku a karfe 10:00 na ranar 4 ga Afrilu, daidai da bikin Qingming, inda gwamnati ta bukaci iyalai su yi wa mamacin sujada ta hanyar intanet don kauce wa kusanci da hana sake barkewar cutar COVID-19.
A ranar 20 ga Janairu, an tabbatar da cewa COVID-19 ya isa Koriya ta Kudu daga China.
A ranar 20 ga watan Fabrairu, Ma'aikatar Lafiya ta Kasa ta ba da sanarwar cewa an sami karuwar wadanda aka tabbatar da cutar, wanda ya fi yawa daga taron da aka gudanar a Daegu na wata sabuwar coci da aka sani da Shincheonji Church of Jesus.
Ana zargin cewa mabiyan Shincheonji da suka ziyarci Daegu daga Wuhan ne suka haifar da cutar.
A ranar 22 ga Fabrairu, daga cikin duka membobin cocin 9,336, 1,261 ko kusan 13% sun ba da rahoton bayyanar cututtuka. a ranar 23 ga Fabrairu, 2020, Koriya ta Kudu ta ba da rahoton mafi yawan adadin masu kamuwa da cutar.
A ranar 28 ga watan Fabrairu, sama da mutane 2,000 ne aka tabbatar da kamuwa da cutar a Koriya, kuma a ranar 29 ga watan Fabrairu adadin ya kai 3,150.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
Hakanan an shafi jadawalin zirga-zirgar jiragen sama kuma an canza su.Koriya ta Kudu ta ƙaddamar da shirin gwaji, wanda aka ɗauka a matsayin mafi girma kuma mafi inganci a duniya don gwajin yawan jama'a don cutar, da bin diddigin da ke keɓewa.
Hanyoyin gwaji sun haɗa da tabbatar da bayyanar cututtuka ga masu zuwa daga ƙasashen waje ta hanyar aikace-aikacen wayar hannu, gwajin kwayar cutar ga mutanen da ba su sauka daga motar ba inda sakamakon zai kasance a rana mai zuwa, da haɓaka ƙarfin gwaji don gwada mutane 20,000 kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin mai nasara wajen hana yaduwar cutar ba tare da buƙatar keɓewa na birni ba. Da farko, mutanen Koriya ta Kudu sun yi jayayya game da yadda Shugaba Moon Jae-in ya magance cutar.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a gurfanar da Moon a gaban kotu saboda rashin kulawar gwamnati game da annobar da wasu suka yaba wa yadda ta magance cutar.
A ranar 23 ga Maris, an ba da sanarwar cewa Koriya ta Kudu ta sami mafi ƙarancin adadin masu kamuwa da cutar a rana ɗaya a cikin makonni huɗu.
A ranar 29 ga Maris, an ba da sanarwar cewa daga ranar 1 ga Afrilu, sabbin masu shigowa daga ƙasashen waje za su shiga keɓewa na makonni biyu.
A ranar 1 ga Afrilu, a cewar rahotannin jaridu, Koriya ta Kudu ta nemi taimako daga kasashe sama da 121 don gwajin cutar.
A ranar 18 ga Fabrairu, Iran ta sanar da tabbatar da cutar SARS-CoV-2 ta farko a Qom, tare da mutuwar mutane biyu a ranar, a cewar ma'aikatar lafiya da ilimin likitanci.
Matakan farko da gwamnati ta ayyana sun hada da dakatar da bukukuwa da sauran ayyukan al'adu, wasanni, sallar Juma'a, rufe jami'o'i, kwalejoji da cibiyoyin ilimi.
Iran ta ba da dala tiriliyan biyar don magance cutar.
A ranar 26 ga Fabrairun 2020, Shugaba Hassan Rouhani ya ce babu wani shiri na keɓe wuraren da cutar ta bulla, amma kawai masu kamuwa da cutar za a keɓe su.
An sanar da iyakance zirga-zirgar jiragen sama a cikin biranen a watan Maris, kodayake yawancin zirga-zirgar jiragen sama tsakanin biranen sun ci gaba kafin bikin bikin sabuwar shekara ta Farisa, Nowruz.
Masallacin Shia a Qom ya ci gaba da kasancewa a bude ga mahajjata har zuwa 16 ga Maris, 2020. A watan Fabrairu, Iran ta sami mafi yawan masu kamuwa da cutar bayan China.
Ana ci gaba da zargin Iran da ɓoye adadin masu kamuwa da cutar, inda har zuwa 28 ga Fabrairu, sama da ƙasashe goma sun gano cewa an gano wasu daga Iran; wanda ke nuna cewa cutar na iya zama mafi muni fiye da 388 da gwamnatin Iran ta sanar a wannan ranar.
Majalisar dokokin Iran ta dakatar da aiki, inda aka tabbatar da 23 daga cikin mambobi 290 da cutar a ranar 3 ga Maris.
A ranar 12 ga Maris, Human Rights Watch (HRW) ta bukaci hukumomin kurkuku na Iran da su saki masu fafutukar kare hakkin dan Adam da aka tsare a kurkuku saboda adawa da gwamnati ba tare da yin amfani da makamai ba kuma su saki dukkan fursunonin da aka amince da su.
Ya ci gaba da cewa, yana da matukar hadari ga kamuwa da cutar a cikin ƙananan yankuna kamar wuraren da ba a samun isasshen magani.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana ɗaya, mafi girma a ƙasar tun farkon annobar.
A ranar 17 ga Maris, aƙalla 'yan siyasa 12 ko ma'aikatan gwamnati da ke aiki ko kuma suka yi aiki a Iran sun mutu sakamakon cutar.
Har zuwa 23 ga Maris, Iran tana da sabbin kamuwa da cutar coronavirus 50 a kowace awa da mutuwa a kowane minti goma.
Wani jami'in WHO ya ce akwai yiwuwar adadin masu kamuwa da cutar a Iran ya ninka na da aka samu sau biyar.
An kuma yi zargin cewa takunkumin da Amurka ta kakaba wa Iran na iya shafar karfin tattalin arzikin kasar wajen magance cutar.
Kwamitin kare hakkin bil adama na Majalisar Dinkin Duniya ya bukaci sassauta takunkumin tattalin arziki kan kasashen da cutar ta shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu lokacin da aka gwada matafiya biyu 'yan China da cutar SARS-CoV-2 a Roma.
Cutar ta fara karuwa sosai, wanda hakan ya sa gwamnatin Italiya ta dakatar da duk zirga-zirgar jiragen sama daga China kuma ta ayyana dokar ta baci a kasar.
An gano wasu cututtukan COVID-19 daban-daban a ranar 21 ga Fabrairu, tare da tabbatar da mutane 16 a Lombardy.A ranar 22 ga Fabrairu, Majalisar Ministoci ta ba da sanarwar sabon tsarin kula da cutar, wanda ya haɗa da keɓe mutane sama da 50,000 daga birane daban-daban a arewacin Italiya.
Firayim Minista, Giuseppe Conte, ya ce: An hana shiga da fita daga yankunan da cutar ta bulla.
An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a waɗannan yankuna.A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe makarantu da jami'o'i a duk faɗin ƙasar bayan Italiya ta sami asarar rayuka 100.
Duk manyan wasannin wasanni, gami da gasar kwallon kafa ta Italiya, an buga su ba tare da magoya baya ba har zuwa watan Afrilu; amma a ranar 9 ga Maris, an ba da sanarwar cewa an dakatar da duk ayyukan wasanni na tsawon wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin rufe kusan duk ayyukan kasuwanci ban da shagunan abinci da kantin magani.A ranar 6 ga Maris, Kwalejin SIAARTI a Italiya ta ba da umarnin likita game da hanyoyin gwajin da za a iya amfani da su.
A ranar 19 ga Maris, Italiya ta zarce China a matsayin ƙasa mafi yawan mutuwar coronavirus a duniya bayan ta sanar da mutuwar 3,405 daga cutar.
A ranar 22 ga Maris, an sanar da cewa Rasha ta aika da jiragen sama na soja guda tara dauke da kayan aikin likita zuwa Italiya.
Zuwa ranar 5 ga Afrilu, an tabbatar da mutum 128,948, mutane 15,887 sun mutu, kuma mutane 21,815 sun warke a Italiya; mafi yawansu daga yankin Lombardy.
Rahoton CNN ya nuna cewa yawan tsofaffin mutanen Italiya da rashin iyawarsu na gwada duk waɗanda ke da kwayar cutar har zuwa wannan lokacin na iya haifar da yawan mutuwar.
Matakan rigakafin cutar a Burtaniya da farko sun kasance masu sauƙi idan aka kwatanta da sauran ƙasashe masu cutar; har zuwa 18 ga Maris 2020, gwamnatin Burtaniya ba ta kafa dokar hana fita ko dokar hana fita ba.
Don haka, gwamnati ta fuskanci zargi saboda rashin gaggauta aiki da tsaurara matakan da ake da su na magance cutar.A ranar 16 ga Maris, Firayim Ministan Burtaniya Boris Johnson ya ba da sanarwar hana duk balaguron da ba dole ba da kuma kusanci da jama'a, yana ba da shawarar mutane su yi aiki daga gida idan ya yiwu kuma su guji wuraren taruwa kamar mashaya, gidajen abinci da gidajen sinima.
A ranar 20 ga Maris, gwamnati ta ba da sanarwar cewa duk wuraren nishaɗi kamar mashaya, wuraren motsa jiki da za a rufe da wuri-wuri, kuma ta yi alkawarin biyan albashi har zuwa kashi 80% na albashi na ma'aikata da iyakar £ 2,500 a wata don hana rashin aikin yi a lokacin annobar.A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar cewa an aiwatar da matakan kariya na kusanci, an hana haɗuwa da mutane fiye da biyu, an dakatar da tafiya da ayyukan waje zuwa abubuwan da suka dace.
Wannan ya bambanta da matakan da aka riga aka ɗauka, waɗanda 'yan sanda suka bi, gami da tara mutane da kuma fitar da masu halarta.
An umarci rufe yawancin kasuwancin, ban da ayyukan da ake la'akari da "mahimmanci", gami da shagunan abinci, kantin magani, bankuna, shagunan kayan gini, tashoshin mai da gareji.
A ranar 20 ga Janairu, an tabbatar da sanannen mutum na farko da ke da cutar COVID-19 a yankin Pacific Northwest na jihar Washington, wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
A ranar 29 ga Janairu, an kafa Kwamitin Kula da Yanar Gizo na Shugaban Amurka.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana gagarumin matsalar lafiya ta jama'a kuma ta kafa dokar hana shigowa daga China.
A ranar 28 ga Janairun 2020, Babban Cibiyar Kula da Lafiya ta Amurka, CDC, ta sanar da cewa ta samar da kayan aikin gwaji na kwayar cutar.
Duk da haka, Amurka ta yi jinkirin fara gwajin cutar, wanda ba ya bayyana ainihin cutar a lokacin.
Gwajin cutar ya ƙare tare da kayan aikin da ba su da inganci da gwamnatin Amurka ta yi a watan Fabrairu, da kuma rashin amincewar da gwamnatin Amurka ta ba da kayan aikin da ba ta yi ba (kamar waɗanda jami'o'i, kamfanoni da asibitoci suka yi) har zuwa ƙarshen Fabrairu, da kuma umarnin da waɗanda aka ba su izinin yin gwaji har zuwa farkon Maris (bayan an ba da izinin izinin likita).
A ranar 27 ga watan Fabrairu, jaridar Washington Post ta ruwaito cewa mutane 4,000 ne kawai aka gwada a Amurka.
A ranar 13 ga watan Maris, jaridar The Atlantic ta ruwaito cewa mutane 14,000 ne kawai aka gwada.
A ranar 22 ga Maris, Associated Press ta ba da rahoto: "Mutane da yawa da ke da alamun cututtuka da kuma takardar likita suna jira na awanni ko kwanaki don gwaji".Bayan mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci a jihar, kuma wasu jihohi sun yi hakan nan da nan.
Makarantun yankin Seattle sun dakatar da karatun a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantun a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, ƙungiyar masana ilmin cututtuka a Imperial College London ta tuntubi Amurka kan tasirin sabon coronavirus a ƙasar.
A wannan ranar ne Shugaba Trump ya sanya hannu kan Dokar Kula da Cutar Korona, wanda ya samar da dala biliyan 8.3 don tallafawa ayyukan gaggawa na hukumomin Amurka don magance cutar.
Kamfanoni sun dakatar da tafiye-tafiye na ma'aikata, sun dakatar da tarurruka, har ma sun ƙarfafa ma'aikata su yi aiki daga gida.
An dakatar da ayyukan wasanni da wasanni. A ranar 11 ga Maris, Trump ya ba da sanarwar dakatar da balaguro daga Turai, ban da Burtaniya na kwanaki 30 daga 13 ga Maris.
A rana mai zuwa, ya kara da Ingila da Ireland a cikin ƙasashen da aka hana.
A ranar 13 ga Maris, ya ayyana dokar ta baci a kasar, wanda ya ba da damar tallafawa Amurka don magance cutar.
Tun daga ranar 15 ga Maris, yawancin kasuwancin sun rufe ko rage awoyi a duk faɗin Amurka don rage yaduwar kwayar cutar.
A ranar 17 ga Maris, an tabbatar da cewa an kamu da cutar a cikin jihohi 50 da Gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa New York City tana da sabbin kamuwa da cutar coronavirus 10,700, wanda ya fi yawan masu kamuwa da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce an sami ci gaba mai kyau a cikin kiyayewar kusanci, daga kwanaki 2.0 zuwa kwanaki 4.7 don ninka adadin masu kamuwa da cutar.
A ranar 28 ga Maris, an tabbatar da mutane 32,308 da cutar a Birnin New York, kuma 672 daga cikinsu sun mutu daga cutar. A ranar 26 ga Maris, Amurka ta ba da rahoton mafi yawan masu kamuwa da cutar coronavirus a duniya, gami da China da Italiya. Har zuwa 8 ga Afrilu, an tabbatar da mutane 400,335 da cutar a Amurka, tare da mutuwar 12,841.
A cewar rahotanni a ranar 30 ga Maris, Shugaba Trump ya tsawaita dokar hana fita har zuwa 30 ga Afrilu.
A wannan ranar, jirgin ruwan USNS Comfort, wanda ke dauke da asibiti mai gadaje 1,000, ya isa tashar jirgin ruwan New York.
A ranar 3 ga Afrilu, Amurka ta samu mutuwar mutum 884 a cikin awanni 24 da cutar coronavirus ta kashe.
A ranar 3 ga Afrilu, New York ta kai adadin masu kamuwa da cutar sama da 100,000. Shugaban Amurka ya fuskanci zargi saboda rage girman annobar da kuma sarrafa saƙon da kuma umarci shugabannin ma'aikatar lafiya da masana kiwon lafiya su bincika maganganun jama'a da bayanan da ofishin Mataimakin Shugaban Amurka, Mike Pence ya bayar.
A cikin duka, ba a sami daidaituwa tsakanin magoya bayan Trump game da yadda ya magance cutar ba.
Wasu jami'an Amurka da 'yan jarida sun soki Amurka saboda ta hana shigo da kayayyakin masarufi daga China, gami da kayan aikin likita na asali.
An yi nazarin tafiye-tafiyen jirgin sama don ganowa da tsara yaduwar cutar kuma an buga su a cikin The Journal of Travel Medicine a tsakiyar Janairu 2020.
Dangane da bayanan 2018 na Ƙungiyar Kula da Sufurin Jiragen Sama ta Duniya (IATA), Bangkok, Hong Kong, Tokyo da Taipei sun sami mafi yawan masu tafiya daga Wuhan.
An kuma bayyana cewa Dubai, Sydney, da Melbourne sune wuraren da aka fi ziyarta daga Wuhan.
An bayyana Bali a matsayin ɗaya daga cikin biranen 20 da aka fi ziyarta amma ba a shirya su sosai don cutar ba, yayin da biranen Ostiraliya suka kasance a shirye sosai.A ranar 7 ga Fabrairu, Ostiraliya ta ba da sanarwar shirin rigakafin sabon kwayar cutar coronavirus (COVID-19).
Ya ce akwai sauran abubuwa da yawa da za a yi bincike a kai game da COVID-19, kuma Ostiraliya za ta mai da hankali kan sarrafa kan iyakoki da musayar bayanai don magance cutar.
A ranar 21 ga Maris, Ostiraliya ta ba da umarnin hana yaduwar cutar da kare jama'a.
Dangane da sakamakon dakatar da zirga-zirgar jama'a a Wuhan, Hubei, ƙasashe da yawa sun shirya kwashe 'yan ƙasa da jami'an diflomasiyyarsu, galibi ta hanyar jigilar jiragen sama, tare da hukumomin China suna ba da takaddun da suka dace.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus da Thailand na cikin ƙasashe na farko da suka fara shirin kwashe 'yan ƙasa.
Pakistan ta ce ba za ta maido da 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu ban da 'yan Poland hudu, da wani dan China da kuma wani dan Indiya.
An sauya wa 'yan ƙasar Poland, China da Indiya zuwa Poland, inda jirgin na Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
Ana keɓe 'yan Brazil da suka yi tafiya zuwa Wuhan a wani sansanin soja kusa da Brasília.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko da 39 daga jirgin biyu da gwamnatin Amurka ta bayar) daga Wuhan zuwa CFB Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin saman Kanada mai dauke da 'yan Kanada 185 daga Wuhan ya yi hatsari a CFB Trenton.
A ranar 3 da 4 ga watan Fabrairu, hukumomin Australia sun kwashe mutane 277 zuwa gidan yarin tsibirin Kirsimeti, wanda aka mayar da shi wurin keɓewa na kwanaki 14.
Jirgin da ke dauke da mutanen da suka dawo New Zealand ya sauka a filin jirgin saman Auckland a ranar 5 ga Fabrairu; an killace fasinjojin (ciki har da 'yan asalin Australia da tsibirin Pacific) a sansanin soja na Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa daga jirgin ruwan Diamond Princess.
A ranar 21 ga watan Fabrairu, jirgin da ke dauke da fasinjojin Kanada 129 da aka kwashe daga jirgin Diamond Princess ya yi hatsari a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar ta daga Iran. A ranar 14 ga Maris, jirgin saman South African Airways wanda gwamnatin Afirka ta Kudu ta bayar ya kwashe' yan Afirka ta Kudu 112.
An fara gwajin asibiti, inda aka cire mutane huɗu daga Afirka ta Kudu waɗanda ke nuna alamun cutar coronavirus don rage haɗarin.
Sai kawai 'yan Afirka ta Kudu da ba su da alamun cutar sun dawo gida.
Sakamakon gwajin ya nuna cewa duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal da ma'aikatan aikin ceto, an ci gaba da sanya su cikin keɓewa na kwanaki 14 a cikin Ranch Resort don kariya.
A ranar 20 ga Maris, Amurka ta fara dawo da wasu dakarun da ke Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen Sin ta ce kasashe 21 (da suka hada da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da tallafi ga kasar Sin.
Wasu ɗaliban jami'o'in kasar Sin a Amurka sun haɗa kai don taimakawa wajen aika kayan agaji zuwa yankunan da cutar ta shafa na China, inda wata babbar ƙungiya a Chicago ta tattara abin rufe fuska N95 kusan 50,000 don asibitoci a lardin Hubei a ranar 30 ga Janairu. Direct Relief, tare da haɗin gwiwar FedEx, sun aika da abin rufe fuska 200,000 da sauran kayan kariya na musamman, gami da safofin hannu da riguna, waɗanda aka kawo su zuwa asibitin Wuhan Union ta jirgin sama na musamman a ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun ba da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da maganin cutar da kuma kare "al'ummomin da ke cikin haɗari a Afirka da Asiya".
Kamfanin talbijin na Interaksyon ya ruwaito cewa gwamnatin China ta ba da gudummawar abin rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta tura tallafin da ya kai dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da kayan rufe fuska miliyan 1 ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta ba da ƙarin tan na kayan aikin likita ga Wuhan, Malaysia ta ba da sanarwar ba da kayan rufe fuska miliyan 18 ga China, Jamus ta ba da kayan aikin likita da suka haɗa da rigunan rigakafi na musamman 10,000, kuma Amurka ta ba da tan 17.8 na kayan aikin likita ga China kuma ta yi alkawarin ƙarin dala miliyan 100 don taimakawa tattalin arzikin sauran ƙasashen da annobar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da ƙwararrun ƙwararru don taimakawa Italiya magance cutar coronavirus.
Babban attajirin Jack Ma ya aika da kayan gwaji miliyan 1.1, abin rufe fuska miliyan 6, da kayan kariya 60,000 zuwa Addis Ababa, Habasha don rarraba su ga Tarayyar Afirka.
Daga baya, ya aika wa Panama kayan gwaji 5,000, abin rufe fuska 100,000, da na'urorin numfashi 5.
Ma kuma ta ba da kayan aikin likita ga Kanada. Netherlands, Spain, Turkey, Georgia, da Jamhuriyar Czech sun nuna damuwarsu game da abin rufe fuska da kayan gwaji da aka yi a China.
Misali, Spain ta dakatar da amfani da kayan gwajin cutar coronavirus 58,000 da aka yi a China waɗanda ke da inganci na kusan 30%, yayin da Netherlands ta cire 600,000 na masks na China saboda suna da lahani.
Belgium ta cire takunkumin rufe fuska 100,000 da ake zargi da shigowa daga China, amma a zahiri sun fito ne daga Colombia.
A wani bangare kuma, an samu karbuwa sosai ga tallafin da kasar Sin ta bayar a sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da ayyukan agaji na gaggawa a kasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa matakin da hukumomin kasar Sin suka dauka na dakile yaduwar cutar.
Hukumar Lafiya ta Duniya ta ce akwai bambanci tsakanin barkewar cutar SARS ta 2002-2004, inda aka zargi hukumomin kasar Sin da yin asirin ta kuma hana matakan rigakafi da sarrafawa, da kuma barkewar cutar ta yanzu inda gwamnati "ta ba da sanarwar kai tsaye don hana fargaba kafin hutun Sabuwar Shekara".
A ranar 23 ga Janairu, bayan babban jami'in ya yanke shawarar aiwatar da dokar hana fita daga Wuhan, Gauden Galea, wakilin Hukumar Lafiya ta Duniya, ya ce duk da cewa "ba shawarar WHO ba ce", amma "alamu ne masu karfi na kokarin dakile cutar a inda ta riga ta bayyana" kuma ya kira ta "babbar tarihi a cikin lafiyar jama'a". A ranar 30 ga Janairu, bayan an tabbatar da wasu mutane a wajen China da kuma karuwar adadin masu kamuwa da cutar a wasu ƙasashe, Hukumar Lafiya ta Duniya ta ayyana cutar a matsayin gaggawa ta lafiyar jama'a ta duniya (ICHEP), wanda shine karo na shida a cikin jerin gaggawa na gaggawa na duniya saboda annobar a shekarar 2009.
Darakta Janar na Hukumar Lafiya ta Duniya, Tedros Adhanom, ya ce PHEIC yana da haɗarin yaduwa a duniya, musamman a ƙasashe masu talauci da matsakaitan kuɗi waɗanda ba su da ingantaccen tsarin kiwon lafiya.
Game da aiwatar da dokar hana zirga-zirga, Tedros ya ce "babu wani dalili da zai sa a hana zirga-zirgar mutane da kasuwanci" kuma "WHO ba ta ba da shawarar dakatar da zirga-zirga da zirga-zirga ba".
A ranar 5 ga Fabrairu, WHO ta nemi ƙasashe su ba da gudummawar dala miliyan 675 don tallafawa shirye-shiryen yaduwar cutar a ƙasashe masu tasowa, tana mai cewa yana da gaggawa don tallafawa ƙasashe waɗanda "suna da ƙwarewar gano ƙwayoyin cuta, koda kuwa suna da ƙwarewa".
Tedros ya kuma bayyana cewa "dukanmu muna da ƙarfin da muke da shi a cikin rauninmu" kuma ya yi kira ga ƙasashe "su saka hannun jari a yau ko kuma su biya ƙarin daga baya".A ranar 11 ga Fabrairu, a wani taron manema labarai, WHO ta tabbatar da cewa COVID-19 shine sunan cutar.
A wannan ranar, Tedros ya sanar da cewa Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince da ba da "dukan ƙarfin Majalisar Dinkin Duniya don neman mafita".
An kafa wani rukunin kula da rikicin na Majalisar Dinkin Duniya don daidaita ayyukan Majalisar Dinkin Duniya, wanda Hukumar Lafiya ta Duniya ta ce zai ba da "mafificin hankali ga kula da kiwon lafiya yayin da sauran hukumomi za su iya ba da gogewarsu don magance tasirin cutar ga zamantakewa, tattalin arziki, da ci gaba gaba ɗaya".
A ranar 14 ga Fabrairu, an kafa wani rukunin hadin gwiwa na WHO tare da kasar Sin don zaɓar ƙwararrun ƙwararrun ƙasashen duniya da WHO da za su tura China don taimakawa wajen kula da kula da cutar da kuma kula da cutar" ta hanyar gudanar da horo tare da manyan hukumomi da hukumomi na cikin gida da kuma ziyarar wurare don kimanta "matsayin tasirin ayyukan rigakafin cutar a larduna da yankuna ciki har da yankuna na karkara da birane".A ranar 25 ga Fabrairu, WHO ta ba da sanarwar cewa "duniya ta yi aiki tuƙuru don shirya don cutar coronavirus", ta ba da shawarar cewa duk da cewa cutar ta fara a farkon lokacin, ana iya kiran ƙasashe "shirye-shiryen".
Don magance yaduwar cutar a Iran, WHO ta aika da wata ƙungiya ta haɗin gwiwa don nazarin halin da ake ciki.A ranar 28 ga Fabrairu, jami'an WHO sun ba da sanarwar cewa za a haɓaka ƙimar cutar coronavirus a duniya daga matakin "babba" zuwa "mafi girma", matakin gargadi da kimantawa mafi girma.
Mike Ryan, babban daraktan shirin agaji na WHO, ya yi gargadi: "Wannan ita ce ainihin ma'auni ga kowace ƙasa a duniya: Ku farka.
Cutar tana gabatowa kuma dole ne ku kasance cikin shiri", ya jaddada cewa tsauraran matakai na iya taimakawa wajen hana "hadarin da ke tattare da ita".
Ryan ya ci gaba da cewa bayanan da ake da su ba su sa hukumomin kiwon lafiya su ayyana cutar a matsayin annoba ta duniya ba, yana mai cewa yin hakan zai nuna cewa "a zahiri mun yi imanin cewa kowa a duniya zai kamu da cutar".
A ranar 11 ga Maris, WHO ta ayyana coronavirus a matsayin annoba.
Darakta Janar ya ce WHO "ta damu matuka game da saurin yaduwar cutar da kuma rashin daukar matakan da suka dace". WHO ta fuskanci mummunan suka saboda rashin daukar matakan da suka dace don hana cutar, kamar sanarwar da ta yi game da matsalar lafiyar jama'a da kuma sanya kwayar cutar a cikin jerin cututtukan.
Wasu daga cikin ƙalubalen da aka fuskanta sun haɗa da neman shugaban WHO Tedros Adhanom ya yi murabus har zuwa ranar 6 ga Afrilu, wanda ya sami sa hannun mutane 733,000.
A ranar 26 ga Maris, 2020, masana kan hakkin dan adam na Majalisar Dinkin Duniya sun jaddada girmama haƙƙin kowane mutum a lokacin annobar COVID-19.
Kungiyar ta bayyana cewa kowane mutum na da hakkin samun kulawar lafiya kuma gwamnati ce ke da alhakin hakan.
Kungiyar ta jaddada cewa rashin kudi ko inshorar lafiya bai kamata ya zama dalilin nuna wariya ga wata kungiya ba.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, gami da nakasassu, membobin kungiyoyin da ba su da wata dama, tsofaffi, masu gudun hijira, marasa gida, masu fama da talauci, fursunoni, har ma da 'yan gudun hijira da sauran kungiyoyin da ke bukatar taimakon gwamnati.
Ƙungiyoyin ƙasa da ƙasa da gwamnatoci suna magance matsalolin tattalin arziki da zamantakewar da cutar COVID-19 ta haifar.
Kungiyar hadin gwiwa ta tattalin arziki da ci gaba ta kirkiro wani dandamali don samar da cikakken bayani da kuma ingantaccen bayani game da manufofi da ke magance wannan matsalar a kasashe a duniya, da kuma ra'ayoyi da shawarwari daban-daban.
Daga manufofi don ƙarfafa cibiyoyin kiwon lafiya da tattalin arziki na duniya don magance tasirin dokar hana fita da rage yawan motsi, matakan da aka tsara ta hanyar fasaha sun haɗa da Tsarin Gano Masu Cutar, kuma suna nufin taimaka wa ƙasashe su koya daga juna da kuma haɗa kan dabarun duniya don magance coronavirus.
Gwamnatin China ta fuskanci suka daga Amurka, Ministan Harkokin Wajen Burtaniya, Michael Gove, da Eduardo Bolsonaro, dan Shugaban Brazil, Jair Bolsonaro, saboda yadda ta dauki annobar da ta fara a lardin Hubei.
An kori wasu jami'an jam'iyyar kwaminis ta kasar Sin (CPC) da dama daga mukaman su a lardin saboda yadda suka dauki matakin killace mutane a tsakiyar kasar Sin, a matsayin wata alama ta rashin jin dadin yadda hukumomin siyasa ke kula da annobar a yankunan.
Wasu masu sharhi sun yi amannar cewa an yi wannan matakin ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da annobar coronavirus.
Wasu jami'an kasar Sin, ciki har da Zhao Lijian, sun musanta cewa cutar coronavirus ta fara ne a Wuhan, suna mai da hankali kan koyarwar yaudara game da COVID-19 daga Amurka ko Italiya.
Gwamnatin Donald Trump a Amurka ta kira coronavirus "Covid-19 na kasar Sin" ko "Covid-19 na Wuhan" a matsayin wani ɓoye-ɓoye da China ta yi don tabbatar da cutar ta zama annoba ta duniya. Amma wasu sun soki wannan a matsayin nuna bambanci da kuma ɓatar da hankali daga gazawar gwamnatin ta wajen dakile cutar.
Shafin "Daily Beast" ya sami rahoton gwamnatin Amurka game da manufofin sadarwa da ake zargin sun samo asali ne daga Hukumar Tsaro ta Kasa, inda aka bayyana cewa "Dukkanin game da China ne.
An gaya mana cewa dole ne mu yi iya ƙoƙarinmu don isar da wannan saƙon a ko'ina kamar a cikin hirar manema labarai da kuma shirye-shiryen talabijin. "Jaridun kamar su Politico, Foreign Policy, da Bloomberg sun nuna cewa yawan tallafin da China ke bayarwa a ƙasashen waje wata hanya ce ta samun rinjaye a duniya.
Shugaban kungiyar Tarayyar Turai Josep Borrell ya yi gargadin cewa akwai matsala a cikin dangantakar siyasa tsakanin kasashen da suka hada da neman iko a kan wasu kasashen ta hanyar nuna kai da kuma 'siyasa ta jin kai'".
Borrell ya kara da cewa "China ta ba da sako a fili cewa, sabanin Amurka, ita abokiyar zama ce mai kyau da kuma abin dogaro".
China ta kuma bukaci Amurka ta dage takunkumin da ta kakaba wa Syria, Venezuela da Iran, yayin da ake zargin cewa China ta tura tallafi ga Venezuela da Iran.
A ranar 3 ga Afrilu, an hana kyautar Jack Ma na abin rufe fuska 100,000 zuwa Cuba saboda takunkumin Amurka.
An kuma zargi shugabannin Amirka da karkatar da taimakon da ake ba wa ƙasashen waje zuwa ƙasarsu.
Akwai kuma wasu takaddama kan abin rufe fuska tsakanin wasu kasashe; kamar Jamus, Austria da Switzerland; har ma tsakanin Jamhuriyar Czech da Italiya.
Ƙari ga haka, Turkiyya ta kwace ɗarurruwan na'urorin numfashi da aka kai Spain.
A farkon watan Maris, gwamnatin Italiya ta soki Tarayyar Turai saboda rashin nuna goyon baya ga Italiya a lokacin da cutar coronavirus ta yi tasiri.
Maurizio Massari, jakadan Italiya a Tarayyar Turai ya ce, "China ita kadai ce ta taimaka wa Italiya.
Wannan ba alama ce mai kyau ba ce ta hadin kan Turai".
A ranar 22 ga Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aikawa da likitoci, motocin kashe kwayoyin cuta, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi amfani da "bayanan da aka samu daga wani babban jami'in" wanda ba a bayyana sunansa ba, yana cewa kashi 80 cikin dari na tallafin Rasha "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Mai gabatar da rahoto ya zargi Rasha da kokarin haifar da "rikicin siyasa da diflomasiyya" tsakanin kasashen.
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya, Luigi Di Maio, sun musanta rahotannin da aka yi a kafofin watsa labarai kuma sun nuna goyon baya ga Rasha.
Rasha ta kuma aika da jirgin sama mai jigilar kayayyakin kiwon lafiya zuwa Amurka.
"A lokacin da Putin ya ba da taimako ga takwarorinsa na Amurka, yana tunanin cewa idan Amurka ta sami ci gaba sosai a masana'antar kiwon lafiya, za su iya taimaka mana idan ana bukatar hakan", in ji mai magana da yawun shugaban Rasha, Dmitry Peskov.
A cikin 'yan kwanaki, za a gudanar da atisayen soji na NATO "Defender 2020" a cikin Jamus, Poland, da Baltic, wanda shine mafi girman atisayen NATO tun bayan ƙarshen Cold War.
Babban sakataren yakin neman yaki da makaman nukiliya, Kate Hudson, ya soki atisayen soja da ake kira Defender 2020: "A cikin wannan matsalar lafiyar jama'a da muke ciki, ba wai kawai sojojin Amurka da sauran kasashen Turai ke fuskantar barazana ba amma har da al'ummomin kasashen da suke aiki". Kwayar cutar ta yi mummunan tasiri ga gwamnatin Iran, inda wakilan jama'a ashirin da huɗu da manyan tsoffin 'yan siyasa suka kamu da cutar.
A ranar 14 ga Maris, 2020, Shugaban Iran Hassan Rouhani ya rubuta wasiƙar neman taimako ga shugabannin duniya, yana mai cewa kasarsa tana fuskantar matsalar magance cutar saboda rashin iyawar ta zuwa kasuwannin duniya saboda takunkumin da Amurka ta sanya wa Iran. Cutar ta sa Amurka ta aiwatar da manufofin inganta rayuwar da aka saba da su a wasu kasashe masu tasowa, gami da kiwon lafiya na yau da kullun, kula da yara a duniya, hutun iyali da aka biya, da kuma ingantaccen tallafi ga lafiyar jama'a.
Masu nazarin siyasa sun yi tsammanin hakan na iya yin tasiri ga damar da Donald Trump ke da ita na sake zaɓar shugaban kasa a zaben 2020.
Koriya ta Kudu ta soki Japan saboda "ta'addanci da ke nuna rashin tsaro" bayan da Japan ta sanar da cewa duk wanda ya bar Koriya ta Kudu za a killace shi na makonni biyu a wani wuri da gwamnati ta tsara.
Da farko dai, al'ummar Koriya ta Kudu sun yi ta jayayya kan yadda Shugaba Moon Jae-in zai magance wannan matsala.
Yawancin 'yan Koriya sun sanya hannu kan takardar neman a kori Moon daga mulki saboda abin da suka ce gwamnati ta yi ba daidai ba wajen magance cutar, ko kuma sun yaba da yadda ta yi. Cutar ta sa ƙasashe su kafa dokar ta baci don magance ta.
Wasu masu sharhi sun nuna damuwa cewa hakan zai iya sa gwamnati ta ci gaba da mulki.
A Hungary, majalisar dokokin ta kasar ta kada kuri'ar ba Firayim Minista Viktor Orbán damar yin mulki har abada, dakatar da majalisa da zabuka da kuma hukunta wadanda ake zargi da yada labaran karya game da kwayar cutar da kuma yadda gwamnati ke magance matsalar.
Cutar kwayar cutar coronavirus ta haifar da karancin kayayyaki da yawa, sakamakon karuwar amfani da kayan aikin rigakafi a duniya, sayayya mai yawa, da kuma katsewar masana'antu da ayyukanta.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargaɗi game da ƙarancin magunguna da kayan aikin likita saboda ƙaruwar buƙatun masu amfani da kuma rikicewar masu jigilar kayayyaki.
A wurare da dama, an sami tashin hankali a cikin cin kasuwa wanda ya haifar da wasu kayan masarufi kamar abinci, takarda na bayan gida, ruwan kwalba, wanda ke haifar da karancin kayayyaki a kasuwa.
Kamfanonin fasaha musamman sun ba da shawara game da jinkirin aikawa da kayan lantarki.
A cewar Darakta Janar na Hukumar Lafiya ta Duniya Tedros Adhanom, ana bukatar kayan kariya sau 100.
Wannan ya haifar da hauhawar farashin kaya sau ashirin kuma ya haifar da jinkiri a cikin samar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Hakanan ya haifar da karancin kayan kariya na duniya, wanda WHO ta ce zai haifar da barazanar lafiyar ma'aikatan kiwon lafiya.
A Ostiraliya, annobar ta samar da sabuwar dama ga masu kasuwanci da ba a yarda da su ba don sayar da kayayyakin Australiya a China.
Wannan ya haifar da raguwar samar da madarar jarirai a wasu gidajen abinci kuma daga baya Gwamnatin Ostiraliya ta dakatar da shi. Duk da karuwar adadin masu cutar COVID-19 a arewacin Italiya da lardin Wuhan, wanda ya haifar da karuwar yawan masu buƙatar abinci, babu wata babbar matsalar karancin abinci a waɗannan yankuna biyu.
Matakan da China da Italiya suka dauka na dakile masu cin kasuwa da yawa da kuma cinikin da ba a yarda da shi ba sun yi tasiri, wanda hakan ya rage karancin abinci da ake tsammani a Turai da Arewacin Amurka.
Arewacin Italiya, inda yawan amfanin gona ya fi yawa, bai ragu sosai ba, amma wakilan masana'antu sun yi gargadin cewa farashin zai iya tashi.
Kasuwancin abinci da ke cikin gida sun kasance na ɗan lokaci, kuma a Wuhan, hukumomin kasar Sin sun buɗe kantunan alade don samar da abinci mai yawa ga jama'a.
Irin wannan dokar ta wanzu a Italiya, inda ake buƙatar masana'antun abinci su ci gaba da adana kayan da za a iya kira a cikin gaggawa.
Sakamakon tattalin arzikin duniya ya shafi China: a cewar rahotannin da aka bayar a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi matukar koma baya a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka don dakile yaduwar cutar, tare da raguwar cinikin da ya ragu da kashi 20.5%.
Saboda tattalin arzikin kasar Sin da masana'antar da ke da karfi, annobar ta zama babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na sashen leken asirin The Economist ya yi gargadin cewa kasuwannin za su ci gaba da zama cikin damuwa har sai an sami cikakken hoto game da yiwuwar samun riba.
A watan Janairun 2020, wasu manazarta sun nuna cewa koma bayan tattalin arziki sakamakon tasirin cutar a kan farfadowar tattalin arzikin duniya na iya wuce barkewar cutar SARS a 2002-2004.
Wani ƙididdigar da masana a Jami'ar Washington a St. Louis suka bayar ya nuna tasirin sama da dala biliyan 300 a kan jerin ƙimar duniya kuma wannan na iya ɗaukar shekaru biyu.
An ce kungiyar kasashen masu samar da man fetur ta OPEC ta "yi matukar damuwa" bayan da farashin mai ya fadi kasa saboda China ba ta da bukatarsa.
A ranar 24 ga Fabrairu, kasuwannin hada-hadar kuɗi da na duniya sun faɗi saboda ƙaruwar yawan masu kamuwa da COVID-19 a wajen China.
A ranar 27 ga Fabrairu, saboda ƙaruwar matsalar yaduwar cutar coronavirus, manyan kasuwannin Amurka da manyan kasuwannin hada-hadar kuɗi, gami da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun bayyana asarar mafi girma tun 2008, inda Dow ya faɗi da maki 1,191, mafi girman asarar rana ɗaya tun farkon rikicin tattalin arziki na 2007-08.
Dukkanin matakan uku sun ƙare mako a ƙasa da 10%.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta amince da darajar bashi na kasar Sin, amma har yanzu yana da mummunan sakamako.
Kasuwancin kuɗi da hannun jari sun faɗi saboda tsoron coronavirus, wanda ya faɗi a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai iya faɗuwa.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa manyan bankuna da gwamnatoci kan matakan tallafi da aka dauka a kan kari.
Babban bankunan duniya sun amsa cutar da sauri fiye da yadda suka yi a lokacin Babban Tashin Tattalin Arziki na 2008.
Yawon shakatawa ya kasance ɗayan ɓangarorin da cutar ta fi shafa saboda ƙuntatawa na balaguro, rufe wuraren taron jama'a da wuraren shakatawa, da kuma umarnin gwamnati na hana duk wani tafiya a duniya.
Sakamakon haka, yawancin kamfanonin jiragen sama sun dakatar da zirga-zirgar jiragen sama saboda ƙarancin fasinjoji, gami da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na Flybe na Burtaniya ya rufe gaba ɗaya.
Sakamakon da aka samu a kan manyan jiragen ruwa na fasinja ya kasance a matakin da ba a taɓa gani ba.
An rufe tashoshin jirgin ƙasa da tashoshin jiragen ruwa da yawa.
Cutar ta zo daidai da Chunyun, babban lokacin tafiya don bikin Sabuwar Shekarar China.
Hukumomin jihohi da na kananan hukumomi sun soke yawancin abubuwan da ke faruwa a cikin jama'a, gami da bikin sabuwar shekara, inda kamfanoni masu zaman kansu suka rufe shagunan su da wuraren yawon bude ido kamar Hong Kong Disneyland da Shanghai Disneyland suma sun rufe.
Yawancin bukukuwan Sabuwar Shekara da wuraren yawon bude ido sun rufe don kauce wa taron jama'a, gami da Forbidden City a Beijing da kuma bikin gargajiya na gidajen ibada.
A larduna 24 daga cikin 31, manyan birane da yankuna na kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara har zuwa ranar 10 ga Fabrairu, suna ba da umarnin cewa yawancin wuraren aiki ba za su sake buɗewa ba har zuwa wannan ranar.
Waɗannan yankuna suna da kashi 80% na GDP na ƙasar da kashi 90% na fitarwa.
Hong Kong ta tsaurara matakan rigakafin cutar, ta ba da sanarwar dokar ta baci, rufe makarantu har zuwa Maris da kuma dakatar da bukukuwan Sabuwar Shekara. An shafi masana'antar gabaɗaya, tare da rage lokutan buɗe shaguna ko rufewa na ɗan lokaci.
Masu ziyartar cibiyoyin kasuwanci na Turai da Latin Amurka sun ragu da kashi 40 cikin ɗari.
Masu siyarwa a Arewacin Amurka da Gabas ta Tsakiya sun ragu da kashi 50-60%.
Wannan kuma ya haifar da raguwar 33-43% a cikin kasuwancin da aka yi a watan Maris idan aka kwatanta da na Fabrairu.
Masu siyarwa a manyan kantunan duniya sun ƙara matakan, kamar inganta tsaftacewa, sanya na'urorin auna zafin jiki don auna zafin jiki na abokan ciniki da dakatar da bukukuwa.A cewar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, annobar za ta bar tsakanin mutane miliyan 14 zuwa 22 a Latin Amurka cikin talauci fiye da yadda za ta kasance ba tare da ita ba.
A watan Janairu da Fabrairun 2020, a lokacin da cutar ta barke a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin ma'aikatan karkara miliyan 300 na kasar Sin suna tsare a gida a cikin lardin ciki ko lardin Hubei.A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma suna neman taimakon gwamnati.
A cewar Babban Bankin Tarayya na St. Louis, annobar coronavirus na iya haifar da asarar ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa kashi 32%. A Indiya, Shirin Tsayawa a Gida ya bar miliyoyin 'yan Indiyawan da ke zaune a gida ba tare da aiki ba. Binciken da Angus Reid ya yi ya nuna cewa kashi 44% na iyalai a Kanada sun sami matsalar rashin aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka fara Shirin Tsayawa a Gida a tsakiyar Maris 2020.
A rabin rabin watan Maris, ma'aikata Faransanci miliyan 4 sun nemi fa'idodin rashin aikin yi na wucin gadi, kuma ma'aikata Burtaniya miliyan 1 sun nemi shiga cikin tsarin bashi na gama gari. Kimanin rabin miliyan na kamfanoni a Jamus sun tura ma'aikatansu zuwa shirye-shiryen wucin gadi na wucin gadi da gwamnati ke tallafawa da ake kira Kurzarbeit'.
An yi amfani da tsarin biyan diyya na ɗan lokaci a Jamus a Faransa da Ingila.
Masana'antar zane-zane da al'adun gargajiya sun sami babban tasiri daga cutar, ta shafi ayyukan hukumomi da mutane (masu aiki da masu zaman kansu) a duniya.
Kungiyoyin al'adu da fasaha sun yi ƙoƙari su kula da alhakin su (galibi tare da tallafin jama'a) don kiyaye abubuwan al'adu, kula da lafiyar ma'aikata da jama'a da tallafawa masu fasaha a duk inda zai yiwu.
A watan Maris na 2020, a duk duniya da kuma a wurare daban-daban, gidajen tarihi, dakunan karatu, wuraren baje kolin, da sauran cibiyoyin al'adu sun rufe gaba ɗaya kuma an soke ko kuma an jinkirta baje kolin su, abubuwan da suka faru da kuma abubuwan da suka faru.
Don magance matsalar, an ɗauki matakan samar da ƙarin sabis na fasaha. Wani babban matakin kwanan nan wanda ke hanzarta raguwar annobar shine dakatar da duk bukukuwa, manyan abubuwan wasanni da sauran abubuwan da ke tattare da jama'a kamar kide kide, taron fasaha da kuma nunin kayan kwalliya.
Masana'antar fina-finai ma ta yi kaca-kaca. Vatican ta sanar da cewa an soke bikin mako mai tsarki a Rome, wanda ke faruwa a karshen makon karshe na lokacin tuba na Krista a lokacin Lent.
Diocese da yawa sun umurci Kiristoci tsofaffi su zauna a gida maimakon su halarci coci a ranar Lahadi; wasu ikilisiyoyi sun watsa taron a rediyo, Intane, ko kuma talabijin, wasu kuma sun yi amfani da na'urar saka idanu a cikin motocinsu.
Sa'ad da cocin Katolika suka rufe majami'u da ɗakunan ibada da kuma babban haikalin St. Peter, wasu addinai sun dakatar da tarurruka kuma sun rage yawan waɗanda suke taro a majami'u, masallatai, majami'u, da kuma wasu wurare.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa da kuma rufe wuraren ibada, yayin da Saudiyya ta hana baƙi masu aikin hajji shiga kuma ta hana mazauna yankin shiga wuraren ibada a Makka da Madina.
Cutar ta haifar da babbar matsala ga tsarin wasanni na duniya tun bayan yakin duniya na biyu.
An soke ko kuma an jinkirta wasanni da yawa, gami da Wasannin Zakarun Turai na 201920, Gasar Ingila ta 201920, gasar cin kofin Turai ta 2020, Gasar Kwando ta Amurka ta 201920, da NHL 201920.
Cutar ta kuma katse jadawalin wasannin Olympics na bazara na 2020 wanda aka shirya fara a ƙarshen Yuli; a ranar 24 ga Maris, Kwamitin Wasannin Olympics na Duniya ya ba da sanarwar cewa za a "canja lokacin zuwa wani lokaci na ƙarshe na 2020 amma ba a wuce bazara na 2021 ba".
Wannan ya haifar da ƙaurawar caca ta yanar gizo, inda yawancin rukunin caca ke ba da rahoton ƙaruwar rajista. An kuma shafi nishaɗi, tare da ƙungiyoyi da yawa suna sokewa ko jinkirta rangadin su.
Manyan gidajen wasan kwaikwayo kamar na Broadway sun dakatar da dukan wasanni.
Wasu masu zane-zane sun nemi ci gaba da samarwa da raba abubuwan da suke yi a kan layi a matsayin madadin al'adun gargajiya na yin balaguro kai tsaye, yin wasan kwaikwayo ta hanyar yanar gizo, ko kuma yin "taron" na yanar gizo tare da masu zane-zane don yadawa da tallata ayyukansu.
Hotunan ban dariya da ke mai da hankali kan cutar coronavirus sun bazu a Intanet saboda mutane da yawa suna son abin dariya da nishaɗi yayin da ba su san inda lamarin yake ba.
Tun farkon annobar COVID-19, an sami babban nuna bambanci, ƙiyayya da ƙiyayya ga mutanen da ke da asalin ƙasar Sin da Gabashin Asiya, da kuma mutanen da ke da asali daga manyan yankuna masu cutar a Turai, Amurka da sauran ƙasashe.
An ga tsoro, wariya, da kuma faɗa a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da kuma yankin Asiya da Fasifik.
Rahotanni daga watan Fabrairu (lokacin da yawancin masu cutar ke cikin China) sun nuna bambancin launin fata a cikin ƙungiyoyi daban-daban a duniya, suna cewa Sinawa sun cancanci cutar ko kuma za su sami hukuncin da ya dace.
Wasu ƙasashe a Afirka ma sun nuna ƙiyayya da Sinawa.
Yawancin mazauna Wuhan da Hubei sun ce an nuna musu wariya bisa asalin yankin.
Akwai tallafi ga Sinawa, a zahiri da kan layi, har ma da waɗanda ke cikin yankunan da cutar ta shafa.
Yayin da annobar ta ci gaba da yaduwa zuwa sabbin ƙasashe, mazauna Italiya, ƙasar da ke da mafi yawan masu cutar COVID-19 a Turai, na iya fuskantar ƙiyayya da ƙiyayya da baƙi. Jama'a a ƙasashe kamar Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardar gargaɗi ga sauran ƙasashe da su hana Sinawa shiga ƙasashensu don hana yaduwar cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama sananne sosai a shafin Twitter.
Mutane da yawa da ke zaune a ƙasar Amirka da kuma Biritaniya sun ce ana yawan cin zarafin mutanen ƙasar Sin da kuma wasu mutanen Asiya.
Shugaban Amurka Donald Trump ya fuskanci suka saboda kiran coronavirus "Covid-19 na kasar Sin", wanda masu sukar kasar Sin ke ganin yana nuna wariyar launin fata da kuma nuna kyamar kasar Sin.
Masu zanga-zangar Ukraine sun kai hari kan bas din da ke dauke da 'yan gudun hijirar Ukraine da kasashen waje daga Wuhan zuwa Novi Sanzhary.
Dalibai daga arewa maso gabashin Indiya, wanda ke iyaka da China, suna karatu a manyan biranen Indiya da ke fama da cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal Dilip Ghosh ya ce kasar Sin ta lalata muhalli "don haka Allah ya hukunta ta".
Ofishin jakadancin kasar Sin da ke Kolkata ya yi tir da wannan lamarin, yana mai cewa "ba daidai ba ne". A kasar Sin, cutar ta kawo karshen nuna kyamar baki da wariyar launin fata, inda ake daukar baƙi a matsayin "sharar waje" kuma ya kamata a zubar da su.
Yawancin jaridu da ke da shafukan yanar gizo masu caji sun cire wasu ko duk farashin da aka biya don labarai game da coronavirus.
Marubutan kimiyya sun wallafa littattafan kimiyya game da cutar kuma kowa yana iya samun su.
Wasu masana kimiyya sun yanke shawarar raba sakamakon binciken su na kwanan nan akan sabobin software kamar bioRxiv.
Cutar cututtuka da ke fitowa - Cutar cututtuka ta kwayar cuta, galibi suna da sabon bayyanar ko kamuwa da cuta
Cin Hanci da rashawa da cututtuka - Bayani game da cin hanci da rashawa da kuma yadda cutar ke yaduwa
Jerin cututtuka da annoba  Jerin mutuwar cututtuka
Fata da Cutar Dabbobi - Sakamakon Lafiya na Cinikin Daji
Gwajin gwaji na cutar numfashi ta coronavirus 2019 (COVID-19) da kuma SARS-CoV-2 mai alaƙa ya haɗa da gano ƙwayoyin cuta da kuma gano ƙwayoyin cuta.
Ana tabbatar da kasancewar kwayar cutar a cikin gwajin da aka kama ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da sabbin kamuwa da cuta ko marasa lafiya.
Ana iya amfani da ganowar rigakafi (binciken jini) don tantancewa da kuma lura da yawan jama'a.
Gwaje-gwajen rigakafi na gano yawan mutanen da ke fama da cutar, gami da waɗanda ke da ƙananan alamun rashin lafiyar da ba za su iya sanar da hukuma ba ko ba su da alamun cutar.
Za a iya tantance ainihin adadin mutuwar cutar da kuma matakin rigakafin cutar a cikin al'umma daga sakamakon gwajin.
Saboda ƙarancin gwajin, babu wata ƙasa da ke da ingantaccen bayani game da cutar a cikin al'ummarsu a watan Maris na 2020.
Har zuwa 23 ga Maris, babu wata ƙasa da ta yi gwajin fiye da kashi 3% na yawanta, kuma akwai bambance-bambance masu yawa a yadda ake yin gwajin a duk ƙasashe.
Waɗannan canje-canjen na iya haifar da tasirin gaske ga yawan mutuwar, wanda zai iya zama mai tsanani a wasu ƙasashe.
Ta hanyar amfani da tsarin bincike na sauri na kwayar cutar (rRT-PCR), za a iya gwada cutar ta hanyar gwajin numfashi ta hanyar amfani da hanyoyi daban-daban, ciki har da gwajin taɓawa ko ruwan hanci.
Ana samun sakamako a cikin awanni da yawa zuwa kwanaki biyu.
Gwajin RT-PCR da aka ɗauka daga hanci shine kawai hanyar da za a iya dogara da ita a farkon makon cutar.
Daga nan kwayar cutar za ta iya shiga cikin makogwaro yayin da ta ci gaba da yaduwa a cikin huhu.
Ga mutanen da suka kamu da cutar a mako na biyu, ana ba da shawarar sake yin wasu gwaje-gwaje kamar su kwayar cutar.
An gwada ɗayan sabbin gwaje-gwajen PCR a Charité a Berlin a watan Janairun 2020 ta amfani da tsarin tattara bayanai da sauri (rRT-PCR) da kayan aikin 250,000 da Hukumar Lafiya ta Duniya ta bayar.
A ranar 28 ga Janairun 2020, kamfanin Kogenebiotech na Koriya ta Kudu ya ƙaddamar da gwajin gwajin PCR (PowerChek Coronavirus) na na'urar bincike ta SARS-CoV-2.
Yana gano kwayar halitta "E" da ke haifar da kwayar cutar coronavirus ta mutum, da kwayar halitta RdRp da aka bayyana a cikin SARS-CoV-2.A cikin China, BGI Group na ɗaya daga cikin kamfanoni na farko da Hukumar Kula da Kayan Kiwon Lafiya ta ƙasa ta amince da su don amfani da kayan gwajin SARS CoV-2 na PCR.A Amurka, Cibiyar Kula da Cututtuka da Cututtuka (CDC) tana tura kayan aikin RT-PCR Diagnostic don sabon Coronavirus 2019 (2019-nCoV) zuwa dakunan gwaje-gwaje na jama'a ta hanyar International Reagent Resource.
Daya daga cikin gwaje-gwaje uku na kwayoyin halitta a cikin tsohuwar sigar kayan aikin gwaji ya haifar da sakamako mara kyau saboda rashin ingancin maganin da aka yi amfani da shi, da kuma matsalolin gwaji a Cibiyar Kula da Cututtuka (CDC) a Atlanta; wannan ya haifar da matsakaicin gwajin 100 a kowace rana a cikin Fabrairu 2020.
Ba a ƙaddara gwajin da aka yi amfani da shi ba har zuwa 28 ga Fabrairu, 2020, kuma sai lokacin ne aka ba da izinin fara gwajin a dakunan gwaje-gwaje na jihohi da na gida.
An ba da izinin gwajin ta Hukumar Abinci da Magunguna don izinin Amfani da Gaggawa. Dakunan gwaje-gwaje na kasuwanci a Amurka sun fara gwaji a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ya ba da sanarwar cewa akwai gwajin COVID-19 na RT-PCR a duk faɗin ƙasar.
Quest Diagnostics kuma ya samar da gwajin COVID-19 a duk ƙasar daga 9 ga Maris, 2020.
Babu takamaiman adadin da aka bayar; ana buƙatar tattarawa da sarrafa samfuran da aka karɓa bisa ga umarnin Cibiyar Kula da Cututtuka (CDC).
A Rasha, Cibiyar Nazarin Kwayoyin Cutar da Fasaha ta VECTOR ta tsara kuma ta gudanar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta Amurka ta fara gwajin kwayar cutar. A ranar 12 ga Maris, 2020, an ba da sanarwar cewa Mayo Clinic ta haɓaka na'urar da za ta iya tantance cutar COVID-19. A ranar 13 ga Maris, 2020, FDA ta ba Roche Diagnostics izinin yin gwajin kwayar cutar wanda zai ba da sakamako a cikin awanni 3.5 a matsakaici, wanda ya ba da damar gwaji guda ɗaya na iya gwada mutane 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don yin gwaji akan Abbott m2000; FDA ta ba da irin wannan izinin ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, an ba da izinin amfani da gaggawa na FDA don gwajin minti 45 na Cepheid.
FDA ta amince da gwajin da ke amfani da fasahar haɓaka yanayin zafi akan acid nucleic maimakon PCR.
Saboda wannan ba ya buƙatar jerin musayar zafin jiki, wannan hanyar tana iya ba da sakamako mai cutarwa a cikin minti biyar da sakamako mara lafiya a cikin minti 13.
Akwai kimanin 18,000 na irin waɗannan na'urori a Amurka a halin yanzu kuma Abbot yana shirin haɓaka ƙarfin zuwa 50,000 a kowace rana.A Taiwan ana yin gwajin da ke amfani da kwayoyin cuta masu kama da kwayar cuta ta N, kuma ana fatan zai iya ba da sakamako tsakanin mintuna 15 zuwa 20 kamar yadda mai gwajin mura yake.
A watan Maris na 2020, takardun bincike sun kammala cewa "a farkon, binciken kirji ba shi da amfani sosai a cikin bincike, kuma alamun CT na iya kasancewa tun kafin bayyanar cututtuka".
Abubuwan fasahar CT na ciki sun haɗa da ikon duba dukkan gefen huhu, yana nuna gefen gefe, tsakiya da baya.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Binciken da aka yi don kwatanta gwajin PCR da CT a Wuhan don gano asalin cutar ya nuna cewa alamun sun nuna cewa cutar ta fi tsanani a Wuhan saboda haɗuwa da wasu cututtukan numfashi masu saurin kamuwa da cuta.
A watan Maris na 2020, Cibiyar Nazarin Magunguna ta Amurka ta ba da umarnin "daina amfani da hanyar Wuhan don gwajin COVID-19". Tun daga watan Maris na 2020, Cibiyar Kula da Cututtuka (CDC) ta ba da shawarar cewa a fara amfani da PCR don gwajin.
Wani ɓangare na tsarin rigakafin jiki shine samar da ƙwayoyin cuta waɗanda suka haɗa da IgM da IgG.
Wannan zai taimaka wajen gano kamuwa da cuta a cikin mutane daga rana ta 7 ko bayan bayyanar alamun farko, don tantance matakin rigakafi da kuma yin bincike a cikin al'umma. Ana iya yin nazarin samfurin a cikin dakin gwaje-gwaje na yau da kullun (CLT) ko a wani wuri don gwaji (PoCT).
Za a yi amfani da allurar rigakafin da ake amfani da ita don gwada mutane da yawa a yawancin dakunan gwaje-gwaje na likita don bincike, amma samun sakamako zai dogara da saurin aikin.
A cikin dakunan gwaje-gwaje na yau da kullum, ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da samfurori da yawa don a gwada rashin lafiyar jiki.
A wani wuri kuma, an gano wani jini a cikin wani ɓoyayyen fata.
Ba kamar PCR ba, ba a buƙatar samfurin da aka samo kafin gwaji. A ranar 26 ga Maris, 2020, FDA ta sanar da cewa kamfanoni 29 da aka sanar da su a matsayin masu buƙata yanzu suna iya samar da samfurin rigakafin rigakafi.
Tun daga 7 ga Afrilu 2020, gwajin guda ɗaya ne kawai FDA ta amince da shi don yin aiki tare da izini na gaggawa.A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostic sun sami takaddun shaida na Turai don kayan aikin gwajin su, waɗanda zasu iya gano IgG da IgA antibodies don cutar a cikin gwajin jini.
Ana iya samun damar gwadawa ta hanyar ɗaruruwan gwaje-gwaje a cikin sa'o'i kaɗan kuma hakan ya fi sauri fiye da gwajin PCR na yau da kullun don gano RNA na kwayar cuta.
Yawancin lokaci ana samun rigakafi a cikin kwanaki 14 bayan kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta gano cewa babu kayan aikin rigakafin da aka saya kuma babu wanda zai iya amfani da su sosai.
Hong Kong ta kafa tsarin da zai iya ba da damar kowane mutum da ake zargi da kamuwa da cutar ya zauna a gida, tare da "kayan aiki na musamman" da aka ba shi ta hanyar sabis na agaji, don yin gwaji da kuma dawo da shi don amsawa a wani lokaci. Sabis na Kiwon Lafiya na Ingila (NHS) ya ba da sanarwar cewa yana shirin yin gwajin gida don mutanen da ake zargi da kamuwa da cutar, wanda zai rage haɗarin mai haƙuri ya iya cutar da wasu lokacin da suka isa asibiti, ko kuma ya buƙaci yin allurar rigakafi a cikin motar da ta kawo mai haƙuri. A yayin da ake yin gwajin COVID-19, likita yana yin hakan ta hanyar da ta dace da duk ƙa'idodin ƙwararru.
Cibiyoyin gwajin cikin motoci sun ba Koriya ta Kudu damar yin wasu gwaje-gwaje mafi sauri, kuma mafi yawa, fiye da sauran ƙasashe.A Jamus, a ranar 2 ga Maris, Kungiyar Inshorar Lafiya ta Likitoci ta ba da sanarwar cewa tana da damar yin gwaji kusan 12,000 a rana ta hanyar gaggawa kuma an gwada kusan 10,700 a makon da ya gabata.
Asusun inshorar lafiya zai biya idan likita ya ba da umarnin gwajin.
A cewar shugaban kamfanin Robert Koch, Jamus tana da ƙarfin gwaji 160,000 a kowane mako.
Tun daga 19 ga Maris, an fara yin gwajin a manyan biranen da yawa.
Har zuwa 26 ga Maris 2020, ba a san yawan gwaje-gwajen da aka yi a Jamus ba, saboda an bayar da rahoton kawai game da masu cutar.
Binciken farko na dakin gwaje-gwaje ya ba da rahoton cewa aƙalla mutane 483,295 sun kamu da cutar a cikin makon 12/2020, gami da 12/2020, wanda a ciki an gano mutane 33,491 (6.9%) masu cutar SARS-CoV-2. A Isra'ila, masu bincike a Technion da Rambam Hospital sun haɓaka da gwada hanyar gwajin marasa lafiya 64 a lokaci guda, inda za a iya yin gwaji da sake gwadawa a baya idan akwai cutar. A Wuhan, an buɗe dakin gwaje-gwaje na gaggawa mai girman murabba'in mita 2,000 da ake kira "Huo-Yan" 火眼 a Sinanci, ko "Ido na Wuta" a Sinanci, wanda aka ƙaddamar a ranar 5 ga Fabrairu 2020 ta BGI, wanda zai iya gwada mutane sama da 10,000 a rana.
Wanda ya kafa BGI, Wang Jian, ya kula da aikin kuma ya ɗauki kwanaki 5, a cewar ƙididdigar da aka yi, cutar a Hubei za ta karu da kashi 47% kuma farashin kula da keɓewa zai ninka sau biyu idan ba tare da wannan ƙarfin gwajin ba.
Nan da nan, dakunan gwaje-gwaje na Huo-Yanmu a Shenzhen, Tianjin, Beijing, da Shanghai, a cikin birane 12 na kasar Sin suka biyo baya.
Har zuwa 4 ga Maris, 2020, ana yin gwaje-gwaje kusan 50,000 a kowace rana. Tsarin da aka samar da sauri da kuma amfani da kowa wanda Origami Assays ya samar zai iya gwada gwaje-gwaje 1,122 na marasa lafiya na COVID19 tare da gwaje-gwaje 93 kawai. Ana iya yin wannan gwajin a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar amfani da mutum-mutumi masu sarrafa ruwa ba.
Har zuwa watan Maris, ƙarancin da kuma rashin magungunan gwaji na asali sun zama babbar matsala ga gwaji a cikin EU, UK da Amurka.
Wannan ya sa wasu marubuta suka rubuta game da shirye-shiryen gwajin da ke buƙatar zafin jiki zuwa 98 ° C (208 ° F) na tsawon minti 5 don gano ƙwayoyin cuta da ke haifar da sake gwaji.A ranar 31 ga Maris, an ba da sanarwar cewa Hadaddiyar Daular Larabawa ta kasance a saman duniya don gwada yawan jama'arta, tare da shirin gwada kusan dukkanin mazaunanta.
Wannan ya faru ne saboda haɗuwa da ƙarfin gwajin mutane a cikin motocin su, da siyan dakunan gwaje-gwaje masu yawa a cikin Group 42 da BGI (wanda ya dogara da dakunan gwaje-gwaje masu sauri na Huo-Yan).
An gina shi cikin kwanaki 14, dakin gwaje-gwaje na iya yin gwaje-gwaje sama da 10,000 na RT-PCR a kowace rana kuma shine farkon duniya na wannan matakin da ke aiki a wajen China.
An kafa wasu gwaje-gwaje daban-daban don gano ɓangarorin cututtukan coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta amince da tayin Jamus na samar da kayan aiki ga ƙasashe masu tasowa waɗanda ba za su iya ɗaukar nauyin kansu ba.
A ranar 17 ga Janairun 2020, Jamus ta sanar da tsarin ta, amma tsarin da Cibiyar Kula da Cututtuka ta Amurka ta samar ba zai kasance ba har zuwa 28 ga Janairu, wanda hakan ya haifar da jinkirin gwaji a Amurka. China da Amurka suna da matsalolin rashin amincewa da ingancin kayan gwajin da ke akwai, kuma waɗannan ƙasashe kamar Australia ba su da ikon biyan buƙatun kasuwa da bin shawarar masana kiwon lafiya.
Koyaya, masana sun ce ƙaddamar da gwajin gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
Gwamnatin Koriya ta Kudu ta gina ƙarfin gwaji, musamman a dakunan gwaje-gwaje masu zaman kansu, tsawon shekaru.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira ga ƙasashe da su ƙara yawan gwaje-gwaje da shirye-shirye don rage yaduwar cutar COVID-19. Yawan buƙatun gwajin cutar da cutar ta haifar ya sa yawancin su sun zama dole ga dakunan gwaje-gwaje na Amurka, wanda ke haifar da babbar matsala don samar da kayan aiki da magunguna da ake buƙata don magance cutar.
A watan Maris na 2020, China ta ba da rahoton cewa akwai wasu matsaloli game da ingancin kayan aikin gwajin su.
A Amurka, kayan aikin da Hukumar Kula da Cututtuka ta Kasa ta samar sun kasance marasa inganci, amma gwamnati ta cire shingen da ke hana gwajin mai zaman kansa. Spain ta sayi kayan aiki daga Shenzhen Bioeasy Biotechnology Co Ltd, wani kamfanin kasar Sin amma ta sami rashin inganci.
Cibiyar ta bayyana cewa sakamakon da ba daidai ba na iya faruwa ne saboda rashin tattara samfurori da kyau ko kuma rashin amfani da kayan aiki.
Ma'aikatar ta Spain ta ce za ta cire kayan aikin da ke ba da sakamako mara kyau daga kasuwa kuma za a maye gurbinsu da kayan aikin Shenzhen Bioeasy. Kashi 80% na kayan da Czech ta saya daga China sun ba da sakamako mara kyau.Slovakia ta sayi kayayyakin da aka gano ba su da inganci miliyan 1.2 daga China.
Firayim Minista Matovič ya yi kira da a zubar da su a cikin kogin Danube. Ateş Kara, Ministan Lafiya na Turkiyya ya ce kayan gwajin da aka saya daga China ba su da inganci kuma saboda haka bai kamata a yi amfani da su ba. Burtaniya ta sayi kayan gwaji miliyan 3.5 daga China amma kwanan nan a watan Afrilu 2020 ta bayyana cewa ba za a iya amfani da su ba.
Gwaje-gwaje, tare da keɓewar masu cutar da kuma gano waɗanda ke da alaƙa da cutar SARS-CoV-2, sun ba da sakamako mai kyau.
Masu bincike da ke aiki a Vò, Italiya, inda aka fara samun mutuwar mutum na farko da ya kamu da cutar COVID-19 a Italiya, sun yi gwajin sau biyu a cikin kusan mutane 3,400 a cikin kwanaki 10.
Kusan rabin wadanda aka gano ba su da alamun cutar, kuma duk wadanda aka gano an killace su.
Harkokin tafiye-tafiye zuwa wasu yankuna sun kawo ƙarshen sabon kamuwa da cutar.
Saboda tsauraran matakan bin diddigin kamuwa da cutar, hana yawan mutane, gwaji da keɓewa, cutar coronavirus ta 2020 a Singapore ta kasance mafi ƙanƙanta idan aka kwatanta da sauran ƙasashe masu tasowa kuma ba tare da rufe gidajen abinci da wuraren kasuwanci ba.
An dakatar da ayyuka da yawa, kuma Singapore ta fara ba da shawarar zama a gida daga 28 ga Maris, amma an sake buɗe makarantu a lokacin hutu a ranar 23 ga Maris.
Yawancin ƙasashe da suka fuskanci cutar sun kafa tsarin bincike na musamman, ƙuntatawa na balaguro na cikin gida, gwaji, keɓewa, da kuma kasancewa a gida amma ba a cikin matsananciyar yanayi ba, kamar Iceland da Koriya ta Kudu.
Binciken ƙididdiga ya nuna cewa ƙasashe da suka gwada mutane da yawa, dangane da yawan mutuwar, suna da ƙananan mutuwar, watakila saboda waɗannan ƙasashe suna da ikon gano waɗanda ke da alamun rashin lafiya ko marasa alamun cutar.
Hukumar Lafiya ta Duniya ta bukaci ƙasashe da ba su da ƙarfin gwaji da kuma dakunan gwaje-gwaje masu inganci da inganci don gwada COVID-19 don aika da gwajin gwajin su na farko na biyar da na farko na goma don tabbatar da cutar COVID-19 zuwa dakunan gwaje-gwaje na misali na 16 na Hukumar Lafiya ta Duniya don tabbatar da gwajin.
Daga cikin dakunan gwaje-gwaje guda 16, bakwai suna cikin Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amurka, ɗaya kuma a Ostiraliya.
A cikin teburin da ke ƙasa, "Cibiyar mai cutar a matsayin kashi na gwaji" na iya canzawa dangane da manufofin gwaji na ƙasa.
Kasashen da ke gwada mutane kawai da aka kwantar da su a asibiti za su sami ƙimar cutar da ta fi ta ƙasa fiye da ƙasashen da ke gwada yawan jama'a, ko suna da alamun cutar ko a'a, idan babu wani canji.
Wanke hannu, wanda aka fi sani da tsabtace hannu, aikin tsabtace hannu ne don kawar da datti, mai, ƙwayoyin cuta, ko wasu abubuwa marasa kyau.
Wanke hannu akai-akai a "mahimman lokuta" na rana yana hana yaduwar cututtuka da yawa kamar zawo, kwalara, da kuma kamuwa da cuta ta hanyar bayan gida-bakin.
Mutane na iya kamuwa da cututtukan numfashi kamar mura ko mura, misali, idan ba su wanke hannayensu ba kafin su taɓa fuska, hanci ko baki (watau, sassan da ke da ƙura).
Abubuwa biyar masu mahimmanci a rana inda wanke hannu da sabulu ya zama dole sun haɗa da: kafin da bayan wankewa, bayan wankewa ko canzawa, kafin ciyar da jariri, kafin cin abinci da bayan shirya abinci ko sarrafa nama, kifi, ko kaza.
Idan babu sabulu da ruwa, za a iya wanke hannu da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin ka shirya abinci, sa'ad da kake yinsa, da kuma bayan ka gama.
Kafin ka kula da marar lafiya da kuma bayan ka gama.
Bayan ka canja wa yaro takalmi ko kuma bayan ka wanke shi bayan ka je bayan gida.
Bayan yin fitsari, tari ko hancinsa.
Bayan ka taɓa dabba, ka ciyar da ita ko kuma ka wanke shara.
Tsabtace hannu a cikin kiwon lafiya yana nufin ayyukan tsabtace jiki da ke da alaƙa da kiwon lafiya.
Wanke hannu kafin a ba da magani ko kula da mai haƙuri na iya hana ko rage yaduwar kamuwa da cuta.
Babban manufar wanke hannu a cikin kiwon lafiya shine tsabtace hannayen da ke da alaƙa da cututtuka (ƙwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta masu haɗari) da kuma ƙwayoyin cuta waɗanda zasu iya haifar da sakamako ko cuta.
Wannan yana da mahimmanci ga masu samar da abinci ko masu aikin kiwon lafiya, amma kuma yana da kyau ga kowa.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage yaduwar mura, coronavirus, da sauran cututtukan cututtuka; hana wasu abubuwan da ke haifar da zawo; rage cututtukan numfashi;
kuma rage yawan mutuwar jarirai da ake haifa a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa wanke hannu sosai yana da tasiri a kan ci gaban yara 'yan kasa da shekara biyar.
A cikin ƙasashe masu tasowa, ana iya rage mutuwar yara daga cututtukan numfashi da zawo ta hanyar sauya halayen sauƙaƙe, kamar wanke hannu da sabulu.
Wannan hanya mai sauƙi na iya rage yawan mutuwar da ke faruwa ta hanyar cututtukan da ke cikin kusan kashi 50%.
Ayyukan da ke ƙarfafa wanke hannu na iya rage kusan kashi ɗaya bisa uku na cututtukan gudawa kuma wannan yana da yawa kamar samar da ruwa mai tsafta a yankunan da ke da ƙananan kuɗi.
Rage cututtukan da ke tattare da zawo da kashi 48% ana iya danganta su da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da rahusa don hana zawo da cututtukan numfashi masu saurin kamuwa da cuta (ARI), wanda yakamata ya zama al'ada a gida, makaranta da kuma cikin babban iyali.
Cutar zazzabin cizon sauro, wadda ita ce cuta mafi muni da ke shafan numfashi, ita ce ke kashe yara da ba su kai shekara biyar ba, kuma tana kashe yara miliyan 1.8 a kowace shekara.
Cutar gudawa da kuma tarin fuka suna kashe yara miliyan 3.5 kowace shekara.
Bisa ga rahoton Hukumar Kula da Yara ta Majalisar Dinkin Duniya (UNICEF), sabulu da sabulu kafin cin abinci da bayan bayan gida na iya ceton rayuka fiye da allurar rigakafi ko wasu hanyoyin kiwon lafiya, kuma zai rage mutuwar gudawa da kashi biyu cikin dari da kuma mutuwar cututtukan numfashi mai tsanani da kashi ɗaya cikin huɗu.
Wanke hannu yana yawanci a cikin sauran ayyukan tsabtace ruwa, tsaftacewa da tsaftacewa (WASH).
Wanke hannu yana hana kamuwa da cututtukan fata ta hanyar hulɗa da wasu.
Wani ƙananan sakamako na wanke hannu shine cewa yawan wanke hannu na iya haifar da lalacewar fata ta hanyar bushewar fata.
Wani bincike da aka yi a Denmark a shekarar 2012 ya nuna cewa yawan wanke hannu yana haifar da ciwon haushi, mai saurin kamuwa da cututtukan fata, wanda aka fi sani da cututtukan fata na hannu, wanda ya fi yawa a cikin ma'aikatan kiwon lafiya.
Wanke hannu sosai yana nuna alamun bayyanar cututtukan damuwa na damuwa (OCD).
Akwai lokuta biyar masu mahimmanci a rana inda wanke hannu da sabulu ya zama dole don rage yaduwar cututtukan hanji da na baka: bayan amfani da bayan gida (suna, motsa jiki), bayan shan ruwa (canza diapers), kafin ciyar da jariri, kafin cin abinci da kafin / bayan shirya abinci ko shan nama, kifi, ko kaza.
A wasu wurare, ana buƙatar yin wanke hannu don hana kamuwa da cuta, gami da kafin da bayan kula da rauni ko rauni; bayan tari, tari, ko hancin mutum; bayan taɓa ƙazamin dabbobi ko kula da dabbobi; da kuma bayan taɓa ƙazamin abu.
A ƙasashe da dama, akwai ƙananan ƙa'idodin wanke hannu da sabulu.
Binciken wanke hannu da aka gudanar a cikin kasashe 54 a shekarar 2015 ya nuna cewa a matsakaita kashi 38.7% na gidaje sun yi amfani da sabulu don wanke hannu. Binciken na 2014 ya nuna cewa Saudi Arabiya tana da mafi girma kashi 97%; Amurka tana da kusan 77%; kuma China tana da mafi ƙarancin kashi 23%. Akwai yanzu sauye-sauyen ra'ayi don ƙarfafa mutane su wanke hannu da sabulu a cikin yanayi mai tsanani. Wanke hannu a lokaci guda ga yara a makaranta a lokacin da aka tsara shi ne daya daga cikin hanyoyin da za a iya amfani da su a ƙasashe masu tasowa don koya wa yara su wanke hannu.
Shirin Kula da Kiwon Lafiya na Mahimmanci wanda Ma'aikatar Ilimi ta Philippines ta aiwatar misali ne mai kyau na ayyukan da ke inganta lafiyar yara da ilimi.
Shan maganin shanyewar ciki sau biyu a shekara, tare da wanke hannuwan yau da kullun da sabulu, goge haƙori kowace rana tare da fluoride, shine tushen tsarin ƙasa.
An yi amfani da shi sosai a Indonesia.
Ana iya ƙara yawan ƙwayar cuta ta fata ta hanyar ƙara sabulu ko kayan tsabtace ruwa.
Babban amfani da sabulu da kayan tsabtace jiki shine rage ƙarancin kayan aiki da haɓaka ƙarfin aiki.
Ruwa kaɗai ba ya tsabtace fata sosai domin mai da mai, da ke kama da ƙasa, ba sa narkewa cikin ruwa.
Yin tsabta yana nufin yin amfani da ruwa sosai.
Sabulu da ba ruwa ba, saboda ana iya sake amfani da su, na iya riƙe ƙwayoyin cuta daga masu amfani da su a baya.
Ƙananan bincike sun bincika hanyoyin da ake yada ƙwayoyin cuta daga sabulu mai ƙazanta kuma sun tabbatar da cewa ba za a iya cutar da su ba saboda an shafe ƙwayoyin cuta ta hanyar kumfa.
Cibiyar Kula da Cututtuka (CDC) ta ce "sabulu da ruwa da kuma kayan aiki da ba sa bukatar shafawa ne mafi kyau".
Sabulu mai kashe ƙwayoyin cuta ya zama sananne ga masu kula da lafiyarsu.
A halin yanzu, babu wata hujja da ta nuna cewa amfani da maganin rigakafi ko maganin kashe ƙwayoyin cuta ya fi dacewa da maganin ƙwayoyin cuta da aka sani da jurewa.
Duk da haka, sabulu masu kashe ƙwayoyin cuta suna ɗauke da magungunan kashe ƙwayoyin cuta kamar triclosan, wanda ke da jerin ƙwayoyin cuta masu ƙarancin ƙwayoyin cuta.
Saboda haka, ko da yake maganin rigakafi ba a samo shi daga sabulu da ke kashe ƙwayoyin cuta ba, ba zai yi tasiri sosai kamar yadda ake faɗa ba.
Baya ga karewa da fata, waɗannan magungunan na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) kamar su hydrochloric acid, benzoic acid mai hana cututtuka, da sauran magungunan fata (cinnamon, protein, menthol, da sauran magungunan tsire-tsire).Binciken da Jami'ar Oregon ta yi ya nuna cewa sabulu na yau da kullun yana da tasirin rigakafi da kuma kawar da ƙwayoyin cuta a hannu kamar sabulu na ƙwayoyin cuta.
Ruwan zafi da za a iya amfani da shi wajen wanke hannu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma cikin sauri a zafin jiki (37 ° C).
Duk da haka, ruwan zafi da sabulu yana da amfani fiye da ruwan sanyi da sabulu wajen kawar da ƙwayoyin cuta da ƙwayoyin cuta.
Sabanin abin da aka fi sani, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba shi da tasiri sosai wajen rage yawan ƙwayoyin cuta a hannayenku.
Sanitizer na hannu ko maganin tsabtace hannu shine maganin wanke hannu wanda ba shi da ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, wanke hannu da maganin kashe ƙwayoyin cuta (wanda aka fi sani da wanke hannu da sukari) ya zama sananne kuma sananne.
Yawancin su an yi su ne da isopropyl ko ethanol, wanda aka hada da Carbomer a cikin mai mai narkewa ko kuma mai saurin warkewa kamar glycerin a cikin kayan shafawa ko foda don sauƙaƙe amfani da rage tasirin ƙarancin abinci.
Ƙara idologen peroxide mai sauƙi yana haɓaka ƙarfin rigakafin ƙwayoyin cuta. Masu tsabtace hannu waɗanda ke da aƙalla kashi 60 zuwa 95% na sinadarin alkaline na iya zama masu tasiri wajen kashe ƙwayoyin cuta.
Sanitizers na hannu masu dauke da sinadarin sukari suna kashe ƙwayoyin cuta, ƙwayoyin cuta masu jurewa (MRSA da VRE), tarin fuka, da sauran ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura, da hepatitis) da kuma ƙwayoyin cuta na ƙwayoyin cuta.
Sanitizers na hannu suna da kashi 70% na kashewa 99.97% (ragewa 3.5, kwatankwacin raguwa na decibel 35) na ƙwayoyin cuta a cikin sakan 30 bayan amfani da kuma 99.99% zuwa 99.999% (ragewa tsakanin 4 zuwa 5) na ƙwayoyin cuta a cikin minti 1 bayan amfani. Sanitizers na hannu suna da tasiri sosai akan ƙwayoyin cuta amma suna da ƙarancin tasirin ƙwayoyin cuta.
Ana amfani da tsabtace hannu da alama ba su da tasiri a kan norovirus (Norwalk) wanda ke haifar da cututtukan ciki. Ya kamata a yi amfani da tsabtace hannu da ruwa ko kuma a yayyafa a hannu biyu.
Ana shafa gaban hannu da bayan hannu da tsakiyar hannu da ƙarshen hannu na kusan sakan 30 har sai ruwa, kumfa ko maganin wankewa ya bushe.
Yana da mahimmanci a wanke yatsun hannu da kyau tare da hannayen biyu. Cibiyoyin Kula da Cututtuka da Rigakafin Amurka suna ba da shawarar wanke hannu da maganin kashe ƙwayoyin cuta musamman idan hannayen sun kasance masu ƙazanta.
Ci gaba da amfani da wannan hanyar ya dogara da sauƙin amfani da saurin kashe ƙwayoyin cuta; duk da haka, wannan ba zai maye gurbin hanyar wanke hannu ba sai dai idan sabulu da ruwa basu samuwa.
Amfani da tsabtace hannu da ke ɗauke da sinadarin sulfur sau da yawa na iya sa fata ta bushe sai dai idan an ƙara shi don taushi ko rage haushi.
Wannan bushewar fata ta hanyar ƙura za a iya rage ko kawar da shi ta hanyar gliselin ko wani mai laushi.
A cikin binciken likita, kayan wanke hannu masu ɗauke da alkali da mai laushi suna da ƙarfi fiye da sabulu ko maganin kashe ƙwayoyin cuta.
Rashin fata, ƙwanƙwasawa, ko ƙwanƙwasawa daga ƙura a cikin tsabtace hannu ba safai ba.
Rashin haɗarin lalacewar fata ya sa wannan hanyar ta fi dacewa idan aka kwatanta da wanke hannu da sabulu da ruwa.
Ko da yake suna da inganci, masu tsabtace hannu da ba su da ruwa ba sa wanke hannaye don kawar da duk wani datti amma suna kawar da ƙwayoyin cuta ne kawai.
Saboda haka, maganin wanke hannu ba shi da tasiri kamar sabulu da ruwa wajen hana yaduwar ƙwayoyin cuta da yawa, saboda ƙwayoyin cuta suna ci gaba da kasancewa a hannu.
Ingancin kayan wanke hannu marasa alkama ya dogara da sinadarin, kuma a baya ba su da inganci kamar alkama da sauran kayan alkama.
A kwanan nan, magungunan da ke amfani da benzalkonium chloride sun nuna ci gaba da rigakafin ƙwayoyin cuta bayan amfani, sabanin alkama, wanda aka gano cewa tasirinsa yana raguwa bayan amfani da yawa, mai yiwuwa saboda tasirin fata.
Mutane da yawa da ba su da isashen kuɗi ba za su iya samun sabulu ba, saboda haka, suna amfani da toka ko ƙasa.
Yin amfani da toka ko ƙasa hanya ce mai kyau fiye da amfani da ruwa kawai, amma ba ta da lafiya kamar sabulu.
Wata damuwa ita ce, ƙura ko ƙasa suna da ƙwayoyin cuta da yawa waɗanda za su iya haifar da cutar fiye da yadda za su iya rage ta.
Kamar sabulu, toka tana kashe ƙwayoyin cuta ta wajen sa su zama acid.
Idan sabulu ba ya samuwa, Hukumar Lafiya ta Duniya ta ce a yi amfani da toka ko yashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka sun ba da shawarar tsaftace hannu don hana yaduwar cutar kamar haka:
Ka wanke hannuwanka da ruwan sanyi ko ruwan zafi.
Ya kamata a yi amfani da ruwa mai gudana saboda ruwan da ke cikin tafkin yana iya zama mai ƙazantawa kuma yanayin zafin jiki na ruwa ba ya canzawa sosai.
Wanke hannayenka da tsabta, shafa su da sabulu mai yawa, kuma wanke bayan hannu, tsakanin yatsunsu, da kuma ƙarƙashin ƙugu.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa wanke hannu da sabulu ya fi kyau fiye da wanke hannu da ruwa kawai.
Wanke hannuwanku na akalla dakika 20.
Yin taɓawa da hannu sosai yana sa a yi taɓawa, yana taimaka wajen kawar da ƙwayoyin cuta daga fata, kuma taɓawa da hannu sosai yana kawar da ƙwayoyin cuta da yawa.
Ka wanke hannayenka da ruwa mai gudana.
Ruwa a cikin ruwa zai iya sake gurɓata hannu.
Ka wanke hannayenka da tawul mai tsabta ko kuma ka bushe su da iska.
Hannun da suka jike ko bushe sosai suna iya sake kamuwa da cutar. Wuraren da aka fi mantawa da su sune yatsan hannu, yatsun hannu, tsakanin yatsun hannu, har ma da ƙarƙashin ƙusoshin hannu.
Ƙwayoyin cuta na iya zama ƙwayoyin cuta na ƙwayoyin cuta ko kuma ƙwayoyin cuta masu launin fata.
Ana ba da shawarar amfani da man shafawa mai laushi don hana hannayen su daga yin sanyi; bushewar fata na iya lalacewa kuma yana ƙara haɗarin yaduwar cutar.
Za a iya amfani da wasu hanyoyi masu sauƙi don sauƙaƙe wanke hannu idan babu ruwan famfo ko sabulu, kamar zubar da ruwa ta hanyar matattarar ruwa (swab) ko kuma amfani da ƙarfe tare da ƙwanƙwasawa ko yin amfani da toka idan ya cancanta a ƙasashe masu tasowa. Idan akwai ƙarancin ruwa (kamar a makarantun ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin da za a iya amfani da su kamar wanka da sauran hanyoyin da ba su da tsada.
Kada ku kalli shi, fasaha ce mai sauƙi ta amfani da kwalban da aka ɗora a kan igiya, zubar da ruwa tare da ƙafafunku, wanke hannuwanku da sabulu da ruwa.
Drying hannu yadda ya kamata yana da mahimmanci ga tsabtace hannu, amma har yanzu akwai muhawara game da mafi kyawun hanyar bushewa a bayan gida.
Bincike da yawa sun nuna cewa takarda mai tsabtace hannu tana da tsabta fiye da na'urar busar hannu ta lantarki da ake amfani da ita a yawancin ɗakunan wanka.
A shekara ta 2008, wata ƙungiyar masu ƙera kayan wanki mai suna European Tissue Symposium da ke Jami'ar Westminster a Landan ta ba da tallafi ta gudanar da bincike don gwada ingancin tsabtace jiki da ke fitowa daga wankin hannu da kuma na'urar tsabtace hannu.
Bayan wankewa da bushewa da bushewa da iska mai zafi, an sami ƙaruwa na ƙwayoyin cuta a matsakaita na 194% a cikin hannayen hannu da matsakaiciyar hannu da 254%.
Drying hannaye tare da iska mai iska ya haifar da ƙaruwa na ƙwayoyin cuta a matsakaita na 42% a cikin hannayen hannu da matsakaiciyar hannu da 15%.
Bayan wanke hannu da bushewa da takarda ta musamman, yawan ƙwayoyin cuta ya ragu da matsakaita na 76% a kan tawul ɗin hannu da 77% a kan hannayen hannu. Masana sun kuma gudanar da bincike don gano yiwuwar kamuwa da cuta tsakanin masu amfani da gidan wanka da kuma yanayin da ke tattare da kowane nau'in bushewa.
Na'urar bushewa, wanda ke fitar da iska a saurin 180m/s (650km/h; 400mph), na iya kawar da ƙwayoyin cuta daga hannaye da sauran wurare da kuma iyawar kamuwa da wasu masu amfani da gidan wanka da kuma kiyaye ƙwayoyin cuta a nesa da mita 2.
Amfani da busar hannu mai iska mai zafi yana kawar da ƙwayoyin cuta zuwa nisan mita 0.25 daga wurin busar hannu.
A cikin binciken da aka yi a 2005 na TÜV Produkt und Umwelt, an bincika wasu nau'ikan bushewar hannu.
An lura da waɗannan canje-canje a cikin ƙididdigar ƙwayoyin cuta bayan bushe hannu:
Akwai masana'antun da yawa da suke ƙera na'urorin tsabtace hannu, kuma an kwatanta su da takardar wanka.
Wanke hannu da maganin wanke hannu wani zaɓi ne da za a iya amfani da shi lokacin da ba a sami sabulu da ruwa a cikin tafiya.
Ya kamata a ƙayyade cewa kayan aikin tsabtace hannu suna da akalla kashi 60 cikin ɗari na alkali.
Bayan likitan Hungary Ignaz Semmelweis ya gano amfanin wanke hannu a asibiti (a shekara ta 1846) sai aka soma yin doka a kan yin hakan.
Akwai wasu na'urorin da ke tunatar da ma'aikatan kiwon lafiya su wanke hannayensu idan sun manta.
Wasu nazarin sun nuna cewa amfani da su ya rage yawan kamuwa da cuta.
Wanke hannu na likita na akalla dakika 15, tare da sabulu da ruwa da yawa ko maganin ƙonewa da kuma shafa hannu biyu tare.
Dole ne a haɗa hannayen hannu a cikin layi don su kasance kusa da juna.
Idan akwai datti a ƙarƙashin kwanon rufi, za a iya cire shi da takardar da aka yi da takarda.
Tun da yake ƙwayoyin cuta suna cikin ruwa a hannaye, yana da muhimmanci a wanke hannuwanku sosai kuma a bushe su da tawul mai tsabta.
Bayan bushe hannu, ya kamata a yi amfani da tawul ɗin takarda don rufe ruwa (har ma da buɗe ƙofar fitarwa idan ya cancanta).
Wannan yana hana sake kamuwa da cutar hannu.
Dalilin wanke hannu a wuraren kula da lafiya shine don kawar da ƙwayoyin cuta da ke haifar da cututtuka da kuma hana su yaduwa.
Jaridar New England Journal of Medicine ta ruwaito cewa wanke hannu a asibitoci har yanzu yana da kalubale, inda yawancin likitoci da ma'aikatan jinya ke mantawa da wanke hannu kafin su taɓa marasa lafiya, wanda ke haifar da yaduwar ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da sauran hanyoyin da suka dace na iya rage yawan kamuwa da cututtukan jini da kashi 66% a cikin shekara. Hukumar Lafiya ta Duniya ta wallafa wani rahoto game da ingantaccen wanke hannu da kuma amfani da magungunan wanke hannu a cikin kiwon lafiya.
Ana iya samun takaddun shawarwarin tsabtace hannu na cibiyar a shafin yanar gizon ta don ra'ayoyi.
Whitby da wasu sun yi gyara mai muhimmanci.
Kayan aiki na kasuwanci na iya gwadawa da tabbatar da tsabtace hannu, idan an nemi su nuna buƙatun da umarnin.
Hukumar Lafiya ta Duniya ta ba da shawarar "Lokaci Biyar" na wanke hannu:
bayan haɗuwa da jini/rawan jini
kafin aikin likita, da
bayan kula da mai haƙuri. Ƙara sabulu mai maganin cututtuka ("mai magani" ko "mai kashe ƙwayoyin cuta") yana taimakawa wajen wanke hannu don kashe ƙwayoyin cuta.
Ana iya buƙatar wannan maganin rigakafi kafin tiyata ko a wuraren da ƙwayoyin cuta masu jurewa sun fi yawa. Don wanke hannaye da kyau kafin tiyata, yana da mahimmanci a sami bututun ruwa wanda za'a iya rufewa da buɗewa ba tare da amfani da hannu ba, chlorhexidine ko iodine mai tsabtace jiki, tawul mai tsabta don bushe hannayen bayan wankewa, da kuma tawul mai tsabta don shafa hannu da kuma kayan aikin tsabta don tsabtace ƙusa.
Dole ne ka cire kayan ado.
Wannan yana buƙatar wanke hannu da hannu har zuwa gwiwoyi, yawanci tsakanin minti 2 zuwa 6.
Wanke hannu na tsawon minti 10 ba lallai ba ne.
Ka mai da hankali don kada ruwa ya sake zubowa a hannunka sa'ad da kake wanke hannayenka.
Bayan ka gama wanke hannuwanka, ka goge su da tawul mai tsabta kuma ka sa tufafin tiyata.
Don rage yawan ƙwayoyin cuta, yana da kyau a wanke hannu ko amfani da maganin wanke hannu kafin da kuma bayan kula da mai haƙuri.
A cikin binciken asibiti na cutar staph, an gano cewa mafi yawan fa'idodin tsabtace hannu sun fito ne daga kashi 20% na wanke hannu da aka fara, tare da ƙarin fa'idodi kaɗan da aka samu lokacin da aka ƙara yawan wanke hannu sama da 35%.
Wankewa da sabulu na yau da kullun yana haifar da sau uku mafi inganci ga cututtukan abinci idan aka kwatanta da wankewa da sabulu wanda aka tsara don kashe ƙwayoyin cuta. Idan aka kwatanta amfani da maganin wanke hannu da sabulu wanda aka tsara don kashe ƙwayoyin cuta a cikin 30 seconds, dukansu sun nuna cewa amfani da sabulu na hannu yana rage kamuwa da ƙwayoyin cuta da kashi 26% idan aka kwatanta da sabulu wanda aka tsara don kashe ƙwayoyin cuta.
Duk da haka, wanke hannu da sabulu da ruwa ya fi amfani da maganin wanke hannu don rage yawan kwayar cutar A/H1N1 da sauran ƙwayoyin cuta masu guba da ke kan hannu. Ayyukan tsabtace hannu na asibiti na iya haɗawa da koyar da ma'aikata don wanke hannu, ƙara yawan maganin wanke hannu, da kuma tunatar da ma'aikata a rubuce ko a magana.
Ana buƙatar ƙarin bincike don tabbatar da ingancin wannan taimakon a cikin kiwon lafiya a wurare daban-daban.
A cikin ƙasashe masu tasowa, wanke hannu da sabulu ana ɗaukar su a matsayin muhimmiyar hanya mai sauƙi don samun lafiya, da kuma abinci mai gina jiki.
Duk da haka, rashin samun ruwa, sabulu, ko kayan wanke hannu a gidajen mutane, makarantu, da wuraren aiki babban kalubale ne da ke hana samun al'adun wanke hannu a cikin al'umma.
Misali, a yankunan karkara da dama na Afirka, akwai karancin bututun wanke hannu kusa da gidajen wanka na jama'a ko na masu zaman kansu, duk da cewa akwai wasu hanyoyin da ba su da tsada don gina wuraren wanke hannu.
Amma, ƙananan yawan wanke hannu na iya zama saboda rashin wanke hannu maimakon rashin sabulu ko ruwa.
Ingantawa da ƙarfafa wanke hannu da sabulu na iya kawo sauyi a cikin manufofi, haɓaka wayar da kan jama'a game da fa'idodin wanke hannu da kuma haifar da canjin ɗabi'a na dogon lokaci.
Don yin wannan yadda ya kamata, lura da bincike yana da mahimmanci.
Binciken bincike 70 ya gano cewa tsarin al'umma yana da tasiri wajen haɓaka aikin wanke hannu a cikin LMICs, yayin da tallatawa a kan kafofin watsa labarun ba shi da tasiri. Misali ɗaya shine inganta aikin wanke hannu a makarantu a matsayin "Tsarin Tauraruwa Uku" na UNICEF don ƙarfafa makarantu don amfani da sauƙi, tsarin da ya fi araha don tabbatar da cewa ɗalibai suna wanke hannu da sabulu, da sauran kayan tsabtace jiki.
Idan an cika ƙa'idodin asali, makarantu na iya zuwa daga tauraro ɗaya zuwa uku.
Gina wuraren wanke hannu na iya zama wani ɓangare na kamfen don inganta wanke hannu don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen don ƙarfafa wanke hannu don cimma burin canjin halaye. Saboda annobar coronavirus ta 2019-20, UNICEF ta haɓaka emojis na wanke hannu.
Wasu ƙananan bincike sun nuna yawan ingancin wanke hannu a cikin ƙasashe masu tasowa idan aka kwatanta da ƙimar DALYs.
Koyaya, wani bincike ya nuna cewa inganta wanke hannu da sabulu ya fi inganci fiye da sauran hanyoyin tsabtace ruwa.
Muhimmancin wanke hannu a rayuwar mutum; musamman ma marasa lafiya kamar mata masu haihuwa ko sojoji da suka ji rauni a asibiti, an bayyana su a tsakiyar karni na 19 ta hanyar masu kirkirar tsabtace hannu biyu: likitan Hungary Ignaz Semmelweis a Vienna, Austria da Florence Nightingale, Ingilishi "wanda ya kirkiro aikin jinya".
A lokacin, mutane da yawa suna ganin cewa cutar ƙamshi tana kama da ƙwayoyin cuta.
A cikin shekarun 1980, cututtukan abinci da cututtukan da ke da alaƙa da magani sun sa CDC na Amurka ya ƙara ƙarfafa wayar da kan jama'a game da tsabtace hannu a matsayin muhimmin mataki na hana yaduwar cututtuka.
Cutar mura ta 2009 da annobar COVID-19 a 2020 sun sa ƙasashe su ƙara fahimtar mahimmancin wanke hannu da sabulu don hana yaduwar waɗannan cututtukan.
Misali, manyan takardu da ke nuna "kyakkyawan hanyoyin wanke hannu" an rataye su kusa da wankin hannu a wuraren wanka na jama'a a gine-ginen ofis da filayen jirgin sama a Jamus.
Kalmar "wanke hannu" game da wani abu tana nufin rashin yarda da abin da aka yi ko rashin yarda da rikici a cikin aikin.
An samo asali ne daga littafin Matta na Littafi Mai Tsarki inda Pontius Bilatus ya wanke hannunsa bayan yanke shawarar giciyen Yesu Kristi, amma wannan magana ta ci gaba da kasancewa a cikin harshen Ingilishi.
A cikin wasan Shakespeare na Macbeth, Lady Macbeth ta fara wanke hannayenta don kawar da tabo da ta yi imanin tana da shi, wanda ke nuna cewa ta damu da laifin da ta yi da kuma abin da ta sa mijinta ya yi.
An gano cewa mutane, bayan tunaninsu ko tunanin yin wani abu mara kyau, suna ƙoƙarin wanke hannayensu sau da yawa fiye da sauran, kuma suna ba da fifiko ga kayan wanke hannu.
Kuma waɗanda aka yarda su wanke hannuwansu bayan sun yi tunani game da waɗannan munanan ayyuka suna da ƙarancin ƙwarewa wajen yin wasu "tsabtace" da suka tuba kamar yin ayyukan da suka dace.
Wasu addinai suna buƙatar mabiyan su su wanke hannayensu a matsayin wani ɓangare na tsabta da kuma nuna al'adun addini. Wanke hannu a matsayin al'adar addini, ta amfani da ruwa kawai ba tare da sabulu ba kuma wanke hannu, wani ɓangare ne na al'adar da ke cikin addinai daban-daban, ciki har da Baha'u'llah, Hindu, Atheists da Diamond Nabanetrat a Yahudanci, Rava'ah a cikin Yesu, da Wudu a cikin Islama. Addinai suna buƙatar mabiyan su su wanke hannayensu, musamman bayan yin ayyuka na musamman.
Hindu, Yahudanci da Musulunci sun umurci wanke hannu bayan bayan gida.
Kuma addinan Hindu, Buddha, Sikh, Yahudanci, da Musulunci sun umurci a wanke hannu kafin da kuma bayan cin abinci.
Matakan da za a dauka don magance cutar COVID-19 a wuraren aiki
Matakan COVID-19 a wuraren aiki suna da mahimmanci don tabbatar da aminci da lafiya a wuraren aiki don hana kamuwa da cutar coronavirus ta 2019 (COVID-19).
Ana ba da shawarar mafi kyawun matakan rigakafin cutar a wuraren aiki dangane da yanayin aiki da yanayin aiki, dangane da nazarin yiwuwar kamuwa da cuta, tsananin kamuwa da cuta a cikin al'umma da haɗarin ma'aikata masu rauni ga kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aiki ta Amurka (OSHA), aikin da ke da ƙananan haɗarin kamuwa da cutar shine aikin da ma'aikata ke hulɗa da mutane da sauran ma'aikata, inda aka tsara matakan kariya na asali, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, jagororin rigakafin cututtukan numfashi da tsaftacewa na yau da kullun da kuma maganin kashe ƙwayoyin cuta a wuraren aiki.
Aikin da ke da haɗarin haɗari na matsakaici shine aikin da ke buƙatar haɗuwa ko kusanci da mutane da ba a san su ba ko kuma waɗanda ake zargi da cutar COVID-19, amma waɗanda za su iya kamuwa da cutar ta hanyar haɗuwa da juna ko tafiya zuwa ƙasashen waje.
Wannan ya hada da ma'aikatan da ke hulɗa da jama'a kamar waɗanda ke aiki a makarantu, wuraren da jama'a ke yawa da kuma shagunan da ke da manyan abokan ciniki.
Kula da cututtuka ga waɗannan ma'aikatan ya haɗa da ƙa'idodin kula da cututtuka na asali, gami da isar da iskar iska ta hanyar masu sanyaya iska, kayan kariya na numfashi da kuma kayan kariya na musamman don haɗuwa da wanda ke da cutar COVID-19.
OSHA ta ba da shawarar cewa ma'aikatan kiwon lafiya da masu nishaɗi waɗanda ke fuskantar haɗarin kamuwa da cutar COVID-19 ko ake zargi da kamuwa da cutar suna da haɗarin kamuwa da cutar, wanda ke ƙara haɗarin idan waɗannan ma'aikatan suka yi aiki tare da masu ba da iska, ɗaukar ko nazarin samfurin daga wanda aka sani ko ake zargi da cutar COVID-19.
Mafi kyawun hanyar hana yaduwar cutar ga waɗannan ma'aikatan shine amfani da kayan aikin da aka tsara kamar ɗakunan iska da tufafin kariya na musamman don aikin su.
Cutar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya yin rashin aiki saboda rashin lafiya, buƙatar kula da wasu, ko tsoron kamuwa da cutar.
Yanayin kasuwanci na iya canzawa, ko dai ta hanyar da ake shigo da kaya ko kuma yadda ake siyan kayayyakin (kamar sayen kaya a lokacin da ba a sayi su sosai ba ko sabis na siyarwa ko isar da kaya ta mota).
Daga nan, za a iya yanke jigilar kayayyaki daga yankunan da cutar ta COVID-19 ta fi shafa. Za a iya amfani da shirye-shiryen rigakafin cutar don ayyukan rigakafi.
Shirye-shiryen sun nuna haɗarin da ke cikin wurare da yawa na aiki da aikin kansa, gami da haɗarin kamuwa da cuta, haɗarin gida da na al'umma da haɗarin ma'aikata na mutum saboda tsufa ko cututtuka masu tsanani.
Hakanan yana ba da jagororin da ake buƙata don magance cutar ta hanyar kawar da waɗannan haɗarin da sauran matakan da za a iya ɗauka idan ba a yi aiki daidai ba yayin annobar.
Za a iya aiwatar da shirye-shiryen kamuwa da cuta da kuma shirye-shiryen sarrafawa a matakin ƙasa ko yanki.
Matakan da aka dauka don magance cutar a cikin wasu mutane sun haɗa da rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da wasu cututtuka, ci gaba da buɗe kasuwancin da rage tasirin tasirin ga sauran kamfanoni a cikin sarrafawa da sarrafawa.
Rashin talauci a cikin al'ummomin da kasuwancin ke aiki na iya shafar matakan da aka ɗauka.
Tsarin kula da cututtuka da aka fi amfani da su don magance cututtukan cututtuka yana kiyaye lafiya da lafiya a wuraren aiki ta hanyar samar da su.
Inda ba za a iya sarrafa cutar ta COVID-19 ba, hanya mafi inganci don magance cutar ita ce ta amfani da kayan aiki na musamman, tare da bin matakan kulawa da kayan kariya na musamman.
Kula da cututtuka ta hanyar kayan aiki na musamman shine kare ma'aikata daga haɗarin aiki ba tare da la'akari da halayyar ma'aikaci ba kuma yana iya zama mai araha don aiwatarwa.
Ayyukan gudanarwa sune canje-canje a cikin ka'idojin aiki ko ayyuka waɗanda ke buƙatar aiwatar da su ta ma'aikaci ko mai aiki.
Ana ɗaukar tufafin kariya na mutum (PPE) da ƙarancin tasiri kamar na biyun da suka gabata, amma yana iya taimakawa wajen hana kamuwa da cuta.
Duk nau'ikan PPE dole ne a zaɓa bisa ga haɗarin ma'aikaci, dacewa da aikin (misali, kayan aiki na numfashi), saka su a kai a kai kuma a hankali, bincika su koyaushe, sarrafa su da kyau, canza su kamar yadda ya cancanta, cire su, tsabtace su, adana su ko zubar da su don hana su kamuwa da cutar.
A cewar OSHA na Amurka, aikin da ke da ƙananan haɗarin kamuwa da cuta shine aikin da ke da alaƙa da jama'a ko abokan aiki.
Dole ne a kiyaye matakan kariya na yau da kullun a duk wuraren aiki kuma sun haɗa da wanke hannu sau da yawa, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ka'idojin rigakafin cututtukan numfashi ciki har da rufewa lokacin tari ko hancin, rarraba takunkumin tsabta da wuraren zubar da shara, tsara hanyoyin sadarwa ta hanyar lantarki, hana ma'aikatan maye gurbin shiga ko fita lokaci ɗaya idan ya cancanta, ƙarfafa ma'aikata su yi amfani da kayan aikin abokan aiki da tsabtace da kuma kashe ƙwayoyin cuta a wuraren aiki da yawa.
Ganowa da kuma keɓewa da wuri na mutanen da ke da yiwuwar kamuwa da cutar yana da mahimmanci don kare ma'aikata, abokan ciniki, baƙi da sauran masu aiki.
CDC na Amurka yana ba da shawarar cewa ma'aikata da ke da alamun cutar zazzabin numfashi su kasance a gida har sai zazzabi, zazzabi da sauran alamun sun ƙare kuma aƙalla awanni 24 ba tare da maganin zazzabi ko wasu magunguna don magance alamun ba, da sauƙaƙe matakan neman izinin rashin lafiya, ba da izinin ma'aikata su zauna a gida tare da wani dangin da ke da rashin lafiya, da kuma sanar da ma'aikata game da waɗannan matakan.
A cewar OSHA, aiki mai matsakaicin haɗarin kamuwa da cutar shine aikin da ke buƙatar haɗuwa sau da yawa ko kusanci na ƙasa da mita 1.8 tare da mutanen da ba a san su ba ko waɗanda ake zargi da kamuwa da COVID-19, amma waɗanda za su iya kamuwa da cutar SARS-CoV-2 ta hanyar watsawa tsakanin mutane a wuraren kasuwanci ko kuma ta hanyar tafiya kwanan nan zuwa yankin da ke da cutar COVID-19.
Waɗannan sun haɗa da ma'aikata waɗanda ke da alaƙa da jama'a kamar ma'aikatan makarantu, waɗanda ke aiki a wuraren da mutane ke taruwa da kuma shagunan da ke da haɗarin kamuwa da cuta. Don magance kamuwa da cuta ta hanyar amfani da kayan aiki na musamman ga waɗannan ma'aikata da sauran rukunin da ke da haɗarin kamuwa da cuta sun haɗa da masu sanyaya iska, ƙara yawan masu samar da iska, da sanya alamun hana wucewa kamar su filastik da aka yi da filastar roba da ke hana su shiga cikin motar. Matakan gudanarwa don hana kamuwa da cuta a cikin waɗannan ma'aikata da sauran rukunin ma'aikata waɗanda ke da haɗarin kamuwa da cutar sun haɗa da ƙarfafa ma'aikatan da ba su da lafiya su kasance a gida, canza shawarwarin rufe fuska da kuma yin amfani da takunkumi, da kuma hana ma'aikata yin amfani da fasahar sirri a wuraren aiki, gami da sanya kayan aikin rufe fuska, sanya takunkumi da takunkumi a cikin wuraren aiki da ba a san su ba, ko kuma rage yawan ma'aikata da ba su da lafiya, ba da takunkumi ko takunkumi, da kuma ba da takunkumi, don hana yaduwar COVID-19, hana yaduwar cutar, ba da sauran hanyoyin da za su iya hana yaduwar cutar, da kuma taimaka wa ma'aikata su hana yaduwar COVID-19, da kuma ba da wasu hanyoyin da za su iya hana yaduwar cutar.
Ma'aikata a cikin wannan rukunin masu haɗari ba sa yawan buƙatar yin amfani da inhaler.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, dole ne a ɗauki matakan kariya don kare ma'aikata da sauran fasinjoji, gami da keɓewa da nisan mita 2, sanya ma'aikacin jirgin sama don kula da lafiyar, sanya abin rufe fuska ko buƙatar rufe baki da hanci da zane idan ya tari ko hancinsa.
Ma'aikatan jirgin sama dole ne su sa safofin hannu na likita da za a iya zubar da su lokacin da suke kula da marasa lafiya a cikin jirgin sama ko taɓa ruwa na jiki ko aiki a wuraren da za su iya zama masu ƙazantawa da kuma sanya kayan kariya na musamman idan ya zama dole idan mai haƙuri a cikin jirgin yana da zazzabi, tari mai tsanani ko wahalar numfashi.
Ya kamata a sanya safofin hannu da sauran kayan aikin da aka yi amfani da su a cikin jaka da aka keɓe kuma a goge wuraren da aka gurɓata da maganin kashe ƙwayoyin cuta bayan amfani.A kan jiragen ruwa masu fasinja, gami da jiragen ruwa masu yawon buɗe ido da sauran jiragen ruwa masu fasinja, sarrafa kwayar cutar ya haɗa da jinkirta tafiya idan akwai rashin lafiya da keɓewa da sanar da asibitin jirgin ruwa nan da nan idan wani ya kamu da zazzabi ko wasu alamun cutar a cikin jirgin.
Zai fi dacewa a sa shi a cikin keɓewa ta hanyar kulawar likita. A makarantu da cibiyoyin kula da yara, CDC ta ba da shawarar a rufe shi na ɗan lokaci don wanka ko maganin kashe ƙwayoyin cuta idan mai cutar ya bayyana a harabar makarantar ba tare da la'akari da yiwuwar kamuwa da cuta ba.
Ko da akwai ƙananan ko manyan adadin kamuwa da cuta tsakanin mutane, ana iya amfani da matakan hana kusanci ta hanyar dakatar da makarantu da taron jama'a kamar motsa jiki ko darussan mawaƙa ko cin abinci a kantin, ƙara nisa tsakanin kujeru, sanya sarari tsakanin waɗanda suka shiga da waɗanda suka fita, guje wa ziyarar da ba dole ba, da kuma amfani da asibiti a wani wuri don yara da ke nuna alamun mura.
Idan akwai kamuwa da cutar a cikin al'umma, ban da matakan kariya na kusanci, ana iya la'akari da rufe makarantu na dogon lokaci.Ga ma'aikatan tsaro da ke aiki a kai a kai, haɗarin kamuwa da cutar nan da nan yana da ƙarancin, a cewar CDC.
Ana buƙatar ma'aikatan tsaro da suka sadu da mutum mai cutar ko wanda ake zargi da cutar COVID-19 su bi ƙa'idodin likita na musamman, gami da sanya kayan kariya na musamman.
Idan akwai kusanci a lokacin kamawa, ma'aikata su goge da kuma kashe kyallen takalmin da ke kan belinsu da kayan aikin su kafin su sake amfani da su tare da gogewar gida ko gogewa kuma su bi ƙa'idodin adanawa da zubar da kayan kariya na musamman da aka yi amfani da su da kuma adanawa da wankewa.
OSHA ta ba da shawarar cewa wasu ma'aikata a cikin kiwon lafiya da nishaɗi suna cikin haɗarin haɗari ko mafi girma.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da ma'aikatan kiwon lafiya, ma'aikatan dakin gwaje-gwaje, da masu jigilar kaya zuwa ko daga asibiti waɗanda ke iya haɗuwa da wani da aka sani ko ake zargin yana da COVID-19.
Waɗannan suna da haɗarin kamuwa da cutar idan masu aikin sun yi aiki tare da yin amfani da iska mai ƙarfi, tattarawa ko nazarin samfurin mutum wanda aka sani ko ake zargi da cutar COVID-19.
Ayyukan sake dawo da iska sun haɗa da yin amfani da iska, tari, numfashi, wasu hanyoyin hakori da bincike ko ɗaukar bayanan ciki.
Yawancin haɗarin kamuwa da cutar a lokacin hutu suna cikin ma'aikatan da ke shirya gawawwakin mutanen da aka sani ko ake zargi da kamuwa da COVID-19 a lokacin mutuwarsu; suna da haɗari mafi girma yayin yin gwajin cutar. Kuma sarrafa kamuwa da cuta ta hanyar kayan aiki na musamman ya haɗa da rukunin haɗari waɗanda suka haɗa da keɓewa ga marasa lafiya da aka sani ko ake zargi da cutar COVID-19, gami da yin aikin oxygenation.
Na'urar numfashi ta musamman na iya zama mai dacewa ga wasu likitoci da masu aikin hutu.
Dole ne a ɗauki gwaje-gwaje bisa ga matakan aminci na asibiti na 3.
WHO ta ba da shawarar cewa marasa lafiya da ke zuwa asibiti su keɓe kansu a cikin ɗakunan jira saboda zargin COVID-19.Kuma game da tufafin kariya na musamman, OSHA ta ba da shawarar yin amfani da inhalers a cikin nisan mita 2 daga mutanen da aka sani ko ake zargi da cutar SARS-CoV-2 da kuma waɗanda ke aiki a cikin aikin oxygenation.
A cikin Amurka, dole ne a yi amfani da kayan aikin N95 na NIOSH ko mafi inganci bisa ga ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin ƙa'idodin
Wasu nau'ikan kwalliyar kwalliya na iya ba da kariya ga masu amfani da su da kuma sa ma'aikaci ya sami kwanciyar hankali. WHO ba ta ba da shawarar cewa ma'aikata su sa kwalliya saboda COVID-19 cuta ce ta numfashi maimakon cutar da ke yaduwa ta hanyar ruwa.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa kawai ma'aikatan kula da asibiti su sanya abin rufe fuska na likita.
Ga masu ɗaukar iska, masu kula da marasa lafiya, ko masu jigilar marasa lafiya na COVID-19 waɗanda ba su da iska mai ƙarfi, WHO ta ba da shawarar sanya abin rufe fuska, fitilu ko kwalkwali, riguna da safofin hannu.
Lokacin da ake ba da numfashi ga mai haƙuri, ana maye gurbin abin rufe fuska na likita da N95 ko FFP2 masks.
Ganin cewa samar da kayan kariya na mutum (PPE) bai isa ba a duniya, WHO ta ba da shawarar rage buƙatun kayan kariya na mutum ta hanyar amfani da kayan aikin likita, sanya abubuwan da ke hana mutane yin jira kamar taga mai haske, da sanya masu kula da lafiya kai tsaye su shiga ɗakin da ke dauke da mai cutar COVID-19, amfani da PPE kawai lokacin da ya zama dole don takamaiman aiki, ci gaba da amfani da inhaler guda ɗaya ba tare da cire shi ba yayin kula da marasa lafiya da yawa, saka idanu da daidaita ayyukan samarwa da kula da PPE da kuma hana amfani da abin rufe fuska ga marasa alamun.
Rubuta ta Katherine Maher, Shugaba na Wikimedia Foundation
Rubuta: Duk ma'aikatan Wikimedia Foundation
MAGANA: [Covid-19] Rage nauyi da shirya don gaba
LOKACI/KYAUTA: 14 ga Maris, 2020, 00:24 UTC
CC0: Babu haƙƙin mallaka na musamman
Mun tsinci kanmu a cikin yanayi na musamman a wannan watan.
Cutar COVID-19 ta zama alama ce ta yadda duniya ta zama ƙauye kuma dole ne mu taimaka wa juna.
Ba mu taɓa fuskantar waɗannan ƙalubalen ba, amma mun san cewa mafi kyawun hanyar magance cutar ita ce ta hanyar sauraron matsalolin duniya, aiki tare da kasancewa tare a cikin wannan al'umma.
Haɗin kai da kulawa da muka gani a cikin duk abokan aikinmu ta hanyar imel, kira da tattaunawa suna nuna halaye na musamman waɗanda muka sami damar yin aiki tare da ku sosai.
Ba zan iya ba da cikakkiyar godiya ko kuma yadda zan yaba muku da ku duka a matsayin abokan aikina ba.
A makon da ya shige, wani ya nuna mini yadda yake jin daɗin aikinmu.
Ya tunatar da ni cewa a yau, duniya tana amfani da Wikipedia sosai, wanda ke nuna cewa ita ce babbar hanyar samar da bayanai masu mahimmanci kuma ya kamata ta kasance a kan layi kuma kowa ya samu.
Aikinku ne ke sa hakan ya yiwu, ko dai don ci gaba da gudanar da shafin ko don biyan abokan aikinmu ko kuma don kiyaye wurin aikinmu.
Duniya tana bukatar bayanan Wikipedia yanzu fiye da kowane lokaci.
Lokaci ya yi da za mu mai da hankali ba kawai ga abin da muke yi ba amma kuma yadda muke yi, don mu kawo canji mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da kake takawa, za mu yi wasu muhimman canje-canje ga yadda muke aiki tare, daga mako mai zuwa.
Yin gyara a ayyukanmu da kuma tsarinmu
Kamar yadda Robyn ta ce, kungiyarmu ta hadu a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A cikin wannan tattaunawar, mun tattauna abin da muke tsammanin zai zama amsar da ta dace ga abin da muke fuskanta da kuma mafi kyawun hanyoyin da za mu ci gaba da kasancewa cikin iyali a wannan zamanin.
Mun yi ƙoƙari sosai mu kawar da matsaloli kuma mu ci gaba da hidimarmu.
Idan kana son kira, ba matsala.
Ga masu hidima, waɗanda aka ba alkawari, waɗanda suke yin aiki bisa ga alkawari,
Ana sa ran aiki na sa'o'i 4 a rana ko sa'o'i 20 a mako har sai an ba da umarni.
Ba hutu ba ne; idan za ka iya yin aiki na sa'o'i da yawa, za mu iya yin amfani da shi a hidimarmu.
Amma a wannan zamanin, abubuwa suna canjawa a duniya kuma idan kana bukatar ka kula da waɗanda kake ƙauna, ka je cin abinci, ko kuma ka fita shaƙatawa, lafiyarka ce ta fi muhimmanci.
Ba ma bin sa'ad da kake aiki.
Idan kana rashin lafiya, kada ka je aiki.
Ba a faɗi ba amma an yi ƙaulin sa.
Ba lallai ne ku nemi izinin rashin lafiya ko kuma ku biya ba, amma ku sanar da shugaba ku kuma ku taimaka wa ƙungiyar ku don sake tsara jadawalin don ci gaba da aikinku na asali.
(Idan an gwada ku da cutar COVID-19, sanar da Bryan a T&amp;C Ops don T&amp;C ta ba ku taimako da kulawa ta dacewa).
Za a biya masu biyan sa'a gaba daya.
Mun sake maimaita wannan kuma mun sake tabbatar da alkawuranmu ga abokan aikinmu da aka ba mu a kan lokaci.
Kowane mutum zai sami ladarsa bisa ga adadin sa'o'in da ya yi a lokacin da ya saba.
Akwai lokutan da ba za ka iya aiki ba saboda rashin lafiya.
Idan kana son yin aiki, muna goyon bayan ka.
Mutane da yawa suna amfani da aikinsu don su guji damuwa da ke tattare da rayuwa a wannan duniyar.
Abubuwan da muke yi za su iya kawo sakamako mai kyau musamman a wannan zamani.
Amma, ka mai da hankali ga kanka.
Manufarmu ita ce ka yi magana da shugaba, don sanin abin da za ka yi tsammani da kuma daidaita ayyukan yadda ya kamata.
Akwai aiki da ake ɗauka da muhimmanci.
Akwai abubuwa da muke bukatar mu ci gaba da yi.
SRE, HR Ops, Trust &amp; Safety ƙungiyoyi an kafa su don tara kuɗi (da sauran) don yin aiki mai mahimmanci wanda ke buƙatar ƙarin tallafi.
Za mu fara bincike a duk sassan don sake nazarin manufofin da muke da su da kuma daidaita abubuwan da muke mayar da hankali don tallafawa mahimman ayyukanmu.
Akwai abubuwa masu muhimmanci da ya kamata mu yi, amma akwai wasu abubuwa masu muhimmanci da ya kamata mu mai da hankali a kai.
Yin wasu ayyuka a yanzu ba zai kawo sakamako ba.
Ba mu da niyyar aiki kusan sau biyu don dawo da lokacin da muka rasa bayan annobar ta ƙare.
Ba za a bukaci ka yi aiki na tsawon lokaci ba don ka cika lokacin da aka ba ka, amma ba za ka iya yin hakan ba yanzu.
Mun amince da canjin yanayi kuma za mu yi aiki don saita manufofi da jadawalin abubuwan da suka dace.
Me zai faru da shirin shekara-shekara?
Don daidaitawa da yanayin da ya zama daidai da lokutan aiki na yau da kullun, muna son canza jadawalin ayyukanmu na 2020-2021.
Manufarmu ita ce neman tsawaita lokacin tsarawa na 2019-2020 don samar da lokacin kasafin kuɗi don ƙarfafa ma'aikata su ba da fifiko ga aikin yau da kullun, kula da kansu da ƙaunatattun su yayin da muke tallafawa waɗanda suke so ko waɗanda ke son yin aiki na ɗan gajeren lokaci a cikin 'yan makonni masu zuwa.
Wannan karin lokaci yana rage yawan aikin da aka tsara da kuma matsin lamba a cikin iyali.
Za mu gabatar da shawarwarinmu ga kwamitin gudanarwa a mako mai zuwa kuma zan ba da sabuntawa ga wakilan sauran kungiyoyi da kungiyoyi kan umarnin da za a bi nan da nan bayan an amince da su.
Ƙungiyar tsarawa ta yi farin ciki da kwarewar jagoranci da ta nuna.
Yanayin ofishi, haɗarin kamuwa da cuta da tsaftacewa
A makon da ya gabata, mun sami labarin cewa wani abokin aikina a SF ya sadu da wani wanda zai iya kamuwa da cutar COVID-19.
Amma, saboda taka tsantsan, mun ba da aikin ƙungiyar tsabtace rigakafin cutar don sanya maganin kashe ƙwayoyin cuta a ko'ina cikin ofishin San Francisco.
Sun yi amfani da tsarin rigakafin cutar a asibiti kuma sun kashe ƙwayoyin cuta a ko'ina, ko'ina cikin wuraren shiga da kuma a cikin ma'aunin ma'aunin banki har zuwa bene na ofishinmu.
Ginin yana amfani da umarnin rigakafin cutar ta hanyar kayan aiki don kare lafiyar masu amfani.
Muna da tabbacin cewa ofishin zai kasance a shirye idan muka yanke shawarar sake yin hakan.
Ofishinmu na DC wanda ke WeWork, ya raba yarjejeniyar COVID-19 tare da mu da kuma duk ma'aikatan da ke aiki a DC.
Har zuwa makon da ya gabata, ofishinmu a DC ya canza zuwa cikakken aiki ta hanyar nesa don bin umarnin San Francisco.
Kamar yadda wasu abokan aikina a birnin New York suka sani, mun fara tattaunawa game da haya a Brooklyn.
Ana ci gaba da tattaunawar, amma za a iya jinkirta hakan.
Wasu abokan aikina suna aiki da na'urar da ke nesa a karon farko.
Abokan aikinmu da suka saba da amfani da nesa sun san cewa za a iya daidaita su kuma muna so mu ba su shawara:
Idan taron ya makara, ka rage tsawonsa zuwa awa ɗaya ko biyu.
Idan ba ku bukatar zaman, ku yi tunanin yadda za ku raba darussan da ake koyarwa a kwanaki da yawa.
Bayyana shawarwari, bayyana ainihin batun, da kuma aika takardun da aka tsara.
Ka daina amfani da bidiyo a matsayin tushen ka ta amfani da manhajoji kamar Google Docs da Zoom don sauƙaƙe sadarwa da raba bayanai nan take.
Bari babban manajan gudanarwa ya jagoranci kowane taro, yana da mai duba tambayoyin da kuma kula da jerin abubuwan da za a yi magana da wanda ke ɗaukar bayanan taron (ko kuma ya haɗa kai da wasu don rubuta bayanan taron).
Aika da imel zuwa ga masu ba da tallafi na fasaha idan kuna buƙatar ingantaccen mai amfani.
Ka ci abinci mai sauƙi don ka kasance da koshin lafiya.
Je zuwa #remoties na Slack don sanar da matsalolin da kuke fuskanta yayin aiwatar da aikin da aka ba ku
Ayyukan ƙungiyar ma'aikata suna nazarin jagororin tsarin horo na kan layi don karɓar taimako da haɓaka aikin da aka bayar a cikin Ƙungiyar.
A makon da ya gabata, mun nemi duk cibiyoyin da ke karɓar tallafi su dakatar da ayyukan Wikimedia na tallafi na jama'a kamar horo don sabbin masu rubutun yanar gizo, har sai WHO ta ba da sanarwar cewa annobar ta ƙare.
Mun sanar da su cewa mun san cewa yin amfani da umarnin da kuma umarnin da aka ba su na hana su kammala aikin tara kuɗi da suka yi niyya kuma ba za a hukunta su ba saboda jinkiri ko sauya manufa.
A mako mai zuwa, za mu ci gaba da bin ƙarin jagororin Wikimania da sauran tarurrukan yanki na musamman a wasu yankuna.
Babban ra'ayi game da ƙungiyoyin duniya shine baƙin ciki game da dakatarwar amma akwai ta'aziyya, fahimta da ikon mai da hankali kan ƙungiyoyin su, Wikimedia da sauransu.
Don haka, CRT yana ƙirƙirar shafi akan Meta-Wiki don ba da sarari ga al'umma don lura da tasirin da kuma lura da bayanan da muke hulɗa da su.
Ci gaba da musayar bayanai kan batutuwan COVID-19
Za mu aika muku da gayyata zuwa taronku na ranar Alhamis mai zuwa, da karfe 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don mu ba ku sabon bayani, mu amsa tambayoyinku, kuma mu ba ku ƙarin lokaci don tattaunawa.
Dukanmu muna cikin wannan annoba kuma muna nan don taimakawa yadda za mu iya.
A halin yanzu, zaku iya ci gaba da samun ƙarin bayani game da wannan imel ɗin da sauran mahimman bayanai game da COVID-19 a kan Wiki Office.
CRT za ta ci gaba da sabunta waɗannan shafukan kuma duk bayanan za su kasance a wuri guda.
Muna kuma neman hanyoyin ci gaba da sadarwa tare da ma'aikatanmu a ƙasashen da ke fama da cutar.
Idan kuna da wata tambaya game da tafiya, aiki, aiki ko matsalar intanet ko kuma duk wani abu da kuke buƙatar taimako, kada ku yi jinkirin sanar da mu kuma kuyi aiki tare da CRT.
Muna nan don taimaka muku wajen daidaita ayyukan kamar yadda ya kamata.
Idan kuna da wata tambaya ta sirri ko buƙatar kulawa, aika imel zuwa Bryan Judan, Manajan Darakta na Ma'aikata da Ayyuka na Duniya.
Babu wani daga cikin waɗannan canje-canjen da za a ɗauka a matsayin barin aikinmu ko matsayinmu.
Maimakon haka, yana nuna cewa aikinmu da kuma hakkinmu a yau suna iya canjawa a hanyoyi da ba a taɓa yi ba a dā.
Waɗannan su ne matakan da muka yi imanin cewa suna da mahimmanci don tallafawa juna don ci gaba da aiki, yin aikinmu bisa ga bukatunsu da samar da duniya mai aiki.
Aikin da muka shirya zai kasance a wurin har sai lokacin ya zo.
A halin yanzu, muna cikin lokacin haɗin gwiwa da samar da lokaci don yin aiki mai mahimmanci a cikin makonni masu zuwa kuma wataƙila a cikin watanni masu zuwa.
Muna bukatar ku duka don mu samu nasara kuma muna bukatar ku kula da kanku da iyalanku don ku kasance lafiya idan kun bukaci hakan.
Yanzu, ku wanke hannuwanku kuma kada ku taɓa fuskokinku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran membobin ƙungiyar gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
bAngiotensin-converting enzyme 2 (ACE2) shine furotin mai samar da hormone wanda aka sanya a cikin ƙwayoyin ƙwayoyin cuta na huhu, jijiyoyin jini, zuciya, koda, da hanji.
ACE2 yana daidaita aikin enzyme mai canza angiotensin (ACE) ta hanyar rage yawan angiotensin-II da haɓaka Ang (((1-7) don samar da magani mai kyau don magance cututtukan zuciya.ACE2 kuma yana taimakawa wajen zama ƙofar shiga cikin ƙwayoyin cuta ga wasu coronaviruses.
Tsarin ɗan adam na furotin mai ƙwayoyin cuta ana kiransa hACE2.
Angiotensin-con 2 mai kwakwalwa shine zinc-mai dauke da metallol-enzyme wanda ke cikin farfajiyar endothelial da sauran ƙwayoyin halitta.
ACE2 yana dauke da N-terminal na peptidase M2 da kuma C-terminal na collectrin wanda ke daukar acid daga magani zuwa koda.
ACE2 shine kwayar halitta mai nau'in I mai aiki guda ɗaya, wanda ke da ɓangaren aikin hormone a saman ƙwayoyin huhu da sauran ƙwayoyin halitta.
Ana cire wani ɓangaren waje na ACE2 daga ɓangaren ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar ƙofar
Ana samun ACE2 a cikin yawancin kwayoyin halitta: ACE2 yana aiki akan ƙwayoyin cuta na ƙwayoyin cuta na II na huhu, ƙwayoyin ƙwayoyin ƙwayoyin cuta, ƙwayoyin jini da ƙwayoyin jini da ƙwayoyin jijiyoyin jini a yawancin sassan jiki.
Ana samun bayanin mRNA na ACE2 a cikin ƙwayar ƙwayar cuta, striatum, hypothalamus, da kuma ƙirar kwakwalwa.
Babban aikin ACE2 shine daidaita daidaitattun matakan ACE.
ACE yana motsawa daga angiotensin I zuwa angiotensin II wanda ke rage karfin jini.
ACE2 kuma yana cire phenylalanine daga amino acid na carboxyl-terminal a cikin angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyses a cikin angiotensin da ke da manyan jijiyoyin jini (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana iya rarraba peptides kamar [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 yana taimakawa wajen hana ƙwayar cuta ta amino acid wanda ke haifar da SLC6A19 kuma yana da tasiri a cikin cututtukan Hartnup.
A matsayin furotin mai ɗaukar hoto, ACE2 yana aiki azaman babbar hanyar shiga ƙwayoyin cuta waɗanda ke ƙunshe da wasu coronaviruses, wato HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
A cikin mafi ƙayyadaddun bayani, haɗuwa da haɓakar furotin S1 na SARS-CoV da SARS-CoV2 zuwa ga ɓangaren hormone na ACE2 akan ƙwayoyin halitta yana haifar da endocytosis da ƙaurawar ƙwayoyin cuta daga sararin samaniya zuwa ƙwayoyin cuta a cikin ƙwayoyin halitta.
Wannan hanyar shiga kuma tana sa furotin S ya yi aiki ta hanyar rarraba TMPRSS2, wanda bincike ke neman hana shi aiki a matsayin wata hanya mai mahimmanci ta magance shi.Wannan ya haifar da ra'ayin cewa rage yawan ACE2, a cikin kwayoyin halitta, na iya taimakawa wajen magance cutar.
Koyaya, yawancin kamfanoni da hukumomin kulawa sun ba da shawarar ci gaba da hana ACE daga yin aiki tare da maganin ARB da aka yarda.
Wani bincike mai zurfi da aka buga a ranar 11 ga Yuli, 2012 ya gano cewa "amfani da maganin hana ACE yana da alaƙa da raguwar haɗarin kamuwa da cutar sankarar bargo da kashi 34% idan aka kwatanta da waɗanda aka sarrafa".
Bugu da ƙari, "an rage haɗarin kamuwa da cutar sankarar bargo a cikin marasa lafiya masu haɗarin kamuwa da cutar waɗanda aka bi da su tare da maganin hana ACE, musamman marasa lafiya na zuciya da waɗanda ke da matsalar zuciya.
Hakanan an haɗa amfani da maganin hana ACE tare da raguwar mutuwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Ana ɗaukar haɗin ACE2 (rhACE2) a matsayin sabon magani don cutar sankarar bargo mai tsanani, kuma yana da alama yana haɓaka ingantaccen jini a cikin huhu da kuma inganta iskar oxygen a wuraren da ƙwayoyin cuta ke haifar da cutar ta huhu.
Rabin rayuwar rhACE2 a cikin mutane shine awanni 10 kuma yana farawa aiki bayan mintuna 30 akan lokacin da tasirin ya fara bayyana (lokaci) a cikin awanni 24.
Yawancin nazarin sun gano cewa rhACE2 na iya zama kyakkyawan magani ga mutanen da ke da rashin haƙuri ga tsarin hanawa na renin-angiotensin (RAS inhibitors) ko kuma cututtukan da ke haifar da hawan jini na angiotensin II. An bincika maganin rhACE2 a cikin gwaji na asibiti don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
COVID-19 aikace-aikacen wayar hannu ne da aka tsara don taimakawa gano lambobin sadarwa don gano cutar coronavirus ta 2019-20, misali ta hanyar gano mutane ("lambobi") waɗanda zasu iya tuntuɓar mai kamuwa da cutar.
An samar da shirye-shirye da yawa ko kuma an ba da shawarar su ga mutane da yawa, tare da tallafin gwamnatoci a wasu larduna da yankuna.
An tsara tsarin da yawa don gina aikace-aikacen da ke fahimtar yadda mutane suke hulɗa.
An nuna damuwa game da keta sirrin mutum, musamman game da tsarin gano wurin mai amfani da aikace-aikacen.
Wani zaɓi mai sauƙi wanda zai maye gurbin wannan shine amfani da hanyar sadarwa ta Bluetooth don shiga tare da wasu wayoyin hannu ta amfani da aikace-aikacen da ke kusa.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa wannan aikace-aikacen don tallafawa aikace-aikacen da ke da tushen Bluetooth da za a iya shigar da su kai tsaye zuwa tsarin aiki na Android da iOS.
A China, Gwamnatin China, tare da haɗin gwiwar Alipay, ta ƙaddamar da aikace-aikacen da ke ba da damar 'yan ƙasa su bincika idan sun taɓa saduwa da mutanen da ke da cutar COVID-19.
Ana amfani da shi a birane sama da 200 na kasar Sin.A Singapore, ana amfani da wata manhaja da ake kira TraceTogether.
An samar da manhajar ta hanyar wata babbar ƙungiyar masu fasaha da IT, kuma an gabatar da ita a matsayin tushen bayanai wanda ke buɗe ga kowa kuma ana samun sa ga gwamnati. Arewacin Macedonia ta ƙaddamar da "StopKorona!", aikace-aikacen Bluetooth don gano kusanci da mutane masu cutar sosai da kuma ba hukumomin kiwon lafiya amsawa cikin sauri.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka kirkiro wannan manhajar.
Tun daga ranar 14 ga Afrilu 2020, ana jiran aikace-aikacen don samun izini daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ce shirin gano lamba ya kai matakin ci gaba kuma ya kamata ya kasance a shirye don rarrabawa a cikin makonni masu zuwa.An shirya irin wannan shirin a Ireland, da kuma Faransa ("StopCovid").
Ostiraliya da New Zealand suna tunanin samar da aikace-aikacen wayar hannu bisa ga samfurin TraceTogether na Singapore da BlueTrace na Rasha. Rasha na shirin ƙaddamar da aikace-aikacen kula da marasa lafiya na COVID-19 a Moscow, wanda ke tabbatar da cewa ba su fita daga gida ba.
Ross Anderson, farfesa a fannin aiwatar da tsare-tsare a Jami'ar Cambridge, ya lissafa wasu matsaloli masu yawa da tsarin da ke da alaƙa da aikace-aikacen wayar hannu ke haifar da su, gami da rashin lafiya da rashin aiki idan amfani da waɗannan aikace-aikacen ya iyakance ga ƙananan jama'a.
Don magance damuwa game da yaduwar ɓatarwa ko aikace-aikacen bincike na cutar coronavirus, Apple ya sanya iyakance iyaka ga nau'ikan kamfanonin da ke loda aikace-aikacen bincike na coronavirus a cikin App Store, suna ba da izinin "aikace-aikacen da aka yarda da su" ko kuma a wasu kalmomin amintattun kamfanoni.
Google da Amazon sun kafa irin wannan takunkumin.
Mutane sun nuna damuwa game da yawan binciken da ake yi ta hanyar wayar salula, musamman idan za a cire matakan da aka sanya don kula da cutar coronavirus bayan annobar ta ƙare.
Kungiyar kare hakkin dan adam ta Amnesty International da wasu kungiyoyi sama da 100 sun wallafa wata takarda da ke kira da a rage amfani da wannan hanyar.
Kungiyoyin sun bayyana ka'idoji guda takwas da gwamnati za ta bi don aiwatar da ayyukanta:
Binciken dole ne ya kasance cikin bin doka, dole ne kuma daidai da manufar ";
tsawaita lokacin bita idan an duba shi dole ne ya haɗa da abubuwan da ke nuna lokacin da zai ƙare;
Ana buƙatar amfani da bayanan ne kawai don dalilai masu alaƙa da COVID-19;
tsaro da kuma sirrin bayanai da za a kiyaye su kuma a tabbatar da su don kare su bisa ga shaida;
Binciken da ke amfani da fasaha dole ne ya zama ba tare da nuna bambanci ko rashin adalci ba;
duk wata jarida dole ne ta kasance bisa doka;
ya kamata a sami hanyoyin da za a magance zalunci da kuma taimaka wa jama'a su hana shi;
"Ana buƙatar haɗin kai na kowane ma'aikacin da ake buƙata, gami da ƙwararrun likitocin jama'a da  ƙungiyoyin da ba a kula da su ba  Cibiyar Fasaha ta Jamus (CCC) da  'Yan Jarida ba tare da Iyaka ba (RSF) suma sun tsara jerin abubuwan da za a kula da su.
Tsarin da Google/Apple suka tsara don magance matsalar ci gaba da bincike ya yanke shawarar cire tsarin gano masu cutar daga tsarin su lokacin da ba a buƙatar wannan tsarin.
Wasu ƙasashe sun yi amfani da hanyar bincike ta gida maimakon na wayar hannu, suna kawar da buƙatar shigar da fasaha ta wayar hannu da kuma yiwuwar kaucewa bincike.
A Isra'ila, an ba da izinin bincika waɗanda ke da cutar ta hanyar mai ba da izini.
Tsarin bincike na mai bincike wanda ke da damar samun bayanan mutum na asali yana da manyan batutuwan sirri.
Koyaya, ba duk tsarin adana bayanai na dijital bane ke buƙatar samun damar gano wurin da keɓaɓɓun bayanan mutum; akwai wasu hanyoyin da aka tsara waɗanda ke ba da damar tsare sirrin mutum kuma suna amfani da bayanan kawai lokacin da akwai buƙatar rarrabawa.
A Koriya ta Kudu, an yi amfani da tsarin wayar salula mara amfani don gano waɗanda suka kamu da cutar.
Maimakon amfani da fasahar wayar hannu ta zamani, an tattara bayanai ta hanyoyi daban-daban da suka hada da amfani da wayar salula, abubuwan da aka yi a katin SIM da kuma sanar da mutane masu fama da cutar ta hanyar saƙon rubutu a wayoyin su.
Baya ga amfani da wannan bayanan don sanar da waɗanda ke fama da cutar, gwamnati ta kuma samar da hanyar samun bayanai na yanki, wanda ya biyo bayan sauye-sauyen dokokin sirri bayan barkewar cutar MERS a ƙasar.
Kowa na iya samun damar wannan bayanin ta hanyar fasahar wayar hannu da kuma shafukan yanar gizo daban-daban.Kasashe da dama ciki har da Jamus sun yi amfani da duka biyun a matakin ƙasa da kuma na sirri.
Tun daga 6 ga Afrilu 2020, ba a buga bayanan ba.
Tsarin bincike na sirri na sirri na sirri ya kasance mai kyau, bisa ga bayanan sirri na musamman aƙalla tun daga 2013.A ranar 7 ga Afrilu 2020, fiye da ƙungiyoyi 12 na masana sun yi nazari kan hanyoyin da za a bi don kiyaye sirrin sirri, kamar amfani da tsarin BLE wanda ke ba masu amfani damar yin amfani da wayar hannu.
Koyaya, PEPP-PT yana da ƙarfi a cikin haɗin tsarin ƙasa da na al'umma kuma yana aiki daban. Tsarin al'umma ya haɗa da tsarin bincike na mutum-mutumin da aka tabbatar (DP-PPT), ƙididdigar ƙididdigar ɗan lokaci (TCN), ƙididdigar haɗuwa da biki (CEN), tsarin bincike na mutum-mutumin da aka tabbatar (PACT) da sauransu.
Ta wannan hanyar, bayanan sirri na mutanen da aka gano ba sa fita waje, kuma ana aiwatar da gano abokan hulɗar ta hanyar fasaha.
Ƙungiyar tsare sirri a MIT Media Lab tana ci gaba da gano ingantaccen tsarin ɓoye bayanai, hanyoyin da za su kiyaye bayanan sirri na mutane da kuma amfani da hanyar gano wuri don samun bayanai game da yaduwar COVID-19.
Wannan ya dogara ne akan binciken Apps Gone Rogue: Tsare Sirrin Bayanai  wanda aka fitar a watan Maris na 2020. Wani sabon tsarin da aka sanar shine Binciken Masu Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin Fashin F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F F
Hanyoyin bincike na amintacce suna amfani da na'urorin lantarki don taimakawa masu amfani da su don sadar da bayanan wuri na cutar da ke da alaƙa da kiwon lafiya ga hukumomin da ke kula da lafiya ba tare da keta sirrin mutane ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyi masu daidaituwa da ƙalubalen da ke tattare da ƙa'idodin ƙa'idodi sun kafa TCN International Platform, wanda ke da niyyar haɗuwa da samar da hanyar haɗin kai ta duniya don fasahar wayar hannu da aka yi amfani da ita don gano waɗanda ke da cutar, wanda ke ba da damar amfani da hanyoyin da za a iya amfani da su.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta kafa tsarin gano masu cutar ta hanyar amfani da fasahar gwamnati.
A ranar 10 ga Afrilu, 2020, manyan kamfanonin wayoyin hannu na Android da iOS, Google da Apple, sun ba da sanarwar cewa suna da hanyar bin diddigin masu cutar, hanyar da kamfanonin ke da'awar cewa ta dace da ƙa'idodin tsare sirri na sirri, wanda ya dogara da haɗin fasaha mai amfani da Bluetooth Low Energy da sauran hanyoyin sadarwa waɗanda ke ba da damar ɓoye bayanan sirri.
Sun kuma bayyana yadda wannan fasaha za ta yi aiki a wannan tsarin.
Google da Apple sun bayyana cewa ana amfani da wannan hanyar a matakai uku:
tattara kayan aiki don taimakawa gwamnati wajen samar da fasaha mai mutunta sirri don gano waɗanda ke fama da cutar.
don ƙaddamar da wannan fasalin a cikin iOS da Android Google da Apple suna shirin ƙaddamar da su don magance matsalolin sarrafawa ta hanyar ƙaddamar da wannan fasalin a cikin wasu na'urori na zamani, wanda za'a cire bayan annobar ta ƙare.
Sake amfani da magani, wanda aka fi sani da sake amfani da magani, sake fasalin, sake aiki ko sauya magani, shine hanyar maye gurbin magani da aka yarda da shi don magance wata cuta daban ko kuma cutar da ta bambanta da cutar da aka yi niyya.
Wannan shine layin bincike na yau da kullun don haɓaka ingantaccen magani mai tasiri don COVID-19.
Wani bincike na gaba shine samar da allurar rigakafin COVID-19 da maganin jini. SARS-CoV-2 yana da magunguna 66 da ake gwadawa a wurare daban-daban.
Binciken wurin yana ba da damar samar da maganin da zai iya magance ƙwayoyin cuta na COVID-19.
Wasu daga cikin manyan kwayoyin SARS-CoV-2 da ake bincike a kansu sune kwayoyin da aka samo a cikin 'ya'yan itacen ayaba, waɗanda ke da alaƙa da RNA, helicase, S protein, da ADP ribophosphatase.
Hussein A A, da abokan aikinsa, sun yi nazarin magungunan da suka nuna suna da alaƙa da magungunan da aka saba amfani da su don hanzarta samar da maganin da zai iya magance SARS-CoV-2 a cikin binciken farko don sanya shi cikin jerin magunguna masu nazari.
Chloroquine magani ne na malaria amma yana iya magance wasu cututtukan rigakafi.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine na iya shiga cikin jerin magunguna huɗu da ƙungiyar gwajin magunguna ta Solidarity ke gudanarwa.
Gwamnan New York Andrew Cuomo ya ba da sanarwar cewa Jihar New York za ta fara gwajin chloroquine da hydroxychloroquine a ranar 24 ga Maris.A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate yayin da babu wani magani a cikin Aikace-aikacen Amfani da Gaggawa (EUA) a Turanci.
Ba a taɓa amincewa da gwajin FDA ba, ana amfani da shi ne kawai a matsayin samfurin EUA, wanda ke cikin binciken don amfani da shi don magance marasa lafiya a asibiti waɗanda ba za su iya jurewa ba.
CDC ta ce amfani, sashi, ko tsawon lokacin da mutum zai iya ɗauka na maganin hydroxychloroquine don rigakafi ko magani na SARS-CoV-2 ba a sanar da su ba tukuna.
Likitoci sun yi gargadin cewa ana amfani da maganin ne kawai idan "babu wani zaɓi".
Wata ƙungiyar masu bincike a Turkiyya a Istanbul suna gudanar da gwaji mai sauƙi kan amfani da chloroquine tare da zinc, bitamin A, bitamin C, da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Jami'ar Oxford.
Makarantar Kiwon Lafiya ta NYU Langone tana gudanar da gwaji kan inganci da ingancin maganin hydroxychloroquine a cikin mutane.
Gwaje-gwaje a Wuhan da Shenzhen sun bayyana cewa favipiravir yana da "haƙƙin gaske" don magance cutar.
Marasa lafiya 35 a Shenzhen sun nuna cewa sun warke cikin kwanaki 4, yayin da marasa lafiya 45 da ba a ba su maganin ba sun ɗauki kwanaki 11 don warkewa.
A cikin binciken da aka yi a Wuhan akan marasa lafiya 240 da ke fama da matsalar numfashi, rabin sun karɓi favipiravir da sauran rabin sun karɓi umifenovir.
Hukumar Kula da Magunguna ta Italiya ta gargadi cewa ba za a yi watsi da bayanan da aka bayar ba kuma har yanzu ana gudanar da bincike na farko.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta iya sayen maganin daga China kuma ta yi amfani da sojojin don kai shi asibitin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya na COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya shawarci gwamnatin Trump da ta sayi maganin, wanda zai iya nuna rashin inganci ga mutanen da ke fama da cutar a yankunan da ke da yawan masu kamuwa da cutar.
ba a ba da shawarar yin amfani da wannan magani ga mata masu ciki ko waɗanda ke shirin yin ciki ba.
Binciken lopinavir/ritonavir (Kaletra), cakuda lopinavir da ritonavir, ya kammala cewa "ba shi da amfani".
An tsara maganin don hana kwayar cutar HIV.
Ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin haɓaka maganin don samar da maganin rigakafin SARS-CoV-2.
WHO ta sanya lopinavir/ritonavir a cikin jerin magunguna masu gwaji a duniya.
Gilead Sciences ta samar da Remdesivir don maganin cutar Ebola da Marburg. Gilead Sciences ta kuma gano cewa Remdesivir na iya yin maganin ƙwayoyin cuta da ba a gano su ba, waɗanda suka haɗa da ƙwayoyin cuta masu saurin haifuwa, masu hana numfashi, masu hana rigakafi, da kuma coronaviruses.
Wata matsala ta yau da kullun game da maganin cututtukan ƙwayoyin cuta ita ce yadda suke jurewa magunguna ta hanyar canza yanayin yanayin da ke haifar da cutar da kuma kamuwa da cuta.
Binciken da aka yi kwanan nan ya nuna cewa remdesivir na iya samun ƙarfin rigakafi. Akwai ƙarin bincike da yawa da ke gudana, gami da biyu a Asibitin Jami'ar Cleveland; wasu a cikin marasa lafiya na yau da kullun da kuma wasu a cikin yanayin rashin lafiya.
Akwai gwaje-gwaje uku na maganin cutar da ke gudana don allurar Vitamin C a cikin asibitoci masu fama da cutar COVID-19; gwaji na farko na gwaji (China, Kanada) da gwaji na farko (Italiya).
A ranar 24 ga Maris, jihar New York ta fara gwajin maganin kashe kwari azithromycin.
Hukumar Kula da Lafiya ta Kasa ta Japan (NCGM) tana shirin gwajin maganin Teijin's Alvesco (ciclesonide ), wanda ke magance cutar asma don kula da marasa lafiya masu cutar coronavirus.
Wani gwaji na jini na 2 yana gudana a kan marasa lafiya 200 da aka zaɓa a asibitoci a Denmark, Jamus, da Austria don tabbatar da ingancin maganin.
Masu bincike a Cibiyar Zuciya ta Montreal a Kanada suna nazarin maganin colchicine don rage zazzabi da matsalolin numfashi a cikin marasa lafiya da ke nuna alamun COVID-19 mai tsanani.
Binciken, wanda ake kira COLCORONA, yana neman mutane 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 kuma suna nuna alamun bayyanar cututtuka amma ba sa buƙatar asibiti.
Mata masu ciki ko masu shayarwa ko waɗanda ba sa amfani da ingantaccen maganin hana haihuwa ba su cikin binciken.
Ana gwada magunguna da yawa da ke hana jini yin jijiya a Italiya.
Ana amfani da maganin hana jini mai ƙarancin ƙwayar heparin a cikin maganin marasa lafiya, wanda ke matsa lamba ga cibiyoyin kiwon lafiya na Italiya don ba da umarnin amfani da maganin.
A ranar 14 ga Afrilu, an ba da rahoton wani bincike na asibiti a Italiya wanda ya shafi marasa lafiya 300 game da amfani da maganin rigakafi da magungunan rigakafi na enoxaparin sodium.
Tun bayan gano SARS-CoV-2 a matsayin kwayar cuta, yawancin bincike sun ci gaba da mai da hankali kan maganin da aka amince da shi don magance cututtukan ƙwayoyin cuta waɗanda aka riga aka yi kafin barkewar cutar kamar MERS, SARS, da West Nile.
Ribavirin: Ribavirin a cikin kundin ka'idoji na 7 na kasar Sin, an ba da shawarar yiwuwar amfani da shi don maganin COVID-19.
Umifenovir: an ba da izinin amfani da umifenovir a cikin umarnin 7 na China don maganin COVID-19.
An ba da shawarar cewa ana iya amfani da wasu magungunan rigakafi don maganin COVID-19:
Tocilizumab (Anti-IL-6 receptor): China ta amince da shi.
Har ma da gwajin Italiyanci. Duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19 wata shawara ce ta neman allurar rigakafin cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu riga-kafi, ana gudanar da bincike mai zurfi kan maganin.
A ƙarshen Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ba da sanarwar cewa babu allurar rigakafi da ake tsammani don SARS-CoV-2, wanda ke haifar da cutar, har zuwa watanni 18.
An yi gwajin kashi na 1 na alluran rigakafi guda biyar a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Cutar ta fara yaduwa a duniya a cikin 2020 wanda ya haifar da ƙarin kuɗi da kuma fara binciken rigakafi.
Yawancin kamfanoni suna amfani da magungunan da ke akwai don samar da allurar rigakafi da za ta iya magance SARS-CoV-2.
Tun daga watan Afrilu, manyan abubuwan da CEPI ke mayar da hankali a kan su shine saurin samar da allurar rigakafi, samar da su, samar da ma'aikata, da kuma isar da su a duk duniya.
A watan Afrilu, masana CEPI sun ba da sanarwar cewa akwai fasahohi daban-daban guda 10 da ake gudanar da bincike a kai da kuma ci gaba a farkon 2020 don samar da allurar rigakafi mai ƙarfi da ke da tasiri ga COVID-19.
A cikin hanyoyin da ake ci gaba da su a cikin binciken na farko sun haɗa da:
Kwayoyin jini (DNA da RNA) a cikin gwajin gwaji na Phase I: Moderna, mRNA-1273)
Kwayoyin cutar (Shirye-shiryen gwaji na farko: CanSino Biologics, adenovirus type 5 vector)
A cewar masana CEPI a watan Afrilu, kimanin gwaje-gwaje 115 na allurar rigakafi suna kan farawa, gami da 78 da aka tabbatar da cewa an fara shirye-shiryen (79, a cewar Cibiyar Milken), kuma aƙalla 37 da aka sanar, amma ba a san ainihin su ba (ana tsammanin akwai shirin ko a cikin aiki).
Gwajin Mataki na I-II yana kimanta inganci da inganci, yana da cikakkiyar tsari, kulawa sosai, da yawa, yayin da aka hana kuskure, kuma ana iya amfani da ma'auni.
Gwajin Mataki na III yana buƙatar ƙarin mutane, gami da ƙungiyar kulawa, don tantance ingancin rigakafin rigakafin cutar, yayin da ya haɗa da bincika ko an rage sauran tasirin rigakafin zuwa matakin jurewa.
Daga cikin alluran rigakafi 79 da ke cikin gwaji (wanda aka amince da su a farkon Afrilu 2020), 74 ba su fara gwajin ɗan adam ba (har yanzu suna cikin binciken farko).
A ranar 24 ga Janairun 2020, Jami'ar Queensland ta Australia ta sanar da cewa tana nazarin allurar rigakafin da za ta iya canza tsarin kwayar cutar don taimakawa tsarin garkuwar jiki.
A ranar 24 ga Janairun 2020 a Kanada, Cibiyar allurar rigakafin duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa an fara aikin samar da allurar rigakafin, wanda zai fara gwajin ɗan adam a 2021.
An sanar da shirye-shiryen samar da allurar rigakafin a Cibiyar Kula da Cututtuka ta kasar Sin a ranar 26 ga Janairu, 2020 kuma a Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, Kamfanonin Magunguna da Hanneke Schuitemaker ke jagoranta, sun sanar da cewa sun fara aikin samar da allurar rigakafi.
Janssen, tare da abokin aikinta Vaxart, suna aiki kan samar da allurar rigakafin da za a iya amfani da ita ta baki.
A ranar 18 ga Fabrairu, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, OncoGen a Romania ya buga wani bincike kan tsarin allurar rigakafi tare da fasahar da ta yi kama da maganin cutar kansa.
A ranar 25 ga Maris, shugaban cibiyar ya sanar da cewa ya kammala babban aikin allurar rigakafin kuma yana gab da fara gwajin.
A ranar 27 ga Fabrairu, 2020, NuGenerex Immuno-Oncology, wani kamfani na Generex, ya ba da sanarwar cewa yana shirin fara aikin samar da allurar rigakafi don gano allurar rigakafi mai ƙwayoyin cuta da ke da damar yin maganin COVID-19.
Manufar su ita ce samar da allurar rigakafin da za a iya gwadawa a kan mutane cikin kwanaki 90.
A ranar 25 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirye-shiryenta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Nazarin Lafiya da Kayan Aiki ta Sojojin Amurka a Fort Detrick da Makarantar Nazarin Kayan Aiki ta Walter Reed, duka biyu a yammacin Maryland, sun ba da sanarwar cewa suna aiki kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta fara hulɗa tare da Novavax Inc.
a cikin aikin samar da allurar rigakafi.
Abokan hulɗar sun kuma sanar da cewa suna shirin fara gwajin rigakafin da fara gwajin gwaji na farko a watan Yuli na 2020.
A ranar 5 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa tana aiki a kan magunguna 11 kuma da farko zai ɗauki aƙalla shekara ɗaya zuwa shekara ɗaya da rabi zuwa shekaru biyu don samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Medicago, wani kamfanin kiwon lafiya a Quebec City, Quebec, ya ba da sanarwar ci gaban maganin rigakafin coronavirus tare da tallafin Cibiyar Nazarin Kiwon Lafiya ta Kanada.
Har yanzu ana gudanar da bincike a kan allurar rigakafin a cikin dakin gwaje-gwaje, tare da shirin gwajin mutum a watan Yuli ko Agusta 2020.
A farkon makon, The Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba da gudummawar kuɗi mai yawa don samar da allurar rigakafin COVID-19, wani abu da gwamnatin Jamus ta ƙi yarda da shi.
A ranar 5 ga Maris, 2020, Kamfanin Pharmaceutical Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
Aikin gwajin rigakafin mRNA mai suna BNT162 yana kan gwaji kuma an shirya fara gwajin a watan Afrilu 2020.
A ranar 17 ga Maris, 2020, a Italiya, kamfanin kiwon lafiya na Takis Biotech ya ba da sanarwar cewa zai sami sakamakon gwajin a watan Afrilu na 2020 kuma nan da nan za a fara gwajin gwajin mutum.
A ranar 19 ga Maris, 2020, a Faransa, Cibiyar Kula da Cututtuka ta Kasa (CEPI) ta sanar da kashe dala miliyan 4.9 don binciken rigakafin COVID-19 da ke gudana tsakanin Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kawo jimlar kuɗin da CEPI ta kashe don binciken rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI waɗanda suka ba da gudummawar kuɗi don samar da allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A watan Maris na 2020, hukumomin kiwon lafiya na Rasha sun sanar da cewa masana sun fara gwajin gwajin dabbobi don allurar rigakafin.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna aiki kan samar da allurar rigakafin COVID-19 ta hanyar kwayar halitta.
An samar da allurar a cikin kwanaki 14 bayan da aka samu takardar sayan kayayyaki daga China.
A ƙarshen Maris, gwamnatin Kanada ta ba da sanarwar dala miliyan 275 na C$ don tallafawa ayyukan 96 don magance COVID-19, gami da ayyukan rigakafi a cibiyoyi da jami'o'in Kanada, kamar waɗanda Medicago da Jami'ar Saskatchewan ke ci gaba.
A kusan wannan lokacin, gwamnatin Kanada ta sanar da cewa an ba da dala miliyan 192 na C$192 don samar da allurar rigakafin COVID-19 kawai, tare da manufar ƙirƙirar taro na allurar rigakafi wanda ke adana alluran rigakafi da yawa don amfani da su idan akwai wani sabon barkewar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da sanarwar cewa suna gwajin gwajin PittCoVacc a cikin beraye, wanda zai iya haifar da allurar COVID-19, suna ba da rahoton cewa wasu kwayoyin SARS-CoV-2 S1 da aka samo daga ƙwayoyin MNA sun nuna ikon samar da rigakafi [a cikin beraye], wanda ya fara bayyana daga farkon makonni 2 bayan amfani. "
A ranar 16 ga Afrilu, 2020, Makarantar Pharma a Jami'ar Waterloo ta sanar da cewa suna haɓaka allurar rigakafin DNA mai amfani da hanci.
Ta hanyar amfani da maganin kashe ƙwayoyin cuta, za a iya sarrafa DNA a cikin kwayar don samar da kwayoyin da ba su da cutar, wanda zai haifar da haɓakar rigakafi da ke haifar da samar da ƙwayoyin cuta da ke hana SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun tattara bayanai don siyan kwamfutocin IBM, da kuma sauran kamfanonin fasaha na Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako masu illa iri-iri, wanda ake kira sakamako mara kyau.
Wannan yana nufin cewa suna iya samun sakamako mai kyau a cikin rigakafin cututtuka.
Wani gwaji a Ostiraliya yana neman likitoci 4,170 don yin aiki.
Zai yiwu cewa alluran rigakafin da ake samarwa ba su da inganci ko tasiri.
Binciken kwanan nan don kimanta ingancin allurar rigakafi tare da wasu nau'ikan COVID-19, kamar ACE2 beraye da birai, ya nuna cewa ana buƙatar matakan kiyaye matakin 3, don magance cutar da ke akwai, da haɗin gwiwar duniya don kiyaye ƙa'idodin aminci.
An gwada alluran rigakafin SARS da MERS a kan dabbobi.
Har zuwa yanzu a cikin 2020, babu magani ko allurar rigakafi don SARS da MERS da aka tabbatar da inganci da inganci a cikin ɗan adam.
Kamar yadda aka nuna a cikin binciken da aka yi a cikin 2005 da 2006, ganowa da samar da alluran rigakafi da magunguna don SARS sun kasance gaggawa a cikin tsarin gwamnati da cibiyoyin kiwon lafiya a duk duniya. Babu riga-kafin MERS da aka tabbatar.
A lokacin barkewar cutar MERS, akwai tsammanin cewa binciken da ake yi zai iya samar da ingantaccen tsarin samar da alluran rigakafi da magunguna don hana kamuwa da MERS-CoV.
A watan Maris na 2020, an kammala gwajin mutum na farko na allurar rigakafin MERS (wanda ya dogara da DNA) kuma an ci gaba da gwaji uku, dukansu suna da kwayar cuta, biyu daga kwayar cutar Adenoviridae (ChAdOx1-MERS, BVRS-GamVac), da ɗayan daga kwayar cutar MVA (MVA-MERS-S).
Kafofin watsa labarun sun yada jita-jita cewa an riga an san COVID-19 kuma an riga an sami allurar rigakafi.
Abubuwan da ke faruwa a shafukan sada zumunta sun danganta da kasancewar kwayoyin halitta da alluran rigakafi ga sauran cututtukan coronavirus kamar SARS.
Cutar kwayar cutar coronavirus ta 2019 (COVID-19) cuta ce mai saurin yaduwa ta hanyar kwayar cuta ta numfashi mai kama da 2 (SARS-CoV-2).
Alamun cututtuka da aka fi sani da zazzabi, tari, da kuma numfashi.
Sauran alamun cutar sun hada da gajiya, ciwon jijiyoyi, zawo, ciwon makogwaro, rashin jin ƙanshi da ƙanshi, da ciwon ciki.
Alamun cutar na iya kasancewa tsakanin kwanaki biyu zuwa 14 bayan kamuwa da cutar.
Yayinda yawancin masu kamuwa da cutar ke nuna alamun rashin lafiya, wasu suna fama da matsalar numfashi da rauni na gabobin jiki.
Ya zuwa ranar 17 ga Afrilu, 2020, sama da mutane miliyan 2.24 sun kamu da cutar a cikin ƙasashe 210 da yankuna, wanda ya haifar da asarar rayuka 153,000.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar ta hanyar kusanci, galibi ta hanyar fitowar jini ta hanyar tari, hancin mutum ko magana.
Idan aka fitar da wannan ruwa a cikin numfashi, yawanci yakan fada ƙasa ko kuma ya faɗi a kan wani abu maimakon ya kamu da cutar daga nesa.
Mutane na iya kamuwa da cutar ta hanyar taɓa fuska, hanci ko baki.
Kwayar cutar na iya rayuwa a waje na tsawon awanni 72.
Yana da haɗari sosai a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yana iya zama mai haɗari kafin bayyanar cututtuka da lokacin kamuwa da cuta.Hanyar da ta fi dacewa don ganowa ita ce real-time reverse transcription polymerase chain reaction (rRT-PCR)  ta amfani da samfurin hanci.
Yana da mahimmanci cewa duk wanda ake zargi da kamuwa da cutar ya sanya abin rufe fuska.
Dokokin da ke nuna cewa kowa ya kamata ya saka abin rufe fuska sun bambanta, wasu hukumomi suna ba da shawarar kada a saka shi, wasu kuma suna ba da shawarar a saka shi.
A halin yanzu, babu wani rigakafi ko magani na musamman don COVID-19.
An gano kamuwa da cuta tsakanin mutane a cikin yankuna shida na WHO.
Masu kamuwa da cutar za su iya zama marasa alamun cutar ko kuma su nuna alamun cutar mura kamar zazzabi, tari, gajiya, da rashin numfashi.
Babban alamun cututtuka sun haɗa da wahalar numfashi, ciwo mai ɗorewa ko ciwon kirji, rashin ƙarfi a fuska, rashin iya tafiya, ja a fuska ko lebe; wanda shine gaggawa don neman likita idan waɗannan alamun sun bayyana.
Ba safai ba ne za ka sami alamun da ke tattare da matsalolin numfashi kamar tari, tari ko ciwon makogwaro.
Alamomin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Marasa lafiya a China sun fara nuna alamun ciwon kirji da bugun zuciya.
A wasu, cutar tana iya zama mai tsanani har ta kai ga shan iska, shanyewar gabobin jiki, ko mutuwa.
Wannan shine ake kira lokacin bayyanar cutar.
Lokacin bayyanar cututtuka na COVID-19 yawanci kwanaki shida ne amma zai iya zama daga 2 zuwa 14.
97.5% na mutane suna nuna alamun cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duk wanda ya kamu da cutar ba zai nuna alamun cutar ba.
Har yanzu ba a san tasirin cutar ga marasa alamun cutar ba; duk da haka, mahimman bayanai shine cewa suna iya cutar da wasu.
Ba a san adadin mutanen da ba su da alamun cutar ba tukuna amma ana nazarin su, bisa ga bayanan Cibiyar Kula da Cututtuka ta Koriya ta Kudu (KCDC) cewa kashi 20% na duk masu kamuwa da cutar ana sallamar su daga asibiti ba tare da alamun cutar ba.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara sanya mutanen a cikin adadin masu kamuwa da cutar a ranar 1 ga Afrilu; daga cikin mutane 166 da aka sanar a ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Rashin sauro na iya ɗaukar ƙwayoyin cuta da yawa.
Yin magana da ƙarfi yana sa jini ya yi ta fitowa fiye da yin magana a hankali.
Binciken Singapore ya nuna cewa yin tari ba tare da rufe baki ba zai iya haifar da zubar da jini mai zurfi na mita 4.5 (ƙafa 15).
Kodayake cutar ba ta yaduwa ta hanyar iska, Cibiyar Nazarin Kimiyya ta Kasa ta ce yana yiwuwa kuma an gwada iska daga ɗakunan keɓewa don cutar.
Hanyoyin likita kamar su CPR da CPR na iya haifar da ƙarancin iska wanda zai iya haifar da kamuwa da cutar.
Ko da yake akwai wasu shakku game da yiwuwar kamuwa da cutar daga uwa zuwa jariri, babu tabbaci sosai. Kwayar cutar tana iya kamuwa da cutar idan mutane suna nuna alamun cutar; yayin da akwai ƙananan yiwuwar kamuwa da cutar kafin bayyanar alamun cutar.
Hukumar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar ke yaduwa ba, mutum ɗaya zai iya kamuwa da mutane biyu zuwa uku.
Musamman, kwayar cutar ta kasance kwana ɗaya a kan allon, kusan kwana uku a kan filastik (polypropylene) da ƙarfe mai ƙarfi ((AISI 304), da awanni huɗu a kan ƙarfe mai laushi mai laushi a kashi 99%.
Wannan, kodayake, na iya canzawa dangane da yanayin sanyi da zafi.
Sabulu shine maganin kashe ƙwayoyin cuta wanda idan aka yi amfani dashi yadda yakamata, zai iya kashe kwayar cutar; sabulu yana lalata ƙwayar cuta ta kwayar cuta, yana hana shi aiki kuma yana kawar da shi daga jiki ko kuma daga wuraren da kwayar cutar take.
Sauran amfani da su sun hada da benzalkonium chloride da chlorhexidine gluconate (wani maganin kashe kwayoyin cuta), amma ba su da tasiri sosai.A cikin binciken Hong Kong, an tattara samfurin yau da kullun a cikin kwanaki biyu bayan asibiti.
A cikin biyar daga cikin marasa lafiya shida, gwajin farko ya nuna babban adadin kwayar cutar, sannan na shida ya nuna babban adadin kwayar cutar a gwajin rana ta biyu.
Cutar coronavirus mai saurin kamuwa da cuta 2 SARS-CoV-2 wata sabuwar kwayar cuta ce da ke haifar da cutar huhu, wanda aka fara ganowa a Wuhan a cikin mutane uku da ke fama da matsalar numfashi da ke tattare da cututtukan numfashi.
Dukkanin siffofin SARS-CoV-2 suna cikin kwayar cutar coronavirus.
A waje da jikin mutum, sabulu na gida yana kashe kwayar cutar ta hanyar kashe kwayar cutar. SARS-CoV-2 yana da alaƙa da SARS-CoV na farko.
COVID-19 yana da tasiri sosai a cikin huhu, saboda kwayar cutar tana shiga ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2) , wanda aka bayyana a cikin yawan huhu.
Kwayar cutar tana amfani da wani ɓangaren jikinta na baya wanda ake kira spike (mai kama da ƙaho) don haɗa shi da ACE2 kuma ya shiga cikin kwayar halitta.
12% na masu kamuwa da cutar da aka kwantar a asibiti a Wuhan, China, an gano su da ciwon zuciya mai tsanani kuma wannan yana faruwa ne a cikin yanayin rashin lafiya mai tsanani.
Yawan alamun cututtukan zuciya yana da yawa saboda kumburi da lalacewar tsarin garkuwar jiki wanda ke faruwa yayin da cutar ke ci gaba, amma matsalolin lalacewar jijiyoyin zuciya na iya kasancewa tare da cutar zuciya ta masu karɓar ACE2.
Kwayar cutar ACE2 tana motsawa cikin zuciya kuma tana tasiri ga aikin zuciya.
Marasa lafiya a cikin ICU da ke fama da COVID-19 sun nuna matsalolin hana yaduwar jini (31%) da lalacewar hanyoyin jini (25%), wanda ke da alaƙa da ƙarancin damar murmurewa. Gwaje-gwajen da aka yi wa mutanen da suka mutu daga COVID-19 sun nuna lalacewar tsarin numfashi (DAD), da kuma ciwon huhu.
Ko da yake SARS-COV-2 na iya kasancewa tare da ACE2 a cikin jiki da kuma cikin ƙwayoyin cuta na numfashi, marasa lafiya na COVID-19 na iya nuna alamun kumburi mai tsanani.
Musamman, ƙwayoyin T da aka samar ta GM-CSF sun kasance masu aiki tare da ƙwayoyin IL-6 masu haifar da kumburi a cikin marasa lafiya na COVID-19.
Gwajin ya nuna cewa akwai ƙwayoyin cuta a jikin wanda cutar ta kashe.
Hukumar Lafiya ta Duniya WHO ta ba da shawarar wasu hanyoyin gwaji.
Mafi inganci da aka sani don tantance cutar shine real-time reverse transcription polymerase chain reaction (rRT-PCR).
Ana yin gwajin gwajin ta hanyar numfashi ta hanyar ruwan hanci; duk da haka, ana iya amfani da allurar rigakafi da taushi.
Sakamakon yana samuwa a cikin sa'o'i kadan zuwa kwanaki biyu.
Ana iya yin gwajin jini, amma yana buƙatar gwajin jini biyu da aka ɗauka a cikin makonni biyu kuma sakamakon ba shi da ƙimar nan take.
Masana a China sun ware kwayoyin cutar coronavirus kuma sun ba da sakamakon gwaje-gwajen ga duniya don samar da kwayoyin PCR da za a iya amfani da su don gano cutar.
Har zuwa 4 ga Afrilu 2020, an yi wasu gwaje-gwaje na rigakafin cutar (wanda zai iya nuna cutar da ke cikin jiki ko kuma haɗuwa da cutar a baya) amma ba a shirya amfani da su a wurare da yawa ba.
Kwarewar gwajin Sinawa ya nuna inganci na 60% zuwa 70%.
Hukumar Kula da Abinci da Magunguna ta Amurka (FDA) ta amince da cibiyar gwajin a ranar 21 ga Maris, 2020 kuma ana sa ran za a fara amfani da ita a ƙarshen watan. Jagoran gwajin da Asibitin Zhongnan na Jami'ar Wuhan ya bayar ya ba da shawarar hanyar gwaji bisa ga umarnin likita da kuma sakamakon cutar.
A farkon kamuwa da cuta yawanci yana faruwa ne ta hanyar ɓoyewar ƙwayoyin cuta, tarawa, warewa daga jikin da suka shiga sannan kuma ya bazu ko'ina.
Yayin da cutar ta ci gaba, tana yaduwa ta hanyar numfashi, tana yin hanya (ƙulla hanyar numfashi ta hanyar toshe hanyoyin numfashi) da kuma haɗuwa.
Akwai karancin bayanai game da hoton microscopy da yanayin COVID-19.
Turanci nazarin kwayoyin cuta akan gawa shine:
Abubuwan da ke faruwa: ciwon huhu, kumburi a kusa da zuciya, toshewar hanyoyin numfashi
an gano nau'ikan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Rashin numfashi mai sauƙi: ƙwayoyin ruwa a cikin huhu, ƙwayoyin cuta na numfashi, ƙwayoyin cuta na numfashi, fashewar ƙwayoyin cuta da kuma ƙwayoyin cuta.
matsanancin ciwon huhu: lalacewar hanyar numfashi (DAD) da kuma yaduwar jijiyoyi.
DAD shine mafi yawan masu kamuwa da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Cutar numfashi ta fara sauƙi: tarin yawa a cikin iska da huhu
Jinin jini: zubar da jini na ciki (DIC); samar da sabbin kwayoyin halitta a cikin jini
Matakan rage yaduwar kamuwa da cuta sun hada da kasancewa a gida, guje wa wuraren taruwa, wanke hannuwanka akai-akai da sabulu da ruwa na akalla dakika 20, tsabtace hanyoyin numfashi, da kuma guje wa taɓa idanu, hanci ko baki ba tare da wanke hannu ba.
CDC ta ba da shawarar rufe baki da tawul mai tsabta yayin tari ko hancin ko sanya wuyan hannu a gaban wuyan hannu lokacin da babu tawul.
Yana da muhimmanci a wanke hannu bayan kowane tari ko hancin.
CDC ta ba da shawarar sanya abin rufe fuska lokacin da suka fita daga gida don hana yaduwar kamuwa da cuta ta hanyar mutanen da ba su da alamun cutar. Matsayin nisantawa yana nufin rage kusanci tsakanin masu lafiya da masu cutar ta hanyar rufe makarantu, wuraren aiki, hana zirga-zirga da hana taron jama'a.
Dokokin sun ce mutane su kasance a tsakanin mita 6 da mita 1.8 daga juna.
Babu wani magani da aka sani don COVID-19. Tunda ana tsammanin za a sami rigakafi a kusan ƙarshen 2021, mafi kyawun hanyar magance cutar ita ce ta hanyar aiwatar da matakan da ke rage yawan sabbin kamuwa da cutar COVID-19 wanda aka sani da "lanƙwasa lanƙwasa".
CDC ta ba da shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa kuma su yi hakan aƙalla na dakika 20, musamman bayan sun fita daga bayan gida ko idan hannayensu sun kasance masu ƙazanta, kafin cin abinci, bayan tari, tari ko hancin.
CDC ta kuma ba da shawarar amfani da maganin kashe ƙwayoyin cuta da ke da kashi 60% na sinadarin chloride, wanda ake amfani da shi lokacin da babu sabulu da ruwa.A wuraren da akwai matsalar samun maganin, WHO ta ba da shawarar amfani da wasu nau'ikan maganin biyu.
A cikin wannan rukunin akwai wasu magungunan kashe ƙwayoyin cuta da ake kira ethanol ko isopropanol.
Hydrogen peroxide yana kawar da ƙwayoyin cuta; ba "maganin cututtukan hannu" ba ne.
An kuma kara glycerol a cikin maganin.
Ana amfani da hanyoyi daban-daban na jiyya, gami da amfani da ruwa, ƙarin iska, da kuma ƙarfafa wasu gabobin da ke fama da kamuwa da cuta.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta ba da shawarar cewa mutanen da ake zargi da kamuwa da cutar su sanya abin rufe fuska.
An ci gaba da amfani da ECMO don magance matsalar rashin numfashi kuma har yanzu ana amfani da shi.
Ana karfafa mutane su kasance masu tsafta, kula da lafiyarsu da kuma cin abinci mai gina jiki don inganta rigakafi.
Za a iya amfani da wasu hanyoyin kula da lafiya ga mutanen da ke da cutar da ke nuna alamun cutar. WHO da Hukumar Kiwon Lafiya ta Kasa ta China sun ba da shawarar yadda za a kula da marasa lafiya da ke cikin asibiti da COVID-19.
Likitocin gaggawa da masu kula da cututtukan numfashi a Amurka sun tattara bayanan kula da cutar daga cibiyoyin bincike na IBCC kuma sun buga su.
A watan Afrilu 2020, babu wani magani da aka sani don COVID-19.
Don magance alamun, masana kiwon lafiya sun ba da shawarar yin amfani da paracetamol (acetaminophen) a maimakon ibuprofen a farkon lokacin cutar.
Ya kamata a ɗauki matakan rage yaduwar kamuwa da cuta, musamman a wuraren da ake gudanar da ayyukan da ke haifar da numfashi, kamar sanya sirinji a cikin iska ko kuma ba da iska ta hannu.
CDC ta ba da shawarar cewa likitocin da ke kula da marasa lafiya da COVID-19 su sanya su a cikin keɓaɓɓun ɗakunan keɓewa na kamuwa da cutar (AIIR) tare da bin ƙa'idodin ƙa'idodin ƙaura, nisantar kusanci da sanya abin rufe fuska. CDC ta ba da jerin ƙa'idodin ƙa'idodin ƙa'idodin amfani da kayan kariya na mutum (PPE) don hana yaduwar cutar.
Waɗannan kayan haɗi sune: rigar PPE, abin rufe fuska ko abin rufe fuska , kayan kwalliya, har ma da abin rufe fuska. Zai fi kyau a yi amfani da kayan aiki na numfashi, idan akwai, maimakon abin rufe fuska.
An yarda da amfani da N95 a masana'antu, amma FDA ta amince da amfani da abin rufe fuska don amfanin kai tsaye (EUA).
An tsara su don kare masu amfani da su daga ƙazantar iska kamar ƙura amma ba a tabbatar da ingancinsu don hana kamuwa da ƙwayoyin cuta ba.
Idan babu abin rufe fuska, CDC ta ba da shawarar amfani da abin rufe fuska ko, a mafi ƙarancin lokuta, abin rufe fuska na hannu.
Yawancin marasa lafiya da ke fama da COVID-19 ba za su sami matsala sosai ba har sai an ba su ƙarin iska ko wasu hanyoyin numfashi amma wasu na iya buƙatar hakan.
Ana gudanar da bincike a asibiti kan nau'ikan kayan aikin numfashi na COVID-19 wanda zai iya zama mai sauƙin amfani da allurar riga-kafi ko wasu abubuwan da ke taimakawa numfashi.
Ba a san ko waɗannan hanyoyin biyu suna ba da sakamako iri ɗaya ba a cikin yanayin rashin lafiya.
Wasu likitoci sun fi son ci gaba da amfani da na'urar numfashi idan akwai saboda wannan hanyar tana rage yawan iskar gas fiye da hanyar da ake amfani da ita ta hanyar inhalation. Wannan kamuwa da cuta yakan faru ne a cikin tsofaffi (sama da shekaru 60 da musamman sama da shekaru 80).
Yawancin ƙasashe masu tasowa suna da matsalar rashin gadaje, wanda ke haifar da ƙalubalen magance ƙaruwar yawan masu cutar COVID-19 masu tsanani da ke buƙatar asibiti.
Wani bincike a China ya nuna cewa kashi 5% an kai su sashin kulawa mai tsanani, kashi 2.3% na bukatar karin iska, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na masu kamuwa da COVID-19 da ke asibiti suna samun kulawar ICU.
Ana ci gaba da amfani da na'urar samar da iska ta hanyar amfani da na'urar don magance matsalar rashin iskar oxygen ta COVID-19.
Ana buƙatar ƙarin kayan aikin PEEP don taimakawa sake dawo da iska don rage haɗarin rauni da kuma toshewa.
Ba a samun wasu hanyoyin da ake amfani da su a cikin kayan aikin PEEP na gargajiya.
An fara binciken maganin cutar a watan Janairun 2020, kuma an fara gwajin magunguna da yawa.
Remdesivir shine magani mafi kyau.
Ko da yake ana iya jira har zuwa 2021 don samun sabon magani, yawancin magungunan gwaji ana amfani da su don magance wasu cututtuka ko kuma ana yin bincike a kansu.
Ana iya gwada maganin rigakafi a cikin mutane masu fama da cutar.
WHO ta gayyaci masu sa kai don shiga cikin binciken don tabbatar da inganci da ingancin magungunan gwaji. FDA ta ba da izinin amfani da magani na ɗan lokaci don ƙarfafa ƙarfin mutum idan ya bayyana cewa yana da haɗari ga rayuwa.
FDA ba ta gudanar da bincike kan ingancin maganin cutar ko ingancin maganin cutar ba.
A watan Fabrairun 2020, kasar Sin ta ƙaddamar da fasahar wayar hannu don magance yaduwar annobar.
Ana buƙatar masu amfani da wannan hanyar su shigar da sunayensu da lambar ID.
Wannan fasaha tana da ikon gano ko akwai kamuwa da cutar a wurin da kake aiki, ta hanyar bayanan kulawa, don haka idan kana kusa da shi zaka iya kamuwa da cutar.
Kowane mai amfani da wannan fasaha zai iya ganin matsayin wasu masu amfani uku.
Singapore Idan akwai cutar a wurin, ban da bayar da shawarar keɓewa, wannan fasaha tana sanar da hukumomin kiwon lafiya na gida.Koriya ta Kudu da Taiwan suna amfani da bayanan wayar hannu, na'urorin gano fuska, na'urorin bincike na wayar hannu da na'urorin sarrafawa na mutum don gano mutanen da ke cikin cutar.
A watan Maris na 2020, gwamnatin Isra'ila ta ba kamfanonin fasaha damar bincika wayoyin hannu na mutanen da ake zargi da kamuwa da cutar.
An yanke wannan shawarar ne don aiwatar da keɓewa da kare waɗanda ke iya haɗuwa da waɗanda ke da cutar.
A watan Maris na 2020, Deutsche Telekom ta ba da damar sarrafa bayanan wayar hannu tare da taimakon Cibiyar Robert Koch ta Jamus don bincike da kuma hana yaduwar cutar.
Rasha ta ƙaddamar da fasahar gano fuska don gano masu keta dokar keɓewa.
Kwamishinan kiwon lafiya na yankin Italiya, Giulo Gallera, ya shaida wa masu amfani da wayar tarho cewa "kimanin kashi 40 cikin dari na mutane suna tafiya a kan hanya".
Gwamnatin Jamus ta gudanar da taron sa'o'i 48 tare da masana kimiyyar kwamfuta sama da 42,000.
Shugabar Estonia, Kersti Kaljulaid, ta yi kira ga al'ummar duniya da su nemi hanyoyin magance yaduwar cutar coronavirus.
Mutane na iya fuskantar matsalolin damuwa saboda keɓewa, takunkumin tafiya, tasirin magani, ko tsoron cutar kanta.
BBC ta ruwaito Rory O'Connor, wanda ya ce "keɓewa, kadaici, damuwa da lafiya, damuwa da talauci suna da tasiri mai tasiri kan lafiyar kwakwalwa da jin daɗin mutane".
Cutar za ta iya nuna alamun rashin alamun cutar ko kuma ba ta nuna alamun cutar ba, wanda ya yi kama da cututtukan numfashi ko mura.
Mutane da ke da ƙananan cututtuka za su iya murmurewa cikin makonni biyu, yayin da waɗanda ke da ciwo mai tsanani za su iya jimrewa cikin makonni uku zuwa shida.
Mata masu ciki suna da haɗarin kamuwa da COVID-19 kamar yadda aka ruwaito game da wasu ƙwayoyin cuta, kamar SARS da MERS, amma ba a san ainihin cutar COVID-19 a cikin mata masu ciki ba. COVID-19 na iya haifar da ciwon numfashi a wasu mutane.
Wasu mutane da ke fama da cutar COVID-19 na iya fuskantar mummunan matsalar numfashi (ARDS) wanda zai iya haifar da rashin numfashi, rikicewar tunani da rauni na gabobin jiki.
Matsalolin COVID-19 sun haɗa da ciwo a jiki, tarin jini da lalacewar zuciya, koda da jijiyoyin jini.
An lura da zub da jini, musamman a cikin duhu, a cikin kusan 6% na marasa lafiya na COVID-19 da aka kwantar a asibiti, yayin da cutar koda ta bayyana a cikin kusan 4%.
Daga kashi 20-30% na mutanen da ke fama da COVID-19 sun nuna haɓakar transaminases.
Rahoton ya kuma nuna cewa, tsawon lokacin da ke tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki 10, tare da biyar da ake kwantar da su a asibiti.
Koyaya, marasa lafiya da aka kwantar a ICU sun kasance a asibiti har tsawon kwanaki bakwai kafin su mutu.
A cikin binciken da aka yi a cikin sabbin kamuwa da cutar, lokacin tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki 14, a matsakaita tsakanin kwanaki 6 zuwa 41.
A wani binciken da Hukumar Kiwon Lafiya ta Kasa (NHC) ta kasar Sin ta gudanar, mace-mace sun fi yawan mace-mace a duniya da kashi 2.8 cikin dari.
Gwaje-gwaje da aka yi akan mutanen da suka mutu saboda cututtukan huhu sun nuna lalacewar ƙwayoyin cuta na huhu ta hanyar ƙwayoyin cuta.
Matsalar numfashi ta nuna cewa kwayar cutar tana canzawa.
Hoton huhu ya bayyana yana da mummunan matsalar numfashi (ARDS).
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Kiwon Lafiya ta Kasa ta kasar Sin ta bayar, an samu ciwon jijiyoyi ko kuma ciwon zuciya.
Rahotanni a watan Maris a Amurka sun nuna cewa kashi 89% na waɗanda aka kwantar da su a asibiti suna da wasu matsaloli. Matsalolin kiwon lafiya da zamantakewar al'umma da tattalin arziki na iya zama sanadiyar mutuwar mutane.
Adadin mutuwar ya bambanta daga yanki zuwa yanki, amma kuma saboda matsalolin da ke tattare da hanyoyin da ake amfani da su.
Rashin kula da ƙididdigar waɗanda ke da alamun rashin lafiya na iya haɓaka yawan mutuwar.
Amma, yawan mutuwar da aka samu daga wasu cututtuka na iya sa a kasa tantance shekarun da mutum zai mutu.
Masu shan sigari sun fi sau 1.4 nuna alamun COVID-19 mai tsanani kuma sau 2.4 na rashin lafiya ko mutuwa fiye da waɗanda ba sa shan sigari. An yi tambaya game da tasirin cutar na dogon lokaci ga mutanen da ke da wasu cututtuka.
Hukumomin asibiti na Hong Kong sun gano cewa kashi 20 zuwa 30 cikin dari na huhu sun kasance masu ruwa a jiki, kuma hotunan na'urar likita sun nuna cutar huhu.
Wannan kuma yana nufin cewa dole ne su ci gaba da kulawa bayan an sallame su daga asibiti.
Har zuwa Maris 2020, ba a san ko kamuwa da cutar ya haifar da haɓakar rigakafi na dogon lokaci a cikin mutanen da suka warke daga cutar ba.
Da alama cewa wannan kariya ta kasance mai ƙarfi, dangane da yanayin sauran coronavirus, amma akwai wasu mutane da suka sake kamuwa da COVID-19 bayan an sanar da su lafiya daga coronavirus.
Wadannan mutane sun fi karɓar ƙwayoyin cuta da suka rage a jikinsu fiye da kamuwa da cutar ta biyu.
Ana ganin cewa cutar ba ta da tushe kuma ta samo asali ne daga dabbobi, kuma ana iya yada ta ta hanyar halittu.
Ba a san ainihin asalin cutar ba, amma har zuwa Disamba 2019 cutar tana yaduwa ne ta hanyar mutum zuwa mutum.
Binciken da aka yi kan marasa lafiya 41 na COVID-19, wanda aka buga a watan Janairun 2020 a cikin Lancet, ya nuna alamun cutar da suka fara bayyana a ranar 1 ga Disamba, 2019.
Hukumar Lafiya ta Duniya ta sanar da bayyanar cututtukan a ranar 8 ga Disamba, 2019.
An dauki matakai da yawa don ƙididdige yawan mutuwar.
Waɗannan ƙididdigar suna canzawa dangane da yanki, lokaci da yawan gwaje-gwajen da aka ɗauka, ƙarfin tsarin kiwon lafiya, hanyoyin kulawa, lokacin da cutar ta fara, da yanayin al'umma wanda ya haɗa da shekaru, jinsi da yanayin lafiyar jama'a.
A ƙarshen 2019, WHO ta ba da lambar ICD-10 ta cutar U07.1 ga marasa lafiya waɗanda aka tabbatar da cutar SARS-CoV-2 da lambar U07.2 ga marasa lafiya waɗanda ke da alamun COVID-19 amma ba a tabbatar da cutar SARS-CoV-2 ba.
Dangane da bayanan da Jami'ar Johns Hopkins ta bayar, yawan mutuwar duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Ƙididdiga suna canzawa ta yanki. Sauran ma'aunin sun haɗa da ƙididdigar yawan mutuwar (CFR), wanda shine ma'aunin yawan mutanen da ke da cutar da ke mutuwa daga cutar, da kuma yawan mutuwar (IFR), wanda shine ma'aunin yawan mutanen da ke da cutar (wanda aka gwada da waɗanda ba a gwada su ba) waɗanda ke mutuwa daga cutar.
Waɗannan ƙididdigar ba su dogara da lokaci ba kuma suna da alaƙa da ƙididdigar yawan mutanen da ke cikin cutar ta hanyar kulawa.
Idan duk mutanen da suka kamu da cutar ba su fara samar da rigakafi ba, bayyanar rigakafin na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A cikin cibiyar cutar da ta fara a Italiya, Castiglione d'Adda, wani karamin gari mai yawan mazauna 4,600, 80 (1.7%) sun mutu.
A Gangelt, cutar ta yadu ne ta hanyar bikin Carnival, wanda ke haifar da ƙarancin yawan masu cutar, amma ba a ba da rahoton duk mutuwar COVID-19 ba.
Bugu da kari, hukumomin kiwon lafiya na Jamus ba su karaya ba.
A cikin Netherlands, kusan kashi 3% na yawan jama'a na iya samun rigakafi, kamar yadda aka nuna a cikin masu ba da jini.
An bayar da rahoton mutuwar mutane 69 (0.004% na yawan jama'a) daga COVID-19.
Sakamakon cutar da yawan mace-mace ya bambanta tsakanin maza da mata.
Yawan mace-macen maza ya fi yawa; kamar yadda binciken da aka yi a China da Italiya ya nuna.
Maza a cikin shekaru 50 suna da haɗarin haɗari, tare da bambanci tsakanin maza da mata a cikin shekaru 90 kawai.
A ƙasar Sin, mace-macen da ke mutuwa a lokacin suna da kashi 2.8 cikin ɗari a tsakanin maza da kuma kashi 1.7 cikin ɗari a tsakanin mata.
Dalilin da ya sa ake samun bambancin jinsi ba a sani ba, amma yana iya zama saboda yanayin jiki da halayyarsu.
Bambancin tsarin garkuwar jiki tsakanin maza da mata, rashin shan taba sigari tsakanin mata da cututtukan da ke shafar maza da yawa, gami da bugun zuciya a cikin shekarun da suka gabata fiye da mata, na iya taimakawa wajen haɓaka yawan mutuwar maza.
A Turai, 57% na masu kamuwa da cutar maza ne kuma 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa Afrilu 2020, gwamnatin Amurka ba ta fara tattara bayanan da ke nuna cewa akwai wasu mutane da ke da alaƙa da jima'i da ke da alaƙa da COVID-19 ba.
Bincike game da cututtukan ƙwayoyin cuta kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Yawancin likitocin, musamman na asibiti, mata ne, kuma suna da haɗarin kamuwa da cutar.
A ranar 11 ga Fabrairun 2020, Hukumar Lafiya ta Duniya ta sanar da sunan cutar a matsayin COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana wakiltar corona, kwayar cutar VI, cutar D, kuma 19 tana nuna lokacin da aka fara cutar: 31 ga Disamba 2019.
An zaɓi sunan don hana sanya shi a cikin wani yanki (misali China), dabba ko rukuni na mutane, bisa ga ƙa'idodin lakabi na duniya don hana rashin amfani ko rashin amfani.Cutar da ke haifar da COVID-19 ita ce kwayar cutar coronavirus ta 2 (SARS-CoV-2).
WHO ta kuma yi amfani da "kwayar cutar COVID-19" da "kwayar cutar da ke haifar da COVID-19" a cikin sadarwa ta hukuma.
Dukansu cututtuka da ƙwayoyin cuta ana kiransu "coronavirus".
A Wuhan, China, an kira kwayar cutar da cutar "coronavirus" da "coronavirus Wuhan".
A watan Janairun 2020, WHO ta ba da sanarwar 2019-nCov da 2019-nCoV a matsayin sunayen wucin gadi na ƙwayoyin cuta da cututtuka a cikin aikin bin ƙa'idodin 2015 na ƙin amfani da sunayen wuri a cikin sunayen ƙwayoyin cuta da cututtuka.
An sanar da sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙarancin damar samar da kasuwa, wasu masana'antun fasaha suna samar da kayan aikin kiwon lafiya kamar su na'urorin daukar hanci, da na'urorin numfashi.
Alal misali, sa'ad da asibiti a Italiya yake bukatar na'urorin iska kuma mai kula da asibitin ya kasa zuwa a kan lokaci, wani kamfani na wurin ya yi na'urori 100 da ake bukata cikin dare ɗaya.
Bayan an gano mutum na farko da cutar COVID-19, jita-jita, ɓatarwa, da kuma rashin fahimta game da asalin cutar, ci gabanta, rigakafinta, magani da sauransu sun fara yaduwa da sauri a kan layi.
Mutane na iya yada kwayar cutar ga wasu dabbobi.
Binciken bai tabbatar da kwayar cutar ba a aladu, dabbobin gida, da kaji.
Babu magani ko allurar rigakafi da aka tabbatar da warkar da cutar.
Akwai binciken duniya kan alluran rigakafi da magungunan COVID-19 da ke gudana tare da hukumomin gwamnati, ƙungiyoyin ilimi da masana'antar bincike.
A watan Maris, Hukumar Lafiya ta Duniya ta ƙaddamar da gwajin "SOLIDARITY" don kimanta tasirin magunguna huɗu da ake zargi da cutar.
Babu riga-kafi, amma akwai cibiyoyin gwaji da yawa da ke gwada wasu alluran rigakafi.
Ana amfani da binciken farko na SARS-CoV da SARS-CoV-2 saboda duka suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin jikin mutum.
Akwai wasu magungunan rigakafi guda uku da ake bincike a kai.
Da farko, masu bincike suna son samar da cikakkiyar allurar rigakafin cutar.
Yin amfani da kwayar cutar, ko ta mutu ko ba ta aiki, yana nufin kunna tsarin rigakafin mutum don gano sabon kamuwa da COVID-19.
Mataki na biyu shine amfani da ƙananan ƙwayoyin cuta, wanda ke nufin samar da allurar rigakafi wanda ke ba da damar tsarin rigakafi ya gane kasancewar ƙananan ƙwayoyin cuta.
A cikin yanayin SARS-CoV-2, binciken ya mai da hankali kan mai mai kama da ƙaho wanda ke taimakawa kwayar cutar ta haɓaka abubuwan ACE2.
Hanya ta uku ita ce ta kwayoyin halitta (DNA ko RNA, sabon tsarin samar da allurar rigakafi).
An fara gwajin inganci da ingancin alluran rigakafin a cikin binciken. A ranar 16 ga Maris, 2020, masu aikin sa kai huɗu a Seattle sun fara gwajin allurar rigakafin.
An ba da shawarar ƙara ƙarfin rigakafi a matsayin ingantaccen hanyar samar da allurar rigakafin SARS-COV-2, amma har yanzu akwai matsala.
A watan Afrilu na 2020, an yi nazarin alluran rigakafi sama da 300.
An gudanar da gwaji bakwai akan magungunan da aka yarda dasu don maganin zazzabin cizon sauro, gami da huɗu na hydroxychloroquine ko chloroquine.
Binciken a China yana mai da hankali kan magungunan gargajiya na cututtukan ƙwayoyin cuta, tare da gwaji na Mataki na III na tara na remdesivir a cikin ƙasashe daban-daban saboda rahoton da aka shirya a ƙarshen Afrilu.
A watan Afrilu na 2020, akwai ci gaba da gwajin gwaji na COVID-19 da yawa. Yawancin magungunan da aka saba amfani da su don magance cututtukan ƙwayoyin cuta ana nazarin su don magance COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir a cakuda tare da interferon beta.
A watan Afrilu na 2020, akwai wasu shaidu masu tasowa game da ingancin remdesivir.
Marasa lafiya da aka kula da su da remdesivir sun nuna ci gaba.
Ana gudanar da gwaji na Mataki na III a Amurka, Kanada da Italiya. An gwada Chloroquine, wani magani na farko don cutar zazzabin cizon sauro, a watan Fabrairun 2020, tare da sakamakon farko.
Duk da haka, ana kiran mutane su yi wasu irin binciken.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar amfani da chloroquine.
Koyaya, Cibiyar Kula da Cututtukan Kwayar cuta ta Wuhan, yayin da take ba da shawarar amfani da gram ɗaya a rana, ta nuna cewa ninka adadin zai iya haifar da matsaloli masu tsanani da mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin wucin gadi ga likitocin da ke kula da marasa lafiya na COVID-19 don amfani da hydroxychloroquine da chloroquine a ɓoye. Umurnin Mataki na 7 ya haɗa da amfani da interferon, ribavirin ko umfenovir don magance COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar ribavirin mai yawa don magance SARS-CoV-2 kafin ya shiga cikin kwayoyin halitta.
Ana iya amfani da nitazoxanide don cutar da ta shiga cikin jiki kuma daga baya ana nazarin ta bayan gano ƙananan adadin SARS-CoV-2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba ya nuna manyan ƙuntatawa ga amfani da waɗannan magungunan ba tare da ƙarin bincike ba. Oseltamivir ba ya fitar da SARS-CoV-2 ba tare da shiga cikin jiki ba kuma ba shi da wani sanannen aiki a cikin maganin COVID-19.
Cytokines na iya haifar da matsaloli a lokacin cutar COVID-19.
Akwai wasu shaidu da ke nuna cewa hydroxychloroquine na iya haifar da cutar cytokine. Hukumar Lafiya ta Kasa ta kasar Sin ta sanya Tocilizumab a cikin jerin magunguna masu amfani bayan ƙaramin bincike.
A Italiya, ana gudanar da gwajin matakin 2 wanda ya haɗa da gwajin ƙasa bayan an sami sakamako mai kyau a cikin mutane masu fama da cutar.
Tare da gwajin jini na jini don gano cytokines, don ganin yadda suke girma, wanda ake zargi da dalilin wasu mutuwar.
A cikin 2017, FDA ta amince da amfani da masu hana masu karɓar interleukin-6 na jini bisa ga binciken da aka yi game da maganin cutar steroid ta wata hanyar, wanda ake kira maganin CAR T cell.
A yau, babu wata hujja da ke nuna cewa tocilizumab yana da tasiri a cikin maganin CRS.
Ana gudanar da bincike kan samar da rigakafi mai tsabta da kuma na asali daga tsarin rigakafin COVID-19 ga mutanen da suke buƙatar su a matsayin madadin rigakafin rigakafin da aka samo daga wani.
An gwada wannan hanyar a kan SARS amma ba ta da tasiri.
Tsarin kashe kwayar cutar shine hanyar da aka yi tunanin ta farko wanda kwayoyin cuta na mutum zasu iya haɗuwa don yaƙar SARS-CoV-2.
Amma akwai wasu hanyoyin da za a iya amfani da su, kamar su kara ko kuma kara yawan rigakafi.
Ana kuma yin wasu gwaje-gwaje na maganin rigakafi na mutum, kamar amfani da rigakafi na halitta.
Ya kamata a ƙara tsarin bayar da jini, wanda ke ɗaukar jini daga mutane masu arziki kuma yana da ƙwayoyin cuta don hana cutar daga shiga cikin jiki da sauri.
Cutar coronavirus, rukuni ne na cututtuka waɗanda ke da alamomi tara kawai.
Li Wenliang, likita a asibitin tsakiya na Wuhan, ya kamu da cutar COVID-19 kuma ya mutu bayan ya sanar da barkewar cutar.
